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General introduction 
The main topic of this Ph.D. thesis is the characterization of gene products 
identified as PLP-dependent enzymes with unknown function. A complete and 
detailed description on function and evolution of PLP-dependent enzymes is 
provided in chapter 1.  
Chapter 2 describes the molecular cloning as well as the recombinant 
expression and the initial biochemical characterization of a threonine synthase 
homolog from mouse. Finally, in chapter 3 I describe the study of two recombinant 
human proteins homolog of alanine-glyoxylate amino transferase 2. 
The last part, Appendix, reports the evaluation of small RNA-cleaving DNAs 
(ribozymes), chemically modified by means of introduction of monomers of locked 
nucleic acids (LNA), in order to improve to cleavage of long and structured mRNAs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduzione generale  
Argomento principale di questa tesi di dottorato è la caratterizzazione di 
prodotti genici identificati come enzimi PLP-dipendenti, ma aventi funzione ignota. 
Nel capitolo 1 viene data una introduzione completa e dettagliata sull’evoluzione e le 
caratteristiche degli enzimi PLP-dipendenti.  
Nel capitolo 2 sono descritti il clonaggio, l’espressione in forma ricombinante e 
l’iniziale caratterizzazione biochimica, di una protiena di topo omologa della treonina 
sintasi microbica. Nel capitolo 3 è illustrato lo studio di due proteine umane, 
omologhe dell’alanina-gliossilato amino transferasi 2. 
Nell’ultima parte, l‘Appendice, sono descritti studi su piccoli DNA ad attività 
ribonucleasica (ribozimi) modificati attraverso l’introduzione di monomeri di locked 
nucleic acid (LNA), con lo scopo di migliorare il taglio di mRNA dotati di struttura 
secondaria. 
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Summary 
Following its identification (Heyl, 1951) vitamin B6, in the form of its 
biologically active phosphorylated derivatives pyridoxal-5’-phosphate and 
pyridoxamine-5’-phosphate (Figure 1), has been subject of extensive research since 
it  represents the nature’s most versatile cofactor (Vederas,1980; John, 1995; 
Jansonius, 1998; Metha & Christen, 2000; Schneider, 2000; Christen & Metha, 
2001). 
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Figure 1. Chemical structures of vitamin B6 (B6), pyridoxal-5’-phosphate (PLP), 
pyridoxamine-5’-phosphate (PMP). 
 
In fact, enzymes that use as cofactor pyridoxal-5’-phosphate (also called PLP-
dependent enzymes) are unrivalled in the diversity of reactions that they catalyze, 
and show a widespread involvement in cellular processes. Versatility arises from the 
ability of pyridoxal-5’-phosphate to covalently bind the substrate and then to function 
as an electrophilic catalyst, thereby stabilizing different types of carbanionic reaction 
intermediates (Vederas, 1980; John, 1995; Schneider, 2000).  
The functional diversity of PLP-dependent enzymes is illustrated by the fact 
that more than 140 distinct enzymatic activities catalogued by the Enzyme 
Commission (EC) are PLP dependent, corresponding to about 4% of all classified 
activities (Figure 2).  
Almost all of these enzymes, with the exception of glycogen phosphorylase 
(Palm, 1990), are associated with biochemical pathways that involve amino 
compounds, mainly amino acids. Generally the reactions carried out by these 
enzymes that act on amino acids include transfer of the amino group, 
decarboxylation, interconversion of L- and D-amino acids, and elimination or 
replacement of chemical groups bound at the β- or γ-carbon.  
Thanks to the amount of genomic information that has accumulated over the 
past few years, new genes have been identified as encoding PLP-dependent 
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enzymes, but a substantial fraction of these putative PLP-dependent enzymes 
remain functionally unclassified or only tentatively classified. For example, about of 
20% of the putative PLP-dependent enzymes, encoded by the human genome, has 
not been assigned to an activity; moreover, more than one-third of all PLP-dependent 
enzymes classified by the EC are still uncharacterized (Christen & Metha, 2001; 
Percudani & Peracchi, 2003).  Therefore, the characterization of putative PLP-
dependent enzymes, together with the discovery of proteins for the “orphan” 
activities, represent fundamental challenges for the enzymologists, ensuing from the 
recent flood of genomic sequences. 
Percudani & Peracchi, EMBO Report, Vol.4, No. 9
 
Figure 2. The catalytic versatility of the PLP-dependent activities classified is illustrated by a 
set of concentric pie charts (Thornton, 2000). Sector are coloured according to EC classes 
(1, oxoreductases; 2, transferases; 3, hydrolases; 4, lyases; 5, isomerases; 6, synthases). Of 
six general classes, five include pyridoxal-5’-phosphate (PLP)-dependent enzymes. The 
circles, from inner to outer, represent the first, second, third and fourth levels in the EC 
hierarchy. The angle substended by any segment is proportional to the number of activities it 
contains, making it clear that aminotransferases (EC 2.6.1) constituite the largest group of 
PLP-dependent enzymes.  
 
My thesis work has focused on three putative PLP-dependent enzymes. Here, 
I will describe the preliminary bioinformatic analysis, the cloning of the cDNA 
encoding these proteins and the initial characterization of the purified recombinant 
proteins, with the goal to clarify their real activity. 
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Catalytic mechanism of PLP-dependent enzymes 
A key feature that has emerged from the investigations of PLP-dependent 
enzymes is the versatility of the coenzyme in supporting very distinct catalytic 
actions. Although these enzymes are able to perform a host of different reactions on 
amino acids, there is a simple unifying principle explaining their mechanistic 
versatility (Figure 3). The first and common step for all PLP-dependent enzyme-
catalyzed reactions is a Schiff base exchange reaction (transimination). Nearly all 
known PLP enzymes exist in their resting state as a “internal” aldimine, in which PLP 
is bound covalently via an imine bond to the ε-amino group of an active-site lysine 
residue.  
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Figure 3. Transformations of amino acids by PLP-dependent  enzymes. (1) Amino acid 
substrate. (2) “Internal” aldimine intermediate in which PLP has formed a Schiff base with the 
ε-amino group of an active-site lysine residue. (3) “External” aldimine intermediate. 
Thereafter, the reactions diverge, as shown . Formation of the planar pyridine-aldimine Schiff 
base 3 is a prerequisite for the catalytic efficacy of PLP, which is due to the electron-
withdrawing effect exerted on Cα by the positively charged imine group and pyridine nitrogen 
atom and mediated through the extensive resonance system of the pyridine ring and the 
imine double bond. 
 
In the first covalency change, the amino group of the incoming substrate 
replaces the lysine ε-amino group, forming a coenzyme-substrate Schiff Base 
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(external aldimine). This is a multiphasic process that includes several facile steps 
and is frequently very rapid compared to the central steps in the reaction mechanism 
(e.g., deprotonation of the substrate) (Figure 4). This “external” aldimine is the 
common central intermediate for all PLP-catalyzed reactions,  enzymatic and 
nonenzymatic. Divergence in reaction specificity occurs from this point onward: 
depending on which bond at Cα is cleaved, one of the various reactions catalyzed by 
PLP-dependent enzymes can occur. Rupture of the covalent bonds involving Cα is 
possible because the coenzyme acts as an electron sink, stabilizing the negative 
charge development at Cα (carbanion) in the transition state, by delocalization 
through the pi system of the cofactor (Metha & Christen, 2000). In this way the 
electrons are stored from cleaved substrate bonds and subsequently dispensed for 
the formation of new linkages with incoming protons or second substrates. The 
completely formed carbanion is named quinonoid intermediate. This quinonoid 
resonance structure is commonly considered the major species responsible for the 
catalytic power of PLP, since the electrons from Cα are neutralized by the protonated 
pyridine nitrogen. In conclusion, the electron sink properties of pyridoxal 5’-
phopshate are exploited to endow the holoenzyme with a variety of reaction types. 
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Figure 4. Principal resonance forms obtained from deprotonation of an aldimine 
intermediate. The quinonoid resonance form is labeled. 
 
The multitude of reactions catalyzed by PLP-dependent enzymes can be 
divided according to the position at which the net reaction occurs. Reactions at the α 
position include transamination, decarboxylation, racemization, and elimination and 
replacement of an electrophilic R group (Figure 5).  
Those at the β or γ position include elimination or replacement (Figure 6). 
Exceptions to these common types include the formation of a cyclopropane ring from 
S-adenosyl-L-methionine (SAM), catalyzed by 1-aminocyclopropane-1-carboxylate 
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(ACC) synthase (Adams, 1979), and the cleavage of ACC to α-ketobutyrate and 
ammonia, catalyzed by ACC deaminase (Walsh,1981). 
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Figure 5. Examples of mechanism of reactions involving net change at the α position. All 
reactions are shown starting with the substrate aldimine, which is formed by 
transaldimination of the lysine-bound PLP. Racemization: the bacterial alanine racemase 
utilizes a tyrosine residue (Shaw, 1997; Sun, 1999) to deprotonate L-alanine, forming the 
quinonoid intermediate, which is reprotonated by a lysine residue on the opposite face of the 
cofactor to produce D-alanine. Decarboxylation: the reaction begins with loss of CO2 from the 
substrate aldimine, producing the quinonoid intermediate. Protonation by an unidentified 
active site residue in ornithine decarboxylase generates the product aldimine. α-
Replacement: the well-studied serine hydroxymethyltransferase (Rao, 2000) initiates the 
retro-aldol cleavage of serine by deprotonation of the hydroxyl group. Formaldehyde is 
released to generate the quinonoid intermediate. Protonation of the quinonoid at Cα by the 
lysine produces the aldimine of the product glycine. Transamination: the first half-reaction 
catalyzed by tyrosine aminotransferase involves initial proton abstraction from the glutamate 
aldimine Cα by the active site lysine, yielding the quinonoid intermediate. Reprotonation at 
C4’ of the cofactor by that lysine generates the ketimine intermediate, which is subsequently 
hydrolyzed to release α-ketoglutarate, leaving the enzyme in PMP form. A complete catalytic 
cycle involves subsequent reaction with hydroxyphenylpyruvate to give tyrosine and to 
regenerate the PLP form of the enzyme. 
 
Due to their common mechanistic features, PLP-dependent enzyme often 
show “catalytic promiscuity”, that is, the ability of a single enzyme to catalyze different 
chemical reactions (O’Brein & Herschlag, 1999; Jeffery, 1999).  
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For example, L-serine racemase catalyses the deamination of L-serine at a 
rate similar to that of serine racemization (Strisovoky, 2003).  
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Figure 6. Examples of mechanism of reactions at the β and γ positions. β-Replacement: 
tryptophan synthase (Miles, 2001) catalyzes a net β-replacement by first deprotonating the 
serine aldimine at Cα, producing the quinonoid intermediate. Protonation of the hydroxyl 
group by the active site lysine promotes its elimination, generating the aldimine of amino 
acrylic acid. Indole adds to Cβ to form a second quinonoid that is subsequently protonated at 
Cα to generate the product aldimine. γ-Replacement: in the cystathionine γ-synthase-
catalyzed γ-replacement reaction (Brzovic, 1990), O-succynil homoserine is deprotonated at 
Cα to produce the quinonoid intermediate that is subsequently protonated at C4’ of the 
cofactor to give the ketimine intermediate. Proton abstraction at Cβ by an unknown active 
site base results in elimination for the succinyl group, which may occur in either a step-wise 
or concerted (shown) manner. Michael addition of cysteine to the β,γ-unsatured ketimine and 
subsequent proton transfers yield a second quinonoid intermediate that is protonated at Cα 
to form the product aldimine. 
 
In addition, PLP-dependent enzymes may have non-strict substrate specificity 
(Han, 2001). A good example is threonine synthase (EC 4.2.3.1), the last enzyme of 
the threonine biosynthetic pathway. This enzyme catalyzes L-threonine formation 
from L-homoserine phosphate and also from DL-vinylglycine (Laber, 1994). 
Furthermore, threonine synthase shows “catalytic promiscuity”, since it can catalyze 
β-elimination reactions with L-serine, DL-3-chloroalanine, L-threonine, and L-allo-
threonine as substrates to yield pyruvate or alpha-ketobutyrate, while L-alanine, L-2-
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aminobutanoic acid, and L-2-amino-5-phosphonopentanoic acid are substrates for 
half-transamination reactions to yield the pyridoxamine form of the enzyme and the 
corresponding alpha-keto acid. 
 
Reaction specificity in pyridoxal phosphate enzymes 
All reactions catalyzed by PLP-dependent enzymes are assumed to take 
place, very slowly, with substrates and PLP in the absence of the apoenzyme. 
Considering that PLP enzyme-catalyzed reactions corresponding to the 
nonenzymatic ones were shown to follow the same basic chemical mechanism, the 
determinants of reaction type specificity have to be shared.  
In 1966 Dunathan proposed that the topology of the amino acid aldimine 
determined which bond to Cα  would be broken (Dunathan, 1966). He postulated that 
the bond to be broken in the substrate-cofactor complex has to be perpendicular to 
the pyridine ring of the cofactor in the transition state of the reaction (Figure 7). It 
is in this conformation that the breaking σ bond achieves maximal orbital overlap with 
the pi system (Corey,1956). This suggest that stereoelectronic effects play a major 
role because enzymes can very specifically orient one bond such that the nascent p 
orbital is aligned with those of the conjugated Schiff base/pyridine ring pi system. The 
bond so oriented would be selectively labilized.  
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Figure 7. The Dunathan stereoelectric hypothesis. Substrates are bound to PLP such that 
the bond to Cα that is to be broken is aligned with the pi orbitals of the cofactor. Control of 
the substrates orientation thus enables the enzyme to distinguish among the reactions type.  
 
In the absence of enzyme the rate of racemization and hydrogen exchange at 
the α carbon of amino acid-pyridoxal Schiff bases is determined by the proportion of 
aldimine substrate having the Cα-Hα bond orthogonal to the pi system (Tsai, 1978). 
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This model has been confirmed later, after the aspartate 
aminotransferase/phosphopyroxyl aspartate complex was solved (Kirsch, 1984). 
Ever since all the determined structures were in accord with Dunathan’s hypothesis. 
Thus, the ensuing carbanion is stabilized by conjugation with the extended pi system.  
The role of the enzyme active site residues is to provide a rate enhancement 
and specificity which is unattainable in their absence. Certainly their major functions 
must include increased acid-base catalysis (Rios, 2000), anchoring of the phosphate 
group (Denessiouk, 1999), and recognition of the correct reaction partners (John, 
1995), in order to enforce catalytic power as well as enhance selectivity of substrate 
binding, determining which of the many potential pathways is adopted by the 
coenzyme-substrate complex. 
 
Spectroscopic properties of PLP-dependent enzymes 
The absorption spectra PLP has been the subject of numerous studies 
(Metzler, 1980; Metzler, 1988). PLP shows in water a deep yellow colour and an 
absorption band at ∼390 nm.  
These features can be used to study the activity of a generic PLP-dependent  
enzyme. Usually, PLP-containing enzymes have still a deep yellow colour, but the 
absorption bands range from 412 to 435 nm. Furthermore, a minor band can appear 
at  ∼330-340 nm.    
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Figure 8. Tautomerism of Schiff bases of PLP.  The absorption peak is shown for each 
tautomer form.  
 
These two bands can be explained by the fact that the Schiff bases of PLP 
can exist in several different tautomeric forms. The predominant  resonance form of 
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those species, having an unprotonated phenolic oxygen and a protonated imino 
group, is the ketoenamine structure, that is in equilibrium with the corresponding 
enolimine tautomer (Figure 8).  
Since the enzyme-bound cofactor as well as certain PLP-derived reaction 
intermediates are known to have distinctive UV-visible absorption maxima, their 
spectrophotometric detection is used as a probe for substrate identification. Moreover 
in some cases it’s also possible to identifiy kinetically competent intermediates in the 
PLP-enzyme catalyzed reactions. For example, the substrate specificity of a 
threonine synthase from E.coli, has been evaluated by looking the changes in the 
absorption spectra of the native enzyme (Figure 9) (Laber, 1994).  
In the absence of substrates the spectrum of threonine synthase (EC 4.2.99.2) 
showed absorbance maxima at 333 and 416 nm, beside the protein absorption at 
279 nm. Spectra taken about 10s after mixing with homoserine phosphate showed a 
sharp increase in absorbance at 448 nm and a broad shoulder extending from 460 to 
510 nm, typical of a quinonoid intermediate.  
 
 
Laber et al., Biochemistry 1994, Vol.30, No.11
 
 
Figure 9. Absorbance spectra for the reaction of 20.0µM threonine synthase with 40mM L-
homoserine phosphate in 50mM potassium phosphate buffer, pH 7.2, containing 0.15 M KCI. 
Spectra were collected 0.2 (l), 2.7 (2), 4 (3), 8 (4), 120 (S), 240 (6), 360 (7), 495 (8), and 675 
(9) min after mixing. 
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¥Exceptions to the general rule, however, include cases where substrate association or product 
dissociation is rate-determining for good substrates, whereas chemistry is rate-determining for poor 
substrate (Herschlag, 1988). In addition, the induced fit can decrease specificity if the two 
substrates induce different active conformations (Post, 1995). 
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Furthermore, it was possible to follow directly the formation of the product, because 
both maxima decrease in intensity with time, and after the absorbance at 448 nm finally 
reached a constant value, the absorbance in the region of 300-350 nm and below 280 nm, 
which is characteristic for of α-keto acids, started to increase slowly.  
This is one of the multitude of examples in literature that capitalize the 
spectroscopic properties of the cofactor to study PLP-dependent enzymes. 
 
Role of the closed conformation 
As it happens with many enzymes not containing PLP as cofactor, an important 
features of a PLP-dependent enzyme, is the possibility of conformational changes after the 
substrate binding, or “induced fit”. The contribution of induced fit to enzyme specificity has 
been much debated and refined over the years, albeit with a remarkable absence of 
experimental data.  
The “induced fit theory” provides a mechanism for substrates discrimination, 
whereby, a good substrate induces an enzyme to adopt an active conformation, whereas a 
poor substrate cannot facilitate this conformational change (Koshland, 1958).  
Now it is accepted that a conformational change induced only by certain substrates 
does not necessarily result in increased specificity for those substrates.  
Thus, it has been argued that the conformational change observed in aspartate 
aminotransferase and many other PLP enzymes does not contribute to their substrate 
specificities (Hayashi, 1995).¥  
Since it has been shown that release of the product oxoalacetate is partially rate 
determining for the reaction of aspartate aminotransferase with aspartate and α-
ketoglutarate (Goldberg, 1996), aspartate aminotransferase is an example of an induced fit 
enzyme in which the conformational change may contribute to substrate specificity. It is 
not yet clear whether this conclusion extends to other PLP enzyme. 
In contrast to the debated potential contribution of induced fit to substrate specificity 
(Pasternak, 2001), the closure of an active site upon substrate binding can certainly 
participate to reaction type specificity.   
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Wolfenden pointed out the advantages of a closed conformation that makes more 
contacts with the bound substrate than are possible in a conformation from which the 
substrate can to dissociate (Wolfenden, 1974). Thus, greater control over proton transfer 
and solvent accessibility provided by the closed conformation can favor specific reactions.  
A well-studied example is serine hydroxymethyltransferase, a PLP-dependent 
enzyme which catalyzes a variety of side reactions (transamination, decarboxylation, 
racemization, etc.) when presented with substrates other than serine.  
The open form of the enzyme is unable to discriminate between the various reaction 
types in the way that the closed form can (Schirch, 1991). Therefore, these reactions 
occur, at least in part, because the substrates in question do not induce the closed 
conformation.  
 
Dual specificity of aminotransferase 
Because the aminotransferase reaction requires two different substrates to bind in 
succession to the same cofactor in the active site, these enzymes must be able to 
accommodate both structures while discriminating against all others.  
One possible solution would be for the PLP itself to move between two different 
substrate binding sites, but such movement has never been observed.  
An alternative is to take advantage of flexible side chains to position the functional 
groups into exclusive binding sites. This is the case for histidinol phosphate 
aminotransferase, which reacts with both histidinol phosphate and glutamate. The 
structures of substrate complexes of this enzyme (Haruyama, 2001) show that, although 
the phosphate and carboxylate groups interact primarily with the same arginine residue, 
the side chains of the two substrates have separate binding sites (Figure 10).  
Most known aminotransferases, however, employ strategies for binding both 
substrates in the same site. Because aminotransferases many use the common substrate 
glutamate (thereby linking other amino acids to the cellular nitrogen pool), the problem of 
dual specificity is generally that of accommodating the negatively charged γ-carboxylate of 
glutamate in a site that must also accept a neutral or positively charged side chain.  
Two common solutions to this problem have been found: the use of an arginine 
switch and  an extended hydrogen bond network. 
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Figure 10. Dual specificity of histidinol phosphate aminotransferase. The phosphate of histidinol 
phosphate and the 1-carboxylate group of glutamate bind in the same site, although and additional 
arginine does interact with the phosphate group. In contrast, the oppositely charged imidazole and 
carboxylate side chains occupy spatially distinct sites and interact with different protein residues. 
The enzyme thus recognize each substrate specifically. 
 
 
Arginine switches 
The first example of an arginine switch was observed in an engineered enzyme that 
was constructed by introducing six mutations into aspartate aminotransferase. These 
changes substantially increased activity toward aromatic substrates (Onuffer, 1995). The 
subsequent determination of the structure of the mutant enzyme (Malashkevich, 1995) 
showed that the large aromatic substrates are accommodated by movement of Arg292 out 
of the active site. Dicarboxylate substrates bind their β- and γ-carboxylate by directly 
interacting with this arginine through a bidentate hydrogen bond/ion pair in the canonical 
aspartate aminotransferase (Figure 11). The position of Arg292 is locked in aspartate 
aminotransferase, thus substrates lacking a carboxylate side chain are effectively 
excluded.  
More recently, direct evolution techniques have been used to broaden the substrate 
specificity of aspartate aminotransferase to include branched chain (Yano, 1998) or 
aromatic amino acids (Rothman, 2003). Crystal structures of mutants with increased 
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activity toward branched chain amino acids (Oue, 1999; Oue, 2000) indicated that they 
also have acquired the ability to switch Arg292 out of the active site when uncharged 
substrates are bound, indicating that this trait is easily induced in aspartate 
aminotransferase and is crucial for dual specificity. 
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Figure 11. Schematic of the arginine switch in aminotransferases that react with both dicarboxylic 
and aromatic amino acids. The γ-carboxylate of glutamate (left) interacts closely with Arg292. This 
residues reorients to point out the active site when aromatic substrates bind (right). This movement 
allows the enzyme to accept both types of substrates. 
 
Arginine switches are not unique to engineered enzymes. Tyrosine (aromatic) 
aminotransferase is a well-characterized enzyme that has natural specificity for the 
aromatic amino acids tyrosine, phenylalanine, and tryptophan, as well as for the 
dicarboxylic amino acids aspartate and glutamate.  
A number of structures are now available of the Paracoccus denitrificans tyrosine 
aminotransferase that clearly demonstrate the arginine switch (Okamoto, 1998; Okamoto, 
1999).  
Crystallographic and modelling studies illustrated a similar strategy employed by the 
GABA (Toney, 1995; Storici, 1999) and ornithine (Storici, 1999) aminotransferase, which 
react with both ω-amino acid substrates, and with the common substrate glutamate. GABA 
aminotransferase, like aspartate aminotransferase and tyrosine aminotransferase, binds 
the dicarboxylic acid substrate via two conserved arginines. The carboxylate of the ω-
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amino acid, GABA, occupies the same position as the γ-carboxylate of glutamate, thereby 
taking advantage of the similar distance between the amino and carboxylate groups of 
GABA and the amino and γ-carboxylate groups of glutamate. The second arginine 
(equivalent to Arg386 of aspartate aminotransferase) moves to interact with a conserved 
glutamate near the active site (Figure 12). 
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Figure 12. Schematic of the arginine switch in GABA aminotransferase. As in the case of 
Aspartate amino transferase, GABA aminotransferase binds the dicarboxylic acid substrate 
glutamate via two conserved arginines. In order to accommodate GABA, Arg445 moves away from 
the cofactor to engage in a salt bridge with a nearby glutamate residue. 
 
 
Hydrogen bond networks 
Arginine switches,  however are not ubiquitous, even among tyrosine 
aminotransferases. Early sequence alignments indicated that a subgroup of 
aminotransferase lack an Arg292 equivalent (Jensen, 1996).  
One of the structures available for a tyrosine aminotransferase of this group is that 
of the unliganded Pyrococcus horikoshii enzyme (Matsui, 2000). Modeling of the 
substrates in the active site suggests that this enzyme binds glutamate via an extended 
hydrogen-bonding network, as has been observed in the aspartate aminotransferase from 
this same organism (Figure 13)  (Ura, 2001).  
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Figure 13. Dual substrate specificity can also be achieved by hydrogen bond rearrangement. 
Pyrococcus horikoshii TATase binds the γ-carboxylate of glutamate via hydrogen bond network 
rather than an arginine residue. Direct interactions are made with a threonine residue and a tightly 
bound water molecule. Modeling of bound tyrosine suggests that the hydrogen bond network 
rearranges, so that the aromatic ring stacks against a nearby tyrosine residue, as well as makes a 
hydrogen bond to the same threonine residue that is involved in glutamate association. 
 
The absence of a positively charged residue in this tyrosine aminotransferase 
makes it much easier to accommodate the uncharged substrates by simple rearrangement 
of the hydrogen bond network.  
The solved structures of the E.coli branched chain amino acid aminotransferase 
(BCAT) (Hayashi, 1993) show that this enzyme also takes advantage of different hydrogen 
bond interactions. BCAT reacts with the branched chain amino acids isoleucine, leucine, 
and valine, as well as with glutamate.  
The hydrophobic substrates and glutamate all bind in the same site, which is a 
hydrophobic pocket consisting largely of aromatic residues. 
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Figure 14. Dual substrate recognition by branched chain amino acid aminotransferase. The 
substrate binding pocket is composed primarily of aromatic residues, and the hydrophobic 
substrate isoleucine is surrounded by five of them, only three of which are shown (Phe36, Tyr164, 
and Tyr31). The longer glutamate substrate extends far enough to form hydrogen bonds with the 
hydroxyl groups of two tyrosines and the guanidinio group of an arginine residue.  
 
In contrast to the tyrosine aminotransferase, there is no large–scale rearrangement 
of the H-bond network to accommodate the charged substrate. Instead, the glutamate side 
chain, which is slightly longer than that of the other substrates, protrudes into a pocket 
where four residues form hydrogen bonds with the carboxylate.  
The arginine in this case forms with the substrate only a monodentate interaction 
rather than the bidentate H-bomd network seen in other enzymes, and it is extensively H-
bonded to neighboring residues, allowing it to remain in position when the small 
hydrophobic substrates are bound (Figure 14).  
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Structural diversity in PLP-dependent enzymes 
PLP enzymes were for a time underrepresented in protein structure databases 
(John, 1995), but the situation has changed in recent years, as an abundance of new 
structures have been solved. Although it was initially postulated that the structures of PLP 
enzymes would correlate with the reaction type (Alexander, 1994), it has since been 
realized that each of the major structural classes contains representatives of multiple 
reaction types. The fact that completely different folds are utilized as a scaffold for PLP 
catalysis indicates that enzymes based on this cofactor has emerged at several occasions 
during evolution.  
 
(a) (b)
(c) (d)
(e)
 
Figure 15. Examples of the five known pyridoxal-5′-phosphate (PLP) binding folds. Secondary 
structure elements are color coded: in the PLP-binding domains β strands are shown in dark blue 
and α helices in yellow; for other domains β sheets are in cyan and α helices in orange. PLP, 
bound covalently to the sidechain of the catalytic lysine residue, is shown in red. The topology 
diagrams are adapted from the Tops database. (a) Diamino-pelargonic acid synthase from E. coli 
(PDB code 1qj5), a representative of the fold-type I family. (b) Tryptophan synthase (PDB code 
1ubs), fold-type II. (c) Alanine racemace (PDB code 1sft), fold-type III. (d) d-Alanine 
aminotransferase (PDB code 1daa), fold-type IV. (e) Glycogen phosphorylase (PDB code 1gpb), 
fold-type V; for clarity, only the C-terminal PLP-binding domain is shown. In addition, an α helix 
from the N-terminal domain (shown in orange) interacts with the pyridine ring of PLP and is 
included in the fold diagram. 
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The vast majority of PLP-dependent enzymes whose structures are available, can 
be subdivided into five independent fold-types (Grishin, 1995; Schneider, 2000) , that are, 
the fold-type Ι with aspartate aminotransferase as prototype enzyme (or aspartate 
aminotransferase family), the fold-type ΙΙ with tryptophan synthase β as prototype (or 
tryptophan synthase β family), the fold-type ΙΙΙ with alanine racemase family (or alanine 
racemase family), the fold-type ΙV with D-alanine aminotransferase as prototype (or D-
alanine aminotransferase family), the fold-type V with glycogen phosphorylase (Figure 
15).  
While the five enzyme folds are unrelated with each other, a few features in the 
interactions of PLP with the active site are conserved. In all cases, the phosphate group is 
bound to the N terminus of an α helix, and a covalent Schiff-base linkage is used to anchor 
the cofactor to the enzyme in the resting state. In four of five folds, the catalytic lysine 
residue is located in the connection between a β strand and the following α helix. 
Moreover, other new fold-types have been discovered: the fold-type VΙ and the 
fold-type VΙΙ with as prototype enzymes, respectively, the D-Lysine-5,6-aminomutase and 
the Lysine-2,3-aminomutase.  
 
Fold-type Ι: The aspartate aminotransferase family 
The majority of known structures belong to this fold-type, a group that includes the 
structurally best characterized PLP enzymes. The aspartate aminotransferase is not only 
the largest but also the functionally most diverse family.  
The enzymes in this class invariably function as homodimers, but in some cases 
assemble into larger complexes. Each subunit folds into two domains, with two active sites 
per dimer.  
Each monomer consists of a large domain, in which the central feature is a seven-
stranded β sheet, and of small domain, comprising the C-terminal part of the chain, which 
folds into a three- or four-stranded β sheet covered with helices on one side.  
The N-terminal part of the chain does not have a common fold within this class but 
often contributes to the small domain.  
PLP is covalently attached to the large domain via the ε-amino group of a lysine 
residue at the N-terminus of a short helix following a β strand. The phosphate is anchored 
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to the N terminus of another a helix on the other side of the β sheet such that the aromatic 
ring of PLP packs against the neighbouring β strands.  
The active site lies at on the dimer interface and residues from both domains and 
both subunits are involved in cofactor binding.  
A multiple structural alignment including ten different enzymes within the family of 
fold-type Ι enzymes (Kack, 1999) showed that, in general terms, the subunits are of 
course similar within this structural family. Despite their similar folds, however, only five 
segments, corresponding to β strands β4, β7, β8, β9 and β10 in diamino pelargonic acid 
synthase, are strictly superimposable between these enzymes.  
In addition, an analysis of the pairwise structurally aligned enzymes provided a 
basis for evaluation of evolutionary relationships within this fold-type. This analysis 
suggested that the fold-type Ι enzymes can be divided into six subclasses, of which three 
are aminotransferase subclasses (Grishin, 1995; Metha, 1993). This classification 
correlates with the structure of the N-terminal part of the chain, which folds similarity within 
a subclasses, but shows entirely different conformations between the subclasses (Kack, 
1999).  
Based on difference in the structure of the N-terminal part, two further subclasses 
can be defined: the serine hydroxymethyltransferase subclass and the 3-amino-5-
hydroxybenzoic acid synthase subclass (Schneider, 2000).  
Superposition of the fold-type Ι enzymes reveals that the location of the cofactor in 
the active site of these enzymes is virtually identical. However, this comparison suggests 
that the active-site lysine residues are not structurally conserved (Kack, 1999). In the 
subclass 2 aminotransferases this residue occurs one position earlier in the polypeptide 
chain than in the other fold-type Ι enzymes, suggesting a deletion in the ancestral 
subclass 2 aminotransferase. Instead, the only structurally and functionally conserved 
residue within this fold-type family is an aspartic acid residue that interacts with the 
pyridine nitrogen, indicating its importance for catalysis.  
Enzyme-cofactor interactions of importance for the mechanism in aspartate 
aminotransferase, such as parallel stacking of the pyridine ring from the re side and the 
hydrogen-bond network to phenolic oxygen, are not conserved.  
These discrepancies suggest that different means are used to tune the catalytic 
process in the different subclasses.  
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Fold-type ΙΙ: The tryptophan synthase β family 
This family includes among other enzymes the tryptophan synthase β subunit 
(Hyde, 1988), threonine deaminase (Gallagher, 1998) and Threonine synthase (Lambert, 
1998).  
Tryptophan synthase fold into an α2β2 tetramer, where β is the catalytic PLP-binding 
subunit and α is a regulatory subunit. Threonine deaminase, active as a homodimer, 
similarity contains one regulatory domain and one PLP-binding, catalytic domain; however, 
these two domains are accommodated within one subunit of the enzyme.  
The PLP-binding regions in these enzymes share the same fold and consist of two 
domains of about equal size: an N-terminal domain containing a four-stranded sheet 
surround by helices; and C-terminal domain built up by a six-stranded sheet with flanking 
helices.  
The active site is accommodated in a cleft formed between the C-terminal ends of 
the two β sheets. PLP is bound to an active site lysine residue, which is located at the 
beginning of an α helix just after a strand in the N-terminal domain.  
The phosphate group binds to the N terminus of another helix in the C-terminal 
domain, which positions the aromatic ring of PLP at a cross-over connection in this β 
sheet.  
The cofactor is bound in the same orientation as in the aspartate aminotransferase 
(i.e., with the re face towards the solvent). In these enzymes, a serine residue coordinates 
the pyridine nitrogen, rather than the aspartic acid used in the aspartate aminotransferase 
family. 
 
Fold-type ΙΙΙ: The alanine racemase family 
Alanine racemase (Shaw, 1997), eukaryotic ornithine decarboxylase (Kern,1999), 
and a putative PLP-dependent enzyme (Eswaramoorty, 1999) are the only members of 
this family with known three-dimensional structure. Other enzymes such as prokaryotic 
diaminopimelate decarboxylase, and biosynthetic arginine decarboxylase have been 
assigned to this class on the basis of similarities in primary sequence (Grishin, 1995).  
Alanine racemase is a homodimer in which each subunit folds into two domains, an 
eight stranded α/β barrel and a domain mainly comprising β strands.  
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PLP binds at the mouth of the α/β barrel in a cleft formed between the two domains. 
The active-site lysine is located at the C-terminal end of the first strand where it turns into 
the proceeding helix.  
The phosphate group of PLP interacts with the N terminus of the last helix of the α/β 
barrel. Contrary to the PLP-dependent enzyme classes described above, PLP binds with 
its re side facing the protein.  
The sidechain of an arginine residue forms a hydrogen bond to the pyridine 
nitrogen, indicating that protonation of the pyridine nitrogen is not crucial for catalysis in 
these enzymes. An arginine residue at this position was also observed in a putative PLP-
dependent enzyme identified in yeast (Eswaramoorty, 1999).  
In the mammalian ornithine decarboxylases, however, the environment of the PLP 
resembles that in the aminotransferases, with a hydrogen-bond interaction to an acidic 
glutamic acid residue (Kern,1999). 
 
Fold-type ΙV: The D-amino acid aminotransferase  family 
This class presently has only two members with known three-dimensional structure: 
D-amino acid aminotransferase (Sugio, 1995) and branched-chain aminotransferase 
(Okada, 1997). Goldsmith and colleagues (Grishin, 1995) also assigned 4-amino-4-
deoxychorismate lyase to this class.  
The fold-type ΙV enzymes are superficially similar to fold-type Ι and ΙΙ. The fold 
consists of a two-domain structure with the active site located at the domain interface. Two 
identical subunits form a catalytically competent dimer; however, branched-chain 
aminotransferase further assembles into a hexamer.  
The smaller N-termianl domain contains a six-stranded antiparallel β sheet with two 
α helices on one side. In the larger C-terminal domain, two four-stranded β sheets form a 
pseudo-β-barrel that is surrounded by a few helices.  
The active-site lysine is situated in a loop between the first strand in the barrel and a 
following helix. The phosphate interacts with the N terminus of an α helix in the same 
domain.  
The cofactor binds with its re side facing the protein rather than the active-site 
pocket as in the fold-type Ι family, accounting for the difference in stereochemistry of the 
products in the reaction of D-amino acid aminotransferase. A glutamic acid sidechain 
forms a hydrogen bond to the pyridine nitrogen.  
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The active site of D-amino acid aminotransferase is virtually a mirror image of the 
active site of the fold-type Ι aminotransferases, and these two enzyme families provide an 
excellent example of convergent evolution (Sugio, 1995). 
 
Fold-type V: The Glycogen phosphorylase  family 
The crystal structure of glycogen phosphorylase was the first structure of a PLP-
binding enzyme to be determined (Weber, 1978; Sprang & Fletterick, 1979). In members 
of this class of enzymes, PLP does not act as an electrophilic catalyst, but instead its 
phosphate group participates in proton transfer. However, because glycogen 
phosphorylase binds PLP in a very specific manner and PLP is used for catalytic purposes 
this enzyme can be included in the superfamily of vitamin B6 dependent enzymes.  
Glycogen phosphorylase is a multidomain protein consisting of an N-terminal 
domain of approximately 310 residues, a glycogen-binding domain spanning 160 residues, 
and a C-terminal domain of about 360 residues. The C-terminal domain has a 
dinucleotide-binding fold and binds the cofactor PLP. The phosphate group interacts with 
the N terminus of an α helix that also harbours the active-site lysine residue one turn 
further down the helix. No hydrogen bonds are made from the protein to the pyrimidine 
nitrogen. 
 
Two new fold-type families:  D-Lysine-5,6-aminomutase & Lysine-2,3-aminomutase  family 
Recently have been identified two new PLP-dependent enzymes that do not fall into 
the five fold-type categories described above and do not resemble any of the known PLP-
dependent enzymes, the D-Lysine-5,6-aminomutase (5,6-LAM; Berkovitch, 2004) and the 
Lysine-2,3-aminomutase (2,3-LAM; Lepore, 2005), representing respectively the Fold-type 
VΙ  and Fold-type VΙΙ.   
 
Fold-type VΙ: The D-Lysine-5,6-aminomutase  family 
The D-Lysine-5,6-aminomutase, it is an adenosylcobalamin and pyridoxal-5’-
phosphate dependent enzyme that catalyzes a 1,2 rearrangement of the terminal amino 
group of DL-lysine and of L-β-lysine. 5,6-LAM cannot be placed into any of five PLP 
enzyme families, although it does share features with fold types II, III, and IV. 
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The overall structure of 5,6-LAM is an α2β2 tetramer (Baker , 1973) that can be 
thought of as a dimer of αβ units. The large α subunit (538 residues) is composed of the 
PLP-binding TIM barrel domain and several additional α-helices and β-strands at the N 
and C termini. The small β subunit (262 residues) comprises two domains: the N-terminal 
dimerization domain, which has the same fold as the Cu-binding domain of the Alzheimer’s 
disease amyloid precursor protein (Protein Data Bank ID code 1OWT), and the AdoCbl-
binding Rossmann domain, which also provides the imine bond to PLP. The Rossmann 
domain interacts with the C terminus of the TIM barrel, placing PLP into the top of the 
barrel while projecting AdoCbl to the edge of the barrel, far from the PLP-binding site. 
The distinctive feature among all PLP-dependent enzymes for the D-Lysine-5,6-
aminomutase is that the imine linkage is formed to the Rossmann domain rather than to a 
lysine of the TIM barrel. 
 
Fold-type VΙΙ: The Lysine-2,3-aminomutase  family 
Lysine-2,3-aminomutase, the only members of this family, catalyzes the 
interconversion of L-α-lysine and L-β-lysine. It does not require a vitamin B12 coenzyme 
but instead requires a [4Fe-4S] cluster, S-adenosyl-L-methionine (SAM), and pyridoxal-5_-
phosphate (PLP) as coenzymes (Petrovich, 1992; Frey, 2001). 
Lysine-2,3-aminomutase crystallizes as a homotetramer, consisting of a dimer of 
tightly associated dimers. The subunits of the dimer are linked through a zinc ion that 
coordinates residues from both subunits.  
Each subunit comprises three domains. The central globular domain composed is 
reminiscent of a TIM barrel (β/α)8; however, the barrel lacks two β-strands and forms a 
(β/α)6-crescent. The β-sheet of the crescent is extended by two β-strands at the C-terminal 
side, the last of which is antiparallel, and an antiparallel β-strand at the N-terminal side. An 
N-terminal domain comprises seven short helices forming a cluster closing off the C 
terminus of the channel formed by the central crescent of the opposing subunit.  The C-
terminal domain contains cysteine residues which coordinate the zinc ion, and a three 
stranded β-sheet that interacts with the last two β-strands of the crescent formed by the 
opposing subunit containing the fourth zinc ligand.  
Thus, the quaternary structure involves an assembly of two domain-swapped 
dimers that are held together by zinc ions in addition to C-terminal coils that converge at 
the tetramer equatorial region in the formation of an extensively hydrogen-bonded tubular 
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structure. The C-terminal domain accounts entirely for the contacts in the dimer–dimer 
interface, the remaining contacts being mediated by water molecules. 
A striking feature of the active site is the hydrogen-bonded contact between PLP 
and a fixed water molecule held in place by backbone hydrogen bonds from the carbonyl 
of Arg-116, amide hydrogen atoms from Tyr-113 and Arg-112, and N1 of PLP. The fixed 
water most likely donates a proton in the hydrogen bond to N1 of PLP, and the pyridine 
ring is not protonated. This mode of PLP binding is unprecedented among PLP-dependent 
enzymes.
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Evolutionary relationship among PLP-dependent enzymes 
PLP provides an impressive example of how biological evolution has exploited the 
catalytic potential of organic cofactors. The versatility of PLP as prosthetic group of 
enzymes is perhaps equaled by zinc as inorganic cofactor of all EC classes of enzymes 
(Vallee & Falchuk, 1993). The indispensable mechanistic role of PLP, the multiple 
evolutionary origin of the enzymes that depend on it, and the uniqueness of PLP as 
cofactor for the transamination of amino acids all argue for PLP to arrive on the 
evolutionary scene before the emergence of the apoenzymes. This hypothesis is 
confirmed by the recent recognition that the main metabolic pathway for the de novo 
biosynthesis of PLP, based on just two enzymes termed Pdx1 and Pdx2, is remarkably 
conserved in plants, fungi, archaea and most bacteria (Mittenhuber, 2001; Fitzpatrick , 
2007). The conservation of this biosynthetic route among modern-day organism¥ suggest, 
at the very least, that the pathway originated before the separation between the three 
kingdoms of life.  
There are general arguments suggesting that organic cofactors and coenzymes 
represent “biochemical fossils” from very primitive stages in the history of life 
(Eschenmoser, 1988). Thus PLP itself, is presumably much older than the separation 
between the three kingdoms of life. In fact, the nonenzymatic synthesis of pyridoxal under 
prebiotic conditions is considered possible (Austin & Waddell, 1999; Aylward & Bofinger, 
2006) while the presence of a 5’ group could hint to an ancestral attachment of the 
cofactor to RNA molecules (Jadhav & Yarus, 2002). 
But if the general arguments about the antiquity of cofactors apply to PLP, how did 
PLP-dependent enzymes emerge and evolve? The emergence of a PLP-dependent 
enzymes family might include the following sequence of events. The first step was the 
reaction of PLP with a lysine residue of the progenitor protein. This reaction was facilitated 
by noncovalent binding of the cofactor.  
A further prerequisite for the development toward an effective protein catalyst was 
the pre-existence of a rudimentary substrate-binding site adjacent to the PLP-binding site 
that allowed the transamination with an amino acid substrate and thus the formation of the 
planar coenzyme-substrate aldimine adduct. Formation of the external aldimine, the 
starting point for all PLP-dependent reactions, is an absolute necessity for the catalytic 
efficacy of PLP toward amino acid substrates. 
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Subsequent optimization of the noncovalent interactions between the protein and 
the PLP-substrate adduct may be assumed to have led to improved catalytic efficiency and 
to specialization for reaction and substrate specificity. In the progenote, the subsequent 
divergent evolution of the protoenzymes was first determined by functional specialization 
for reaction as well as substrate specificity and then by the phylogenetic divergence, that 
is, by speciation (Figure 16).  
Prebiotic evolution
Molecular specialization
in progenote
Phylogenesis
Ancestor B6 enzyme without reaction
and substrate specificity
Reaction-specific enzymes
Reaction and substrate-specific enzymes
Modern reaction and substrate-specific PLP dependent enzymes
 
 
Figure 16. Synopsis of the molecular evolution of PLP-dependent enzymes. The scheme depicts 
the temporal sequence of the processes that led from the ancestor of the given PLP-dependent 
enzymes family, which very likely was an allrounder catalyst, to the reaction and substrate-specific 
enzymes of amino acid metabolism in recent species. The PLP-dependent enzymes are of 
multiple evolutionary origin, the course of events outlined in the scheme has occurred in parallel a 
couple of times, each time starting from a different ancestor protein with another fold. For brevity’s 
sake, the development of only one PLP-dependent enzyme family is shown. The main features of 
molecular evolution are most clearly evident from the data on the large α family (Figure 17). 
However, the data on the other much smaller PLP-dependent enzyme families, (Figure 18) (i.e., 
the β family, as well as the D-alanine aminotransferase and the alanine racemase family) comply 
with the same scheme. The first cells and last common ancestor of prokaryotes and eukaryotes 
are estimated to have been in existence about 3500 and 1500-2000 million years ago respectively 
(Doolittle ,1996).    
 
 The process of formation of a primordial PLP-dependent enzyme by reaction of 
PLP with suitable apoprotein has happened more than once and has led to the emergence 
of several independent evolutionary lineages. 
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Family pedigrees and course of functional specialization 
Because of its many diverse member enzymes, the evolutionary pedigree of the 
Fold-type Ι family is most informative for deducing how functional specialization 
proceeded.  
Scrutiny of the pedigree (Figure 17) reveals a clear pattern in the temporal 
sequence of events that led to the functional specialization of these enzymes. Apparently, 
the ancestor enzyme of the α family was specific for covalency changes limited to Cα. 
 The region-specific ancestor enzyme then diverged into reaction-specific enzymes, 
such as the three subfamilies of aminotransferase, the three subfamilies of amino acid 
decarboxylases, the CoA-dependent acyltransferases like 5-aminolevulinate synthase, etc.  
The subdivision of the enzymes into subfamilies of aminotransferases (subfamilies 
AT Ι, ΙΙ, and ΙV in the Fold-type Ι family and subfamily AT ΙΙΙ in the D-alanine 
aminotransferase family; Metha,1993), subfamilies of amino acid decarboxylases 
(subfamilies DC Ι-ΙΙΙ in the Fold-type Ι family and subfamily DC ΙV in the alanine 
racemase family; Sandmeier, 1994), a γ subfamily (Alexander, 1994) and a CoA subfamily 
(Metha & Christen, 2000). The enzymes that catalyze reactions extending to Cβ and Cγ, 
for example, the glycine (serine) hydroxymethyltransferase/tyrosine phenol-lyase group or 
the γ subfamily seem to have diverged from sublineages of the α family just prior to the 
specialization for substrate specificity. The philogenetic tree shows clearly that the last and 
also shortest phase was the specialization for substrate specificity.  
For some enzymes, a further subdivision of subfamilies into different groups seems 
appropriate on the basis of their relative degree of relationship among themselves and with 
other enzymes. The subdivision of subfamily AT Ι into groups a-c of aspartate 
aminotransferase and of subfamily DC ΙΙ into groups a and b of glutamate decarboxylate 
and groups a and b of histidine decarboxylase seems by and large to reflect the course of 
phylogenesis (Table 1).  
Conceivably, these enzymes were already fully specialized for their particular 
reaction and their substrate very early in phylogenetic evolution. The 1-
Aminocyclopropane-1-carboxylate synthase is as yet the only enzyme in the three AT 
subfamily of the α family that is not an aminotransferase but rather catalyzes an α,γ-
elimination reaction. 
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AT ΙΙ
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DC ΙΙΙ
Glycine hydroxymethyltransferase
Threonine aldolase
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Selenocysteine-lyase
ine-glyoxylate aminotransferase
Phosphoserine aminotransferase
Serine aminotransferase
Glycine dehydrogenase
2-Amino-3-ketobutyrate CoA ligase
5-Aminolevulinate synthase
8-Amino-7-oxononanoate synthase
Serine palmitoyltransferase
Kynureninase
Isopenicillin N epimerase
Cysteine desulfurase (nifS gene product)
O-Succinylhomoserine sulfhydrase
Cystathionine γ-synthase
Methionine γ-lyase
Cystathionine γ-lyase
Cystathionine β-lyase
Aspartate aminotransferase a
Aromatic-amino-acid aminotransferase
Tyrosine aminotransferase
Alanine aminotransferase
malY gene product
Glutamine-phenylpyruvate aminotransferase
1-Aminocyclopropane-1-carboxylate synthase
Rhizopine catabolism regulatory protein
Aspartate aminotransferase b
tRNA splicing protein SPL1
Histidinol-phosphate aminotransferase
cobC gene product
Valine-pyruvate aminotransferase
Acetylornithine aminotransferase
Succinylornithine aminotransferase
Ornithine aminotransferase
Alanine-glyoxylate aminotransferase
2,2-Dialkylglycine decarboxylase
β-Alanine-pyruvate aminotransferase
AdoMet aminooxononanoate aminotransferase
DNTP-hexose aminotransferase
Glutamate-1-semialdehyde 2,1-aminomutase
4-Aminobutyrate aminotransferase
Lysine-ε-aminotransferase
2,4-Diaminobutanoate aminotransferase
Histidine decarboxylase a
Glutamate decarboxylase a
Tyrosine/ DOPA decarboxylase
Glutamate decarboxylase b
Histidine decarboxylase b
Ornithine decarboxylase 1
Arginine decarboxylase 1
Lysine decarboxylase
Allinase
Aspartate aminotransferase c
Mehta & Christen, Adv Enzymol Relat Areas Mol Biol 2000; 74:129-184
Fold-type Ι family
 
 
Figure 17. Evolutionary pedigree of the α family. The evolutionary tree was constructed with the 
GrowTree program on the basis of FPA (for details on the constructions of the evolutionary trees 
see, Metha and Christen, 2000). The subfamilies are numbered as previously (Mehta, 1993; 
Sandmeier, 1994; Alexander, 1994). Within subfamilies, some enzymes have been subdivided into 
different groups, that is, aspartate aminotransferase groups a to c in subfamily AT Ι, glutamate 
decarboxylase groups a and b, as well as histidine decarboxylase groups a and b in decarboxylase 
subfamily DC ΙΙ, because the sequences of the different groups could not be aligned with each 
other due to a distant relationship. A different situation is found with ornithine and arginine 
decarboxylases. The members of ornithine decarboxylase group Ι have an α family fold and are all 
of prokaryotic origin. The single known amino acid sequence of arginine decarboxylase group Ι is 
from Escherichia coli (biodegradative enzyme). However, other forms of these enzymes belong to 
the alanine racemase family with a (α/β)8-barrel fold (ornithine decarboxylase 2 and arginine 
decarboxylase 2, Figure 18).  
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The other enzymes of the fold-type Ι (Figure 17) that do not catalyze an α reaction, 
include the γ-family (with one member enzyme, cystathionine β-lyase, catalyzing a β 
reaction), an evolutionary branch with glycine hydroxymethyltransferase, threonine 
aldolase, tryptophanase, tyrosine phenol-lyase, selenocysteine synthase, an evolutionary 
branch with kynureninase, isopenicillin N epimerase, cysteine desulfurase, as well as the 
very distantly related alliinase.  
The pedigrees of the β family, the D-alanine aminotransferase family, and the 
alanine racemase family are small and do not allow general conclusions (Figure 18). The 
two enzymes of the β family that act on enantiomeric substrates, that is, D- and L-serine 
dehydratase fall into two different branches of the tree.  
 
Table 1 
Species representation in the different groups of subfamily AT Ι of Aspartate Aminotransferases and 
subfamily DC ΙΙ of Glutamate Decarboxylases and Histidine Decarboxylases 
   Occurrence in  
Enzyme Group Eukaryotes Eubacteria Archeabacteria 
a + +  
b  + + Aspartate aminotransferase in subfamily AT Ι 
c   + 
     
a Animals   Glutamate decarboxylase in 
subfamily DC ΙΙ b Plants + + 
     
a Animals   Histidine decarboxylase in 
subfamily DC ΙΙ b Plants +  
 
Table 1. All enzymes belong to the α family (Figure 15). The subdivision of aspartate 
aminotransferases subfamily AT Ι into group a and b was first proposed by Okamoto (1996) and 
Nakai (1999).  
 
What were the properties of the hypothetical intermediates of the evolutionary 
process delineated by the pedigrees of the PLP-dependent enzymes?  
The primordial enzyme with covalently bound PLP probably collected L-amino acids 
of any type and facilitated the formation of PLP-amino acid aldimine adducts thus 
accelerating all types of PLP-dependent transformations of amino acids.  
In a later evolutionary phase, the reaction-specific ancestor enzymes must have 
favored one particular reaction over all others without differentiating between the various 
amino acids.  
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Why came specialization for reaction specificity before specialization for substrate 
specificity? Two explanations may be offered, one mechanistic and one metabolic. 
Mechanistically, specialization of the catalytic apparatus for reaction specificity may 
be assumed to require more extensive structural adaptations than the modifications of the 
substrate-binding site necessary to make it interact with a specific substrate. This notion is 
supported by the relatively short evolutionary time that was used for developing substrate 
specificity (Figure 17).  
A substrate-unspecific enzyme is not necessarily equivalent to an enzyme with low 
affinity for the substrates. The relative facility to interact with different substrates is 
illustrated by the relatively broad substrate specificity of many PLP-dependent enzymes, in 
particular by the aminotransferases, many of which accept a particular amino acid/oxo acid 
substrate pair, for example, aromatic or basic, in one half reaction and act on glutamate 
and 2-oxoglutarate in the second half reaction with reverse direction.  
The recommended names of the aminotransferases (Figure 17, 18) are derived 
from the amino acid substrates for which the given enzyme is considered to be specific. 
However, it should be borne in mind that for many enzymes the second substrate pair, 
glutamate and 2-oxoglutarate, provides the link between the metabolism of the amino acid 
carbon skeleton and nitrogen metabolism.  
For the organization of metabolism in the uncompartmented progenote cell, the 
development of catalysts that accelerate one particular reaction of diverse substrates 
seems more important than the development of catalyst that act only on one substrate but 
do not accelerate any of the diverse reactions to an extent exceeding that reached already 
by the primordial ancestor PLP-dependent enzyme.  
Evolutionary precedence of reaction specificity over substrate specificity is also 
observed in numerous other instances, for example, in families of proteinases or sugar 
kinases (Perona and Craik, 1997). As corollary of the course of functional specialization, it 
should be easier to change experimentally the substrate than the reaction specificity of a 
PLP-dependent enzyme.  
This observation is consonant with the conclusion drawn from experiments of 
proteins engineering (Hedstrom, 1994) that it might be easier first to select an enzyme with 
the desired catalytic activity and then to tailor its substrate binding site to new substrate 
instead of trying to adapt pre-existing binding sites for catalysis of a new reaction. 
Chapter 1 Introduction   
 
32
Fold-type ΙΙ family         
Fold-type ΙV family         
Fold-type ΙΙΙ family         
Mehta and Christen , Adv Enzymol Relat Areas Mol Biol 2000; 74: 129-184
Aminocyclopropane-1-carboxylate deaminase
Tryptophan synthase β
chain
Cystathionine β-synthase
O-Acetylserine sulfhydrylase
D-Serine dehydratase
L-Serine dehydratase
Threonine dehydratase
Threonine synthase 1
Diaminopropionate ammonia-lyase
Threonine synthase 2
D-Alanine aminotransferase
4-Amino-4-deoxychorismate lyase
Branched-chain amino acid aminotransferase
Ornithine decarboxylase 2
Diaminopimelate decarboxylase
Arginine decarboxylase 2
Alanine racemase
 
 
Figure 18. Evolutionary pedigrees of the Fold-type ΙΙ family, Fold-type ΙΙΙ family, and Fold-type 
ΙV family. Within a given family, the length of the branches is a measure of the relative 
evolutionary time. In the Fold-type ΙΙ family, the sequences of threonine synthase fall into two 
groups (1 and 2). Threonine synthase 1 includes gram-positive bacterial and archebacterial 
sequences. Threonine synthase 2 includes sequences from mainly gram-negative bacteria and 
sequences from yeast. This group proved still to be closely related to threonine synthase 1 and to 
some other members of the Fold-type ΙΙ family, for example, L-serine dehydratase and 
cystathionine β-synthase. The Fold-type ΙV family includes branched-chain amino acid 
aminotransferase acting on L-valine and L-isoleucine. It is to be noted that this enzyme (EC 
2.6.1.42) is distinct from the valine-pyruvate aminotransferase (EC 2.6.1.66) in the α family, the 
two enzymes use glutamate/2-oxoglutarate and alanine/pyruvate, respectively, as the second 
substrate pair in the transamination reaction. The Fold-type ΙΙΙ family also includes three 
decarboxylases acting with basic amino acids substrates. Ornithine decarboxylase 2 (OrnDC2), 
which appears to be exclusively eukaryotes, and arginine decarboxylases 2 (ArgDC2), which has 
been found to occur in both eukaryotic and eubacteria, represent the second group of the 
respective enzymes. Groups OrnDC1 and ArgDC1 are part of the Fold-type Ι family (Figure 17).   
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Divergence in catalytic mechanisms 
In view of the numerous constraints apparently due to the particular chemical 
properties of PLP and the mechanistic similarity of its interactions with the amino acid 
substrates, it seems remarkable that the following mechanistic features vary rather widely 
(Jansonius, 1998):  
 
1. The noncovalent interactions between the phosphate group of the coenzyme and the 
apoprotein are quite different both in type and number, resulting in different degrees of 
local electrostatic compensation of the negative charge of the phosphate group.  
 
2. The group interacting with N1 of the pyridine ring is the distal carboxylate group of an 
aspartate or glutamate residue in all known enzyme structures of the Fold-type Ι family, 
the Fold-type ΙV family and in orntihine decarboxylase of Fold-type ΙΙΙ family; in the Fold-
type ΙΙ enzymes and in alanine racemase, however, it is a serine and an arginine residue, 
respectively. Apparently, the stabilization of a positive charge at N1 is not a prerequisite for 
PLP catalysis. The effect of the group interacting with N1 on the electron distribution within 
the cofactor has been experimentally probed by site-directed mutagenesis experiments 
with aspartate aminotransferase (Yano, 1992; Onuffer & Kirsch, 1994) and the β-subunit of 
tryptophan synthase (Jhee, 1998).  
 
3. K+ ions have been found to be essential for catalytic activity of particular PLP-
dependent enzyme such as 2,2-dialkylglycine decarboxylase (Toney,1993, 1995), 
tryptophan synthase β (Peracchi,1995), tyrosine phenol-lyase (Sundarararju, 1997), and 
tryptophan phenol-lyase (Isupov, 1998). In most PLP-dependent enzymes, however, 
monovalent cations play neither a mechanistic nor structural role. 
  
4. Virtually all PLP-dependent enzymes seem to be oligomeric proteins, the degree of 
oligomerization ranging from dimers such as aspartate aminotransferases to dodecameric 
ornithine decarboxylase of prokaryotes (Momany, 1995). The only PLP-dependent 
enzymes that has been reported to be a monomer is D-serine dehydratase (Dowhan & 
Snell, 1970) and also threonine synthase (Omi, 2003).  
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On the basis of the present knowledge on the structure-function relationship of PLP-
dependent enzymes, it does not seem possible to attribute a functional significance to the 
above divergent features. They might have arisen by chance in the different evolutionary 
lineages, in contrast to the features that are common to all PLP-dependent enzymes. 
 
Time of emergence and rate of evolution 
In three B6 enzyme families, enzymes are found of which sequences from all 
biological kingdoms are available (Table 2). For each enzyme, its sequences in 
archebacteria, eubacteria, and eukaryotes are all homologous with each other and are 
more closely related among each other than with the sequences of any other PLP-
dependent enzymes in the three biological kingdoms. This suggest that these enzymes 
were already completely developed, that is, endowed with reaction and substrate 
specificity, in the universal ancestor cell.  
Table 2 
Family Enzyme (EC Number) 
Glycine hydroxymethyltransferase (2.1.2.1) 
8-Amino-7-oxononanoate synthase (2.3.1.47) 
Histidinol-phosphate aminotransferase (2.6.1.9) 
Acetylornithine aminotransferase (2.6.1.11) 
Phosphoserine aminotransferase (2.6.1.52) 
α 
AdoMet 8-amino-7-oxonanoate aminotransferase (2.6.1.62) 
1-Aminocyclopropane-1-carboxylate deaminase (4.1.99.4) 
Tryptophan synthase β chain (4.2.1.20) β 
Threonine synthase (4.2.99.2) 
D-alanine aminotransferase Branched-chain amino acid aminotransferase (2.6.1.42) 
 
Table 2. Enzymes with Homologous Sequences in all three biological kingdom. 
 
These enzymes must have arisen and specialized before the three biological 
kingdoms branched off from each other 1500 to 1000 million years ago. An emergence so 
early in biological evolution probably applies to numerous other PLP-dependent enzymes, 
e.g. other aminotransferases and amino acid synthases, as they catalyze reactions that 
link different areas of metabolism and must have been essential in organizing the 
metabolic pathways in the progenote. This notion of an early organization of amino acid 
metabolism is consonant with a general study on the phylogenetic distribution of protein 
families into the three biological kingdoms. The analysis showed that in the last universal 
ancestor of contemporary cells the major metabolic pathways were already established 
(Ouzounis & Kyrpides, 1996). 
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Functional specialization during phylogenesis 
In some instances, however, specialization for (or change of) substrate specificity 
seems to have overlapped with phylogenetic evolution. Within the aminotransferase 
subfamily AT Ι, the aspartate aminotransferases sequences are subdivided into three 
groups a-c (Figure 16). Aspartate aminotransferase group a includes eukaryotic 
sequences, that is of higher vertebrates and plants, and certain eubacterial sequences. 
Aspartate aminotransferase group b consists exclusively of prokaryotic sequences, some 
of them of hyperthermophilic and archebacterial species. Aspartate aminotransferase 
group c is exclusively archebacterial (Table 1).  
The sequences of group a prove to be more closely related to those of aromatic-
amino-acid aminotransferase, tyrosine aminotransferase, and alanine aminotransferase in 
the same evolutionary branch than to the aspartate aminotransferases in group b and c. 
The latter groups, though distantly related with group a, clearly constitute evolutionary 
branches on their own.  
Apparently, in the case of these aminotransferase the specialization for substrates 
specificity occurred in parallel with early phases of phylogenetic evolution when the three 
kingdoms diverged.  
Another example of molecular evolution concomitant with phylogenesis and 
perhaps due to functional constraints specific for a particular phylogenetic branch, is also 
observed in the amino acid decarboxylase subfamily DC ΙΙ.  
Glutamate decarboxylase group a is more closely related to histidine decarboxylase 
group a than to glutamate decarboxylase group b. Glutamate decarboxylase group a 
occurs exclusively in animals; apparently it developed after the divergence of animals from 
plants and lower eukaryotes and might perhaps relate to the newly acquired function of the 
decarboxylation product 4-aminobutyrate (GABA) as a neurotransmitter. A third example 
of specialization during phylogenetic evolution are the two threonine synthase groups in 
the β family (Figure 17). How fast did PLP-dependent enzymes, after their specialization 
for reaction and substrate specificity, change their amino acid sequence? Two 
prerequisites have to be met in order to explore this question: enough sequences that can 
be reliably aligned and a reliable time scale of phylogenetic divergence. Screening of the 
PLP-dependent enzymes sequence database with these two criteria allowed estimation of 
the rate of evolution of a number of PLP-dependent enzymes. 
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 The values cover a relatively broad range from the fast-changing serine pyruvate 
aminotransferase with a unit evolutionary period (or UEP)¥ of only 4.6 million years, which 
is slightly longer than the 3.7 million years for the α chain of haemoglobin, to the slowly 
changing glutamate decarboxylase with 45 million years, which compares with other 
relatively slowly changing intracellular enzymes such as triosephosphate isomerase and 
glutamate dehydrogenase with unit evolutionary periods of 20 and 55 million years, 
respectively (Wilson, 1977; Salzmann, 2000). The glutamate decarboxylase sequences 
that were considered are all from mammalian species in which this enzyme plays a 
delicate role as producer of GABA (the most important inhibitory transmitter in the central 
nervous system). Glutamate decarboxylase is found only in neurons that use 4-
aminobutyrate as transmitter.  
Rate of evolution and subgroup affiliation do not seem to correlate. Fast-changing 
serine pyruvate aminotransferase and slowly changing glutamate decarboxylase belong 
both to the α family and the evolutionary rates of the enzymes of the other families seem 
to intermingle at random with those of the α enzymes. The differential rates of neutral 
evolution of the PLP-dependent enzymes do not correlate with their different folds. 
Apparently, the rates of evolution are largely determined by functional constraints. 
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Genomic distribution of PLP-dependent enzymes 
A recent study (Figure 19A), on PLP-dependent enzymes in complete genomes, 
demonstrated that nearly 1.5% of all genes in most prokaryotic genomes encode PLP-
dependent enzymes and that 4% of the 140 distinct enzymes classified by the Enzyme 
Commission depend on PLP (Percudani & Peracchi, 2003).  
The number of genes for PLP-dependent enzymes in extant, free-living 
microorganis presumably depends on their adaptation to specific nutrient sources. Only 
two EC-classified activities are present in all the available genomes of free-living 
organisms: aspartate aminotransferase (EC 2.6.1.1) and serine hydroxymethyltransferase 
(EC 2.1.2.1). 
 If the importance of PLP as a biological cofactor in prokaryotes is underscored by 
the high fraction of genes encoding PLP-dependent enzymes, this fraction decrease with 
expansion of the size and complexity of the genome (Figure 19B), perhaps because PLP-
dependent enzymes are mostly involved in basic metabolic pathways rather than in more 
specialized regulatory functions.  
Although the absolute number of PLP-dependent enzymes is somewhat larger in 
higher eukaryotes than in microorganisms (Figure 19A), the number of EC-classified 
activities that are represented is not (Figure 19C). This can be explained in part by the 
occurrence of organelle-specific or tissue-specific isozymes, which are encoded by 
different genes but have the same enzymatic activity.  
However, the relatively modest number of classified activities that are found in 
higher eukaryotes might also imply that some gene products assigned to the same EC 
number on the basis of sequence homology actually have different activities.  
 
Limitations to the identification of PLP enzymes 
The current picture of the genomic distribution of PLP-dependent enzymes is 
informative, but it is also preliminary, and to some degree incomplete. This is partly due to 
limits that are inherent to homology searches, which may fail to recognize PLP-dependent 
genes in at least two situations.  
First, it is possible that structurally similar enzymes escape detection if their 
sequence similarity has become negligible. A case in point is provided by the crystal 
structure of the yeast hypothetical protein YBL036C.  
This molecule was not predicted to be a PLP-dependent enzyme and was even 
suggested to possess a novel protein fold. However, the solution of the crystal structure 
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revealed a classic (α/β)8 barrel, with pyridoxal phosphate covalently bound at the bottom. 
Thus, YBL036C closely resembles PLP-dependent enzymes such as alanine racemase, 
and it has indeed been shown to possess some amino-acid racemase activity 
(Eswaramoorthy, 2003).  
A second case in which homology searches can fail to identify PLP-dependent 
genes is when the enzymes that they encode do not fall into the five fold-type categories 
described above and do not resemble any of the known PLP-dependent enzymes. For 
example, some recently sequenced bacterial aminomutase (such as D-lysine-5,6-
aminomutase) which use vitamin B12 cofactor in addition to PLP, show no significant 
similarity to other PLP-dependent enzymes at the sequence level, but instead resemble 
some B12-containing proteins (Chang & Frey, 2000; Chen, 2001).  
  
Limitations to the functional assignment  of PLP enzymes 
A substantial fraction of the genes that have been identified as encoding PLP-
dependent enzymes remain functionally unclassified or only tentatively classified; for 
example, there is no assignment of catalytic activity for about 20% of the putative PLP-
dependent enzymes encoded by the human genome, and one-third of all PLP-dependent 
enzyme classified by the Enzyme Commission are still uncharacterized in terms of 
sequence (Metha & Christen, 2000). 
These number are enough to evidence the lack of information regarding the family 
of PLP-dependent enzymes, and, on the other side, how much work is needed before to 
fully exploit the wealth of information contained in the genome sequences. 
In fact this number might even be an underestimate because, although 
bioinformatics tools are well suited to detecting structural similarities and determining 
phylogenetic relationships, they are much less reliable for establishing protein function 
solely based on homology, even when sequence identity is > 50% (Thornton, 2000; Rost, 
2002).  
This problem is particularly severe for PLP-dependent enzymes, as their catalytic 
mechanisms almost invariably involve the formation of carbanionic intermediates that are 
stabilized by the cofactor.  
Such constant mechanistic features have presumably favoured the apparence of 
enzymes with identical or highly similar activities several times during the course of 
evolution (Mehta & Christen, 2000).  
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Figure 19. Distribution of genes that encode pyridoxal-phosphate-dependent enzymes in 
representative genomes. The organisms used as examples are: Mycoplasma genitalium (not a 
free-living organism),Methanococcus jannaschii, Sulfolobus solfataricus, Aeropyrum pernix, 
Pyrococcus abyssi, Clostridium perfringens, Staphylococcus aureus, Synechocystis sp. PCC 6803, 
Escherichia coli, Pseudomonas aeruginosa, Saccharomyces cerevisiae, Neurospora crassa, 
Arabidopsis thaliana, Caenorhabditis elegans, Anopheles gambiae and Homo sapiens. (A) Total 
number of pyridoxal-phosphate (PLP)-dependent genes per genome; the fraction of sequences 
that could not be classified in terms of function, on the basis of our search criteria, is shown in red. 
The relatively high number of PLP-dependent genes in A. thaliana can be explained in part by the 
occurrence, for many enzymes, of at least three isoforms (cytoplasmic,mitochondrial and plastidic) 
that are encoded by different genes. (B) The percentage of genes in each genome that encode 
PLP-dependent enzymes. (C) The number of Enzyme Commission (EC)-classified PLP-dependent 
activities for which sequences were found in each genome.Note that similar numbers of activities 
can be found in organisms with very different assortments of enzymes. For example, only about 
one-third of the PLP-dependent activities found in E. coli are also found in H. sapiens, despite the 
fact that the two organisms have a similar absolute number of activities. 
 
Chapter 1 Introduction   
 
40
In addition, PLP-dependent enzymes are involved in a surprising variety of cellular 
processes, so that even for an enzyme for which the catalytic activity can be assigned with 
high confidence on the basis of its sequence, the actual biological function may remain 
uncertain. Enzymes that have the same catalytic activity but are evolutionarily unrelated 
and functionally diverse are exemplified by a group of PLP-dependent enzymes with 
desulfhydrase activity, that is, enzymes that release H2S from thiol-containing amino acids. 
Bacteria use desulfhydrase not only in amino acids metabolism and in adaption to new 
nutrient sources (Soutourina, 2001), but also sometimes as virulence factors (Krupka, 
2000; Fukamachi, 2002). One Escherichia coli enzyme with desulfhydrase activity is even 
known to act as a modular of gene expression, although this function seems to be 
unrelated to catalysis (Clausen , 2000). Sulfhide production by PLP-dependent enzymes is 
also important in vertebrates, in which H2S has been shown to function as a 
neuromodulator (Kimura, 2002). PLP-dependent enzymes with desulfhydrase activity 
come from several evolutionary lineages. For example, although most bacterial L-cysteine 
desulfhydrases belong to the fold-type Ι group, cystathionine β-synthase (the enzyme 
responsible for H2S production in the mammalian brain) is a fold-type ΙΙ enzyme. A L-
cysteine desulfhydrase from Fusobacterium nucleatum is also a fold-type ΙΙ enzyme, and 
its closest sequence homologue is a cysteine synthase (Fukamachi,2002). D-cysteine 
desulfhydrase from E.coli is not closely related to other desulfhydrase, and is most similar 
to 1-aminocyclopropane-1-carboxylate deaminase (Soutourina, 2001). 
 
In search of novel PLP-dependent enzyme 
Even in the cases of model organism, the difficulties in establishing function on the 
basis of gene genealogies imply that much experimental work will be required to achieve a 
genome-wide classification of all PLP-dependent enzymes. With the advancement in 
functional genomics it is likely to expect the discovery of many ‘novel’ PLP-dependent 
enzymes that have activities that are not yet described or characterized.  
In fact, the recent literature supports this assumption. One example is provided by 
the identification of Salmonella typhimurium gene that encodes an enzyme with L-
threonine-O-3-phosphate decarboxylase activity (Brushaber, 1998). This was the first 
enzyme described as having this activity, and its discovery shed new light on the pathway 
that leads to cobalamin biosynthesis in Salmonella. The sequence of this enzyme is only 
distantly related to those of other PLP-dependent decarboxylase, but is highly similar to 
those of histidinol-phosphate aminotransferases (Brushaber, 1998).  
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In another case, (Wolosker, 1999) described a PLP-dependent serine racemase 
that is expressed in the human brain. The existence of this enzyme had been previously 
overlooked, as D-amino acids were not known to have any metabolic or physiological 
function in vertebrates. However, it is now recognized that D-serine is a neurotransmitter 
(Wolosker, 1999; De Miranda, 2000). The human serine racemase does not show 
sequence similarity to bacterial amino acid racemases (fold-type ΙΙΙ), but instead 
resembles threonine ammonia-lyases, which are fold-type ΙΙ enzymes (De Miranda, 2000). 
The discovery of new enzymes that produce chemical mediators in higher eukaryotes may 
have interesting implications for the recycling of certain proteins for new physiological 
functions. Indeed, plant and animal cell often use PLP-dependent enzymes for the 
synthesis of hormones and chemical messengers, and these enzymes can be close 
homologues of enzymes involved in basic metabolic pathways.  
 
Orphan PLP-dependent activities and catalytic promiscuity 
Some PLP-dependent enzymes are still uncharacterized at the sequence level 
because they exist only in obscure organisms, or because their function is not of sufficient 
scientific interest. However, these reasons doesn’t explain the large number of ‘orphan’ 
PLP-dependent activities.  
A probable explanation refer to the phenomenon of ‘catalytic promiscuity’, that is the 
ability of a single enzyme to catalyze different chemical reactions (O’Brien & Herschlag, 
1999). This phenomenon is particularly frequent among PLP-dependent enzymes. Due to 
their common mechanistic features the occurrence of catalytic promiscuity, in addition to a 
low substrate specificity, suggest that an organism may have less genes encoding PLP-
dependent enzymes than PLP-dependent activities (Percudani & Peracchi, 2003).  
Furthermore, the possibility of alternative splicing in higher eukaryotes, this can 
increase the functional diversity of proteins in general (Graveley, 2001). It must be 
stressed, however, that although many alternatively spliced PLP-dependent genes have 
been described in animal cells, splice variants that differ significantly in terms of reaction or 
substrate specificity have not been reported.  
Moreover, in some cases it has been shown that certain splice variants cannot bind 
PLP and presumably do not function as enzymes (Bond, 1990; Liu, 2001).  
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Introduction 
L-threonine (L-Thr) is known as an essential amino acid for many metazoans, 
including insects, birds and mammals (Kasting & McGinnis, 1958; Fitzgerald & 
Szmant, 1997; Reeds, 2000). ‘Essential’ means that these animals must obtain L-Thr 
from food sources, since their body is unable to synthesize it (Reeds, 2000). In 
contrast, plants and microorganisms can synthesize L-Thr endogenously, via a 
specific metabolic pathway (Kaplan & Flavin, 1965; Cami, 1993; Azevedo, 1997) the 
last step of which is catalyzed by threonine synthase (TS; EC 4.2.3.1). 
TS is an enzyme that employs the organic cofactor pyridoxal-5'-phosphate 
(PLP) to carry out the conversion of O-phospho-L-homoserine (PHS) to threonine 
and phosphate (Scheme 1).  
 
Scheme 1 
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Scheme 1. Threonine synthase reaction. 
 
Structurally speaking, TS is a member of the fold-type II group of PLP-
dependent enzymes (sometimes also termed β-family) (Grishin, 1995; Mehta & 
Christen, 2000; Christen & Mehta, 2001). This group encompasses enzymes that 
catalyze transformations of amino acids with covalency changes occurring not only at 
Cα but also at the β and/or γ carbons. Representative members of this group, in 
addition to TS, are tryptophan synthase, cystathionine β-synthase, O-acetylserine 
sulfhydrylase and L-serine ammonia-lyase (Mehta & Christen, 2000). 
Recently our group has scanned a series of complete or near-complete 
genomes to obtain an inventory and a preliminary classification of genes that encode 
PLP-dependent enzymes (Percudani & Peracchi, 2003). This analysis identified, in 
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the genomes of several vertebrates (including man) two genes showing a high 
similarity to microbial TSs. This observation raised the intriguing possibility that 
threonine might be, after all, synthesized in humans and in other animals. 
If L-Thr were produced, at least under some physiological or developmental 
conditions, this could have important biological implications. Alternatively, the 
existence of TS-like sequences in animal genomes may mean that the gene products 
have acquired new physiological roles upon dismissal of the threonine biosynthetic 
pathway during vertebrate evolution. 
Herein, I describe a bioinformatic analysis of the two TS-like genes, as well as 
the cloning of a cDNA encoding a murine TS homolog and the characterization of the 
expressed and purified recombinant protein. 
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Materials and Methods 
Materials  
DNA primers were purchased from MWG Biotech (Ebersberg, Germany). The 
clone of homoserine kinase from Methanococcus jannaschii, inserted in an 
expression vector, was a kind gift from Hong Zhang (University of Texas 
Southwestern Medical Center). The recombinant enzyme was expressed and purified 
as described (Zhou, 2000; Krishna, 2001). 
Rabbit muscle lactate dehydrogenase, L-homoserine, L-threonine and L-
serine were from Fluka; O-phospho-L-threonine (PThr) and other potential TSh 
substrates (O-succinyl-homoserine, O-phospho-L-serine, etc.) were from Sigma-
Aldrich. PHS was synthesized employing homoserine kinase, as described 
previously (Laber , 1994), and purified on an Amberlite IRA-410 anion-exchange 
column (Fluka). 32P-labeled PHS was also prepared enzymatically, using homoserine 
kinase and γ-32P-ATP.  
The reaction products were run on a 20% polyacrylamide gel (30 min, 25 
watts); the band corresponding to PHS was identified by autoradiography, cut and 
eluted in distilled water. 
 
Bioinformatics  
Initial identification of TS homologs (TSh) in mammalian genomes was 
achieved through a search of PLP-dependent enzymes in genomic sequences using 
profiles Hidden Markov Models (HMM; Percudani & Peracchi, 2003). Definition of the 
precise coding sequence boundaries of the matched genes was based on protein 
HMM and EST comparisons using Genewise and Estwise 
(http://www.ebi.ac.uk/Wise2); this procedure helped identification of the intron-exon 
structure of TSh genes and of alternative splice products.  
The tissue-specific expression profile of mouse TSh sequences was inferred 
using the UniGene's EST ProfileViewer at the National Center for Biotechnology 
Information (NCBI). Homology searches were performed at the NCBI using Blast and 
genomic Blast. Multiple sequence alignments were produced with ClustalX 
(Thompson, 1997).  
Chapter 2 mTSh2: a threonine synthase homolog from mouse   
 
54 
Phylogenetic analysis of TS and TSh proteins was performed with the 
maximum-likelihood method as implemented in the proml program of the PHYLIP 
package (http://evolution.genetics.washington.edu/phylip.html). 
 
Recombinant expression and purification of the mouse TSh2 protein (mTSh2)  
A clone of the complete cDNA for mTSh2 (IMAGE Consortium ID 5250319, 
cDNA from mouse mammary tumor) was obtained from RZPD (Berlin, Germany). 
 The mTSh2 coding sequence was amplified from this clone, using the Pfu 
Turbo DNA polymerase (Perkin–Elmer) and adopting the following ‘‘touchdown’’ PCR 
conditions: 5 min of initial denaturation at 94°C, 10 cycles of 30 s denaturation at 
94°C and 30s annealing at progressively lower temperatures (from 60 to 55°C, with a 
decrease of 1°C every other cycle), followed by 25 additional cycles at an annealing 
temperature of 55°C. The gene-specific primers were: 
 
 mTSh2_cpo+  taCGGTCCGatgtggtacactagcacccg 
mTSh2_cpo-   taCGGACCGttccagcctgtctattctgag 
 
Underlined residues correspond to the start codon and to the stop codon. The 
5’ region of both primers contained sequences (uppercase letters) recognized by the 
restriction enzyme CpoI, so that the amplification product contained restriction sites 
near to both ends. 
The amplicon was treated with CpoI and directly cloned into the expression 
vector pET11-H6-Cpo. This plasmid is a derivative of pET11 (Novagen, Madison, WI) 
modified to present a single CpoI restriction site in the cloning region, downstream to 
a sequence encoding a hexahistidine tag (Bolchi, 2005). The cloned insert was then 
sequence-verified and the plasmid was transformed into BL21-CodonPlus®-RIL 
Escherichia coli cells (Stratagene). 
In these cells the recombinant protein was expressed efficiently, but under 
most induction conditions it was found exclusively in the insoluble fraction of the 
bacterial lysate. Attempts were made to improve the solubility of mTSh2 by reducing 
the growth temperature, varying the induction time and varying the concentration of 
added isopropyl β-D-thiogalactoside (IPTG).  
A modest but sufficient yield of soluble protein (~3% of the total recombinant 
protein) was obtained by carrying out the induction with 0.1 mM IPTG and by 
allowing protein expression to proceed for 8 h at 24 °C. 
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After cell lysis, the soluble lysate fraction was loaded onto a metal-affinity resin 
(Talon; Clontech) equilibrated in Buffer A (5% glycerol/ 300 mM NaCl/ 50 mM 
phosphate-Na buffer pH 7.0) supplemented with 40 µM PLP, 5 mM β-
mercaptoethanol and protease inhibitors (1 µM leupeptine, 1 µM pepstatine, 0.5 mM 
benzamidine, 0.5 mM phenyl methyl sulfonyl fluoride).  
The recombinant mTSh2, bearing an N-terminal hexahistidine tag, was 
purified following the manufacturer’s instructions.  
The composition and purity of protein fractions were assessed by gel 
electrophoresis on SDS-polyacrylamide (11%) gels (Laemmli, 1970); mTSh2 
fractions with a purity > 90% were pooled, dialyzed against buffer A supplemented 
with 10 µM PLP and 1 mM dithiothreitol, and stored at -80 °C. 
The concentration of purified mTSh2 was estimated by the Bradford assay 
(Bradford, 1976) with bovine serum albumin as a standard, and confirmed based on 
the calculated extinction coefficient at 280 nm (60440 M-1 cm-1; 
http://expasy.org/tools/protparam.html) (Gill & von Hippel, 1989). 
 
Spectrophotometric measurements  
Solutions containing recombinant mTSh2 (6 µM final) in 50 mM PIPES-NaOH 
buffer (pH 6.8), were supplemented with various potential substrates. Spectral 
changes were monitored using a Cary 400 spectrophotometer (Varian).  
Cuvette holders were thermostated at 25 °C. Time-dependent spectral 
changes (time-courses) and titration data were analyzed by nonlinear least-squares 
fitting to the appropriate kinetic or thermodynamic equation using Sigma Plot (SPSS 
Inc.). 
 
Enzymatic assays  
The release of phosphate from PHS was established by incubating a trace of 
32P-labeled PHS (∼1 nM) with mTSh2 (∼1 µM) in 30 mM PIPES-Na buffer, pH 6.8 to 
8.0, 25°C. Time-points were collected at appropriate intervals and quenched with 6 M 
urea. Substrates and products were separated on a 20% polyacrylamide gel and 
quantitated using a Personal Molecular Imager (Biorad). To make sure that the 
observed release of radioactive phosphate could be attributed to the recombinant 
protein, control experiments were carried out in which the enzyme was either omitted, 
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heat-denatured (by treatment at 100ºC for 5 min) or inactivated by reduction of the 
protein-bound PLP cofactor with sodium borohydride: in all these cases the reaction 
was essentially abolished. 
The possible formation of threonine was tested by incubating PHS with mTSh2 
for a few hours (30 mM PIPES-Na buffer, pH 6.8) and then running the reaction 
mixture on a silica TLC plate, side-by-side with amino acid standards (PHS, 
homoserine and L-Thr). Amino acids were visualized with ninhydrin (Friedman, 
2004). 
The rates of α-ketobutyrate production were measured spectrophotometrically 
by a coupled assay, in which mTSh2 (2 µM) and PHS (or PThr) were incubated in the 
presence of lactate dehydrogenase and NADH. The reaction mixture (200 µl final 
volume) contained 30 mM PIPES-Na (pH 6.8), 10 µM PLP, 0.25 mM NADH, 12.5 
units/ml lactate dehydrogenase. The reactions were conducted at 25 ºC, or 37°C, 
and the disappearance of NADH was monitored at 340 nm. 
 
Mass spectrometry identification of α-ketobutyrate  
The recombinant mTSh2 protein (7.5 µM) was incubated with 8 mM PHS for a 
few hours, in a buffer solution (pH 7) containing 4 mM PIPES, 8 mM phosphate and 
9.4 mM imidazole, plus 6 µM PLP. In parallel, a control reaction was conducted 
omitting the protein. 
15 µl of the reaction mixture were diluted to 100 µl with 0.1 M formic acid. Non-
charged solutes were then extracted with 100 µl of dichloromethane, and the organic 
phase was diluted to 1 ml with ethyl acetate. The sample was directly perfused into 
an ESI-MS spectrometer (Micromass ZMD 4000, equipped with a single quadrupole 
analyzer) at 20 µl min-1 rate (other working conditions: negative ion mode, capillary 
voltage 3.0 kV, cone voltage 30 V, source temperature 180 °C, desolvation 
temperature 80 °C). 
In the mass spectrum of the enzymatic reaction mixture the base peak showed 
an m/z ratio of 101.2, identical within error to that expected for α-ketobutyrate (M-1 
species). Such a peak was totally absent in the mass spectrum of the control 
reaction.
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Results 
Identification of the TSh genes 
Our group is developing a curated database of PLP-dependent enzymatic activities, 
as well as bioinformatic tools for the identification and functional classification of PLP-
dependent enzymes in genomic sets of predicted protein sequences. While performing an 
inventory of PLP-dependent enzymes in different organisms (Percudani & Peracchi, 2003) 
it was noticed that, in several vertebrate genomes, contained genes encoding proteins 
highly similar to TSs. These TS homologs (TShs) could be subdivided in two distinct types, 
which generally were co-present in the same organism.  
A first group of genes encoded proteins (TSh1 proteins) that contain, in addition to 
the TS-like sequence, an N-terminal domain strongly similar to bacterial shikimate kinase.; 
a second group of gene products (TSh2 proteins) lack such an additional domain.  
A list of TSh genes, some of which are annotated as threonine synthase-like in 
public databases, is presented in Table 1. 
These genes were found only in vertebrates and in organisms belonging to basal 
Deuterostomia lineages, such as the urochordate Ciona intestinalis and the echinoderm 
Strongylocentrotus purpuratus (Table 1). Both TSh1 and TSh2 sequences are apparently 
missing in insects (Drosophila, Anopheles or Apis) and in Caenorhabditis genomes. 
Examination of the ESTs databases indicated that mRNAs for both genes are 
present in tissues from their respective organisms, confirming that the genes are 
expressed. Based on the modest frequency with which transcripts are found in public EST 
libraries, expression of TSh1 and TSh2 appears to occur at low levels in mouse and 
human. In mouse, TSh1 gene transcripts are observed predominantly in the brain and 
endocrine glands, whereas TSh2 transcripts are most abundant in the kidney and liver. 
The two TSh genes show very distinct intron-exon organizations. In most 
organisms, the TSh1 gene is constituted by an uninterrupted coding sequence, over 2000-
nucleotides long. 
In contrast, TSh2 genes contain multiple intervening sequences (e.g., both the 
human and the mouse gene include seven introns) and may thus undergo alternative 
splicing. In particular, the human TSh2 gene (hTSh2) gives rise to several documented 
alternative transcripts (http://www.ebi.ac.uk/asd/), the longest of which encodes a protein 
significantly smaller than the other mammalian TSh2 gene products (Table 1).  
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Table 1 
Some metazoan genes encoding TS-like proteins 
Group Organism GenBank/Ensembl Accession # 
Predicted 
Protein Size (aa)a 
TSh1 Homo sapiens CAH70791 743 
 Pan troglodytes XP_521671 743 
 Pongo pygmaeus CAH92923 743 
 Macaca fascicularis Q9BH05 743 
 Mus musculus NP_808256 747 
 Rattus norvegicus AAH91213 745 
 Bos taurus XP_581830 748 
 Canis familiaris XP_535167 743 
 Gallus gallus CAG32314 680 
 Danio rerio XP_700684 702 
 Tetraodon nigroviridis CAG05472 680 
 Fugu rubripes SINFRUP00000155654 695 
 Strongylocentrotus purpuratus XP_791506 710 
    
TSh2 Homo sapiens AAH64423 405 
 Pongo pygmaeus CAH89511 484 
 Mus musculus AAH51244 483 
 Rattus norvegicus NP_001009658 485 
 Bos taurus XP_615043 488 
 Canis familiaris XP_532965 484 
 Gallus gallus XP_420866 521 
 Xenopus laevis AAH84269 472 
 Danio rerio AAI10122 476 
 Strongylocentrotus purpuratus XP_793160 461 
 Ciona intestinalis AK115020 474 
 
Table 1. The group, organism source, databank accession number, protein size, are shown for all 
the metazoan genes encoding threonine synthase-like proteins. aWhen multiple splice variants of 
the gene product are included in the databases, the size refers to the longest predicted 
polypeptide. 
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Comparison and phylogeny of TSh gene products 
BLAST searches of the GenBank non-redundant database confirmed that bona fide 
TSs are the enzymes most similar to TShs. For example, when the mouse TSh2 (mTSh2) 
sequence was used as a query, the first match corresponding to a functionally validated 
protein was Saccharomyces cerevisiae TS (Ramos & Calderon, 1994) (38% identity to 
mTSh2 over 458 positions; E-value=10-80), followed by several TSs from eubacteria, such 
as the enzyme from Pseudomonas aeruginosa (Clepet, 1992) (36% identity; E-
value=2×10-77). 
For both TSh1 and TSh2 proteins, all these best matches belong to the so-called 
subfamily II of TSs, which includes monomeric proteins from fungal and eubacterial 
sources (Laber, 1999; Omi, 2003). A lesser similarity is found to TSs of subfamily I 
(enzymes that function as homodimers and occur in plants and archaea, as well as in 
some Gram-positive eubacteria).  
The genes for TSh1 and TSh2 proteins do not seem, however, derived from a 
recent duplication of a single ancestor gene. In fact, it is noteworthy that TSh1 and TSh2 
sequences are more similar to microbial TSs than they are to each other (only 26% identity 
is observed between the two mouse TSh sequences). Consistent with this hypothesis, 
phylogenetic analyses of TS and TSh sequences (Figure 1) indicate that the TSs of 
subfamily II fall into at least two distinct clades. Each clade contains both microbial and 
metazoan sequences, with one of the two TSh families at the higher end of the 
phylogenetic tree.  
However, with respect to sequences belonging to the same clade, the metazoan 
TShs show some distinctive features. TSh1 sequences are characterized, as mentioned 
above, by an N-terminal kinase domain that is unique to this group of proteins, while TSh2 
sequences contain mutations at some sites that are conserved in all functionally validated 
TSs.  
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Figure 1. Phylogenetic relationships of TS and TSh proteins. The unrooted maximum likelihood 
phylogenetic tree was constructed with the proml program of the PHYLIP package and displayed 
with the TreeIllustrator program with branch length correction for visibility enhancement. In the 
case of TSh1 sequences, only the PLP-dependent domain was used for the phylogenetic 
reconstruction. Sequences are indicated with the abbreviation of the binomial name of species 
followed by the GenBank gi number. Terminal nodes corresponding to TSh1 and TSh2 sequences 
are indicated by dotted lines. A plus sign and an asterisk sign mark ancestral modifications leading 
to the TSh1 and TSh2 lineages, respectively. 
 
The latter point is illustrated in Figure 2, which shows a multiple sequence 
alignment of the two mouse TShs with two validated TSs – the enzymes from Thermus 
thermophilus (subfamily I) and from yeast (subfamily II). At least 24 residues (boxed in the 
figure) are strictly invariant in all characterized TSs (Ramos & Calderon, 1994; Clept, 
1992; Laber, 1999; Omi, 2003; Laber, 1994; Malumbres, 1994; Malumbres, 1995; Curien, 
1996). All of these residues are conserved in the TSh1 protein lineage, but four of them 
are mutated in most mTSh2 proteins (Figure 2). The mutations, referred to the numbering 
of the T. thermophilus TS, are: Ala83Gly, Phe134Ser, Asn188Ala (in non-mammalian 
sequences: Asn188Gly) and Thr317Pro (or Thr317Ser). 
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Figure 2. Multiple sequence alignment of the mouse TSh proteins with TSs from Saccharomyces 
cerevisiae (GenBank P16120) and from Thermus thermophilus HB8 (GenBank BAD70314). For 
mTSh1, only the PLP-dependent domain is shown. Positions that are absolutely conserved in all 
functionally validated threonine synthases (but not necessarily in TSh proteins) are boxed. The 
black arrows signal those conserved residues that are mutated in mTSh2. The asterisk marks the 
catalytic lysine residue that binds the PLP cofactor through a Schiff base linkage. The white arrow 
indicates a position where all mammalian TSh1 and TSh2 proteins contain a Ser residue in place 
of Ala or Gly (as present in all TS). The mutations prevent the recognition of these proteins by the 
Prosite pattern for threonine synthases/dehydratases PLP attachment site (PS00165; 
http://www.expasy.org/prosite/). 
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Cloning, expression and purification of recombinant mTSh2 
We obtained the cDNA clones corresponding to the full-length human TSh1 
(hTSh1) and mouse TSh2 (mTSh2) genes from the IMAGE consortium 
(http://image.llnl.gov). Since Escherichia coli is currently the system of choice for the 
heterologous expression of bacterial and eukaryotic TSs ( Laber, 1999; Omi, 2003; 
Garrido-Franco, 2002), this organism was used for the expression of recombinant TShs.  
Several attempts to subclone the hTSh1 gene in an E. coli expression vector were 
unrewarding: in the very few positive colonies, the cloned insert contained frameshifts or 
large deletions, suggesting that perhaps the intact hTSh1 protein is toxic to the host cells, 
even when expressed at very low levels in the absence of induction. 
In contrast, overexpression of the mTSh2 protein was accomplished promptly, even 
though soluble protein could only be obtained in low yields. Approximately 0.4 mg of pure, 
recombinant mTSh2 protein was isolated per liter of bacterial culture (see Methods).  
The recombinant protein was 506 residues long (including the N-terminal 
hexahistidine tag) with a calculated molecular mass of 56.5 kDa. Purified mTSh2 was 
homogenous by SDS-PAGE (data not shown), and exhibited the characteristic PLP 
absorption maximum at 410 nm (Figure 3A). 
 
Interaction of mTSh2 with potential substrates 
In PLP-dependent enzymes, the presence of a light-absorbing cofactor in the active 
site provides a convenient means for monitoring the binding of substrates, substrate 
analogs and inhibitors, as well as the formation of catalytic intermediates (e.g.,  Laber, 
1994; Mozzarelli, 1989; Sterk & Gehring, 1991; Karsten & Cook, 2002).  
The interaction of mTSh2 with PHS (the physiological substrate of TSs) have been 
tested spectroscopically, with L-Thr and with the following compounds that show similarity 
to either the substrate, the product or to intermediates of the TS reaction: L-homoserine, 
O-succinyl-homoserine, 2-amino-5-phosphonopentanoate (AP5), PThr, L-allo-threonine, 
O-phospho-L-serine (Pser), O-phosphoethanolamine, L-vinylglycine, cystathionine, L-
homocysteate and O-phospho-L-tyrosine. Addition of these compounds (millimolar 
concentrations) to the enzyme led in most cases to negligible changes in the PLP 
spectrum. L-Thr and L-allo-threonine induced a slight increase and a red shift of the main 
PLP band to 414 nm (data not shown), hinting that the enzyme may be binding these 
amino acids, albeit with low affinity. 
 
Chapter 2 mTSh2: a threonine synthase homolog from mouse   
 
63
However, much more striking spectral changes were observed with PHS, AP5 and 
PThr (Figure 3A).  
 
 
 
Figure 3. (A) Absorption spectra of recombinant mTSh2 in the presence and absence of amino 
acid ligands. The protein (6 µM) was incubated in 50 mM PIPES-NaOH, pH 6.8, 25°C. Absorption 
spectra were recorded in the absence of ligands (dotted line) or in the presence of 5 mM PHS or 
20 mM PThr or 20 mM AP5. (B) Spectroscopic titration of the mTSh2 protein with PHS and PThr. 
Solid lines are best fits to binding isotherms, yielding apparent Kd values of 0.9 mM (PHS) and 9.5 
mM (PThr).  
 
PHS induced the appearance of a sharp band at 452 nm, which decayed over time 
(hours). Such a band strongly resembled the peak that is observed upon the reaction of 
the E. coli TS with PHS (Laber, 1994) and that is attributed to a stabilized carbanionic 
intermediate (quinonoid) formed upon removal of the amino acid α-proton (Laber, 1994).  
A titration with PHS yielded an apparent Kd of 0.9 mM (Figure 3B), comparable to 
the Km of E. coli TS towards the same substrate (Km=0.5 mM;  Laber, 1994).  
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AP5, a well-known TS substrate analog (Laber, 1994), was also bound by mTSh2. 
Reaction of mTSh2 with racemic AP5 yielded a stable spectroscopic species, 
characterized by maxima at 432 and at 456 nm (Figure 3A). The latter peak, again 
attributable to a quinonoid adduct, is reminiscent of the peak that bacterial TS forms with 
the L-enantiomer of AP5 (Laber, 1994). 
In contrast to the cases above, reaction of mTSh2 with PThr produced a broad band 
centered at ~450 nm, with a shoulder at 480 nm, and a substantial absorbance increase at 
330 nm (Figure 3A). This suggests that PThr binding leads to a mixture of PLP-bound 
species, but not to the accumulation of a quinonoid intermediate (apparent Kd≈10 mM; 
Figure 3B). 
 
mTSh2 catalyzes slow phospho-lyase reactions with PHS and PThr 
We studied in more detail the reaction of mTSh2 with PHS. Reactions carried out 
with 32P-5’-labeled PHS showed that mTSh2 was capable of releasing the phosphate 
group from the amino acid, albeit at a modest rate (Figure 4). Phosphate release is of 
course accomplished also by bona fide TSs. 
 
PHS
Pi
mTSh2 mTSh2 
reducedTS
mTSh2 
heat-denatured 
Minutes 0.33 0.33 0.3320 20 2090 90 9020180 180 180 180
 
 
Figure 4. Analysis of phospho-lyase activity of mTSh2. Individual reactions were realized as 
described in the Materials and Methods. mTSh2 represent the reaction with the enzyme, mTSh2 
heat-denatured and mTSh2 reduced are the negative; TS is the positive control (TS is a cellular 
extract of a strain of Escherichia coli overexpressing Threonine synthase). Reactions were 
incubated at 25°C in 30 mM PIPES-Na buffer, pH 6.8. Time-points were collected at 0.33, 20, 90 
and 180 minutes, for reactions with mTSh2 and the negative controls, while for the positive control 
time-points were collected at 20 and 180 minutes. PHS and Pi were separated by denaturing 
PAGE, and results were quantitated using a Phosphor-Imager. 
 
 However, when the recombinant mTSh2 was incubated with PHS for a few hours 
and the reaction products were analyzed by TLC followed by ninhydrin coloration, no 
evidence was found for the generation of L-Thr (or of homoserine; data not shown). While 
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the physiological role of TS is to convert PHS to L-Thr and phosphate (formally a γ,β-
elimination/replacement reaction), the bacterial enzyme also slowly catalyzes a parasitic 
phospho-lyase (α,γ-elimination) reaction, converting PHS to α-ketobutyrate, phosphate 
and ammonia (Schildkraut & Greer, 1973). Two evidences indicated that mTSh2 was also 
capable of converting PHS to α-ketobutyrate.  
 
 
Figure 5. Analysis of reaction products. Both Control and Reaction were incubated 8 hours at 
25°C in 30 mM PIPES-Na buffer, pH 6.8. In the control the enzyme was omitted. (A) The presence 
of α-ketoacid in the reaction mixture was evaluated by measuring the oxidation of NADH at 340 nm 
(see Materials and Methods) after the addition of Lactate dehydrogenase. (B) ESI mass spectrum 
of the reaction mixture. The base peak shows an m/z ratio of 101.2 has reference to the expected 
product α-ketobutyrate.  
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First, when the products of the reaction between mTSh2 and PHS were added to a 
solution containing lactate dehydrogenase and NADH, they induced a complete oxidation 
of NADH to NAD+, suggesting that these products included a short-chain α-ketoacid 
(Figure 5A).  
Second, an analysis of the reaction products by electrospray ionization mass 
spectrometry (negative mode) revealed an intense peak corresponding to the mass 
expected for α-ketobutyrate (Figure 5B; see Materials and Methods).  
TSs are capable of forming α-ketobutyrate also from L-Thr (Laber , 1994; Skarstedt 
& Greer, 1973), but we exclude that this mechanism might be operating in the case of 
mTSh2. In fact, as noted, L-Thr was not formed in detectable amounts upon incubating 
mTSh2 with PHS. Moreover, the kinetics of formation of α-ketobutyrate, measured through 
a coupled assay with lactate dehydrogenase, were linear with time, with no lag phases. 
Finally, when mTSh2 was incubated with an excess L-Thr (10 mM), no appreciable 
formation of α-ketobutyrate was detected in several hours. Thus, α-ketobutyrate must be 
formed directly from PHS. The putative mechanism for such an α,γ-elimination reaction is 
given in Figure 6. 
The rate constant of α-ketobutyrate formation, measured in the presence of 
saturating PHS (6 mM), was 0.03 s-1 (pH 6.8, 25°C) and somewhat slower at higher pH 
values (up to pH 8.0; data not shown). When the kinetics were measured under near-
physiological conditions (pH 7.4, 37°C; Figure 7A) the calculated maximum activity was 
~80 nmoles min-1 mg-1, with a KM of 0.42 mM. 
Interestingly, the recombinant protein was also capable of producing α-ketobutyrate 
from PThr, at about the same rate (0.04 s-1 in the presence of 20 mM PThr), while it was 
almost inactive towards PSer. This datum indicates that mTSh2 can carry out both α,γ-
eliminations and α,β-eliminations on phosphorylated substrates.  
The PThr phospho-lyase reaction was somewhat faster than the reaction with PHS, 
but required higher substrate concentrations (Figure 7B). In fact, the calculated maximum 
activity of recombinant mTSh2 was ~500 nmoles min-1 mg-1, with a KM of 12 mM, with 
PThr as substrate. Not unexpectedly, the reaction was inhibited competitively by 
phosphate (Figure 7B). 
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Figure 6. Proposed mechanism for the reaction catalyzed by mTSh2 with PHS. The substrate 
(PHS) binds initially to the cofactor forming an aldimine (external Schiff base; the phosphate group 
of PLP is omitted for clarity). Removal of the α-proton of the amino acid yields a stabilized 
carbanionic intermediate (quinonoid, characterized by an absorption maximum in the 450-500 nm 
region). Subsequently, elimination of the phosphate group and protonation of the γ-carbon leads to 
formation of a new aldimine, the Schiff base of aminocrotonate. In the reaction catalyzed by TSs, 
the double bond of this intermediate undergoes a stereospecific hydration, to generate the Schiff 
base of L-Thr (dashed arrow). In mTSh2, instead, aminocrotonate may be released into the 
solvent, where it readily hydrolyzes to α-ketobutyrate and ammonia. 
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Figure 7. Kinetics of α-ketobutyrate formation. Initial rates of product formation were measured at 
pH 7.4, 37°C, in the absence or in the presence of 10 mM potassium phosphate. Least-squares fits 
to the Michaelis-Menten equation yielded. (A) PHS phospho-lyase reaction. Vmax=84 nmoles min-1 
mg-1 and KM=0.4 mM (no phosphate). (B) PThr phospho-lyase reaction. Vmax=560 nmoles min-1 mg-
1
 and KM=12 mM (no phosphate, black circles) and Vmax=540 nmoles min-1 mg-1 and KM=41 mM (10 
mM phosphate, white circles). The phospho-lyase reaction with PSer was ≥100-fold slower (no 
phosphate, black triangles down). 
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Discussion 
Why mTSh2 is not a TS 
mTSh2 shows a 38% identity to the yeast TS, but lacks TS activity, confirming that 
sequence similarity is a weak criterion for ascribing a function to a newly identified enzyme 
(Rost, 2002). A finer analysis of conservation at key active site positions helps understand 
why mTSh2 does not act as a TS. 
  There are a few crystal structures of TSs, showing the arrangement of amino acids 
in the active site (Omi, 2003; Garrido-Franco, 2002; Mass-Droux, 2006). In particular, a 
structure of the T. thermophilus TS (tThrS) complexed with the PHS analogue AP5 shows 
the interactions of the PLP-ligand conjugate with the active site residues (Omi, 2003), 
providing insights into TS function. In this structure, Phe134 and Asn188 interact closely 
with the side chain of the substrate analogue: the Phe ring forms a van der Waals contact 
with the γ-carbon of AP5, whereas the Asn amido group donates a hydrogen bond to the 
phosphonate of AP5 (Omi, 2003; Figure 8).  
 
 
 
Figure 8. Stereoview of the active site in tThrS. Close-up view of the active site of the tThrS-AP5 
complex in the closed form. The front and back of the figure are the solvent side (entrance of the 
active site) and the protein side (bottom of the active site), respectively. The α-helices, β-strands 
and loops are drawn in red, light blue, gray. Ala83, Phe134, Asn188 are coloured in light blue. The 
cofactor and AP5 are drawn in yellow with red phosphates. 
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In mTSh2, Phe134 and Asn188 are replaced by smaller amino acids (Ser and Ala, 
respectively; Figure 2), which seems consistent with a significant divergence in reaction 
specificity or mechanism. For example, since Phe134, Asn188 and Ala83 are located near 
the entrance of the TS active site, the mTSH2 active site could be more open to the 
solvent. 
 
An enzyme with phospho-lyase activity 
The occurrence of several active-site mutations might even suggest that mTSh2 is 
catalytically inactive. Recent genomic observations indicate that, in metazoa, enzyme 
homologs often assume non-catalytic functions – a role switch signaled by the 
accumulation of inactivating mutations (Pils & Schultz, 2004). In contrast to this 
hypothesis, however, we have shown that mTSh2 can still bind PLP, react with potential 
substrates (including PHS) forming recognizable reaction intermediates, and carry out 
specific elimination reactions.  
What is the physiological function of mTSh2? The preferential transcription of the 
gene in the liver and kidney is consistent with a catabolic role for the enzyme. The 
selectivity of recombinant mTSh2 toward a battery of ligands shows a preference for large 
phosphorylated amino acids. Both observations are substantiated by the finding that 
mTSh2 catalyzes elimination reactions with PHS and PThr. Nevertheless, it is doubtful that 
the reaction with PHS may have any metabolic relevance, as this compound is not known 
to be formed in animal metabolism (Connick, 1986). Free PThr, on the other hand, occurs 
in animal tissues, possibly deriving from the hydrolysis of phosphorylated proteins 
(Kataoka, 1991), and degradation of this amino acid may be one biological task of mTSh2.  
The activity of mTSh2 in the PThr phospho-lyase reaction is relatively modest, but 
comparable to those of other PLP-dependent enzymes. For example, TS from Arabidopsis 
thaliana, in the absence of the allosteric activator S-adenosylmethionine, shows a similar 
turnover number (Curien, 1998). In mouse cells, mTSh2 might be activated allosterically or 
through prost-translational modifications; alternatively, the main physiological substrate for 
mTSh2 might be some phosphorylated amino compound other than PThr. 
At least two PLP-dependent mammalian phospho-lyases have been described in 
the past: O-phosphoethanolamine phospho-lyase (Fleshood & Pitot, 1970) and O-
phosphohydroxylysine phospho-lyase (Tsai & Henderson, 1974). Both were originally 
purified from rat liver, and both have remained uncharacterized at the molecular level.  
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Clearly, mTSh2 cannot be identified with O-phosphoethanolamine phospho-lyase, 
since it does not bind O-phosphoethanolamine and since its predicted mass (≈54 kDa for 
the nonrecombinant protein) does not fit the mass reported for the rat enzyme (168 kDa; 
Fleshood & Pitot, 1970), even considering the possibility that in vivo mTSh2 may form 
dimers, as is the case with some TSs. 
The mass discrepancy also holds when comparing mTSh2 to O-
phosphohydroxylysine phospho-lyase (140 kDa; Tsai & Henderson, 1974); however we 
did not directly test the activity of mTSh2 against O-phosphohydroxylysine, a compound 
not available from commercial sources. 
 
Evolution of TSh2: a case of ‘enzyme recycling’ 
During evolution, the development of new enzyme functions is believed to occur 
mainly by recruiting proteins that already exist and catalyze similar reactions (O’Brien & 
Herschlag, 1999). In the simplest scenario, the triggering event is a duplication of the gene 
encoding the enzyme, which relieves the selective constraints on one gene copy, allowing 
for potential functional diversification.  
The TSh2 case hints at the possibility of a different evolutionary mechanism. 
Namely, it suggests that dismissal of the L-Thr biosynthetic pathway (somewhere after the 
separation between the fungal and animal lineages), rather than gene duplication, may 
have freed the TS gene from the selective constraints of ancestral function, allowing 
evolution of the gene product into a catabolic phospho-lyase.  
Analogous instances of ‘enzyme recycling’ are rare, but not unprecedented. For 
example, while mammals have lost the ability to degrade allantoin, they retain some of the 
enzymes in the allantoin degradation pathway, for reasons that are not fully clear (Fujiwara 
& Noguchi, 1995; Vigetti, 2002).  
Of course, we cannot rigorously exclude that TSh2 might have originally emerged 
as a duplicated copy of TS, before disappearance of the latter gene in the metazoan 
lineage. However, homology searches in complete genomes did not reveal any extant 
organism containing both a TS and a TSh2 gene (not shown). 
It should be noted that the biochemical requisites underlying the ‘enzyme recycling’ 
mechanism sketched above are similar to those required by the ‘gene duplication’ 
scenario. In both instances, evolution of a novel catalytic function is greatly facilitated if the 
original enzyme already possesses (perhaps at low levels) a secondary activity, which can 
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be improved and selected (O’Brien & Herschlag, 1999). This is the case for TS, which is 
intrinsically able to act as a degradative phospho-lyase (Schildkraut & Greer, 1973). 
 
Speculative considerations on TSh1 
Compared to TSh2 proteins, the enzymes encoded by TSh1 genes show a slightly 
lower overall similarity to fungal TSs, but retain all the strictly conserved residues (Figure 
2).  Despite this, we deem that these enzymes, too, do not act physiologically as TSs. This 
view is in keeping with the long-standing recognition of L-Thr as an essential amino acid in 
animals (Fitzgerald & Szmant, 1997; Payne & Loomis, 2006) and with the absence of 
other L-Thr biosynthetic genes in vertebrate genomes (Payne & Loomis, 2006). 
At present, we can only speculate about the possible function of TSh1 genes. In 
particular, since transcription of such genes occurs mainly in the brain and in endocrine 
glands, it is tempting to hypothesize the involvement of TSh1 in the metabolism of some 
chemical mediator. In fact, higher eukaryotes often employ PLP-dependent enzymes for 
the synthesis and degradation of hormones and chemical messengers, and these 
enzymes can be strict homologs of enzymes involved in basic metabolic pathways 
(Percudani & Peracchi, 2003; Iyer, 2004).  
 
Conclusions 
In the past, TS was considered a promising target for the development of selective 
antimicrobial drugs or herbicides (Harde , 1994), as it was postulated that this enzyme 
would not occur in animals, but only in prokaryotes, fungi and plants. However, the 
occurrence in vertebrates of TShs (at least some of which can bind the true TS substrate) 
casts serious doubts on this axiom, implying that the design of selective TS inhibitors may 
be extremely challenging. 
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Introduction 
Alanine-glyoxylate aminotransferase (AGT; EC 2.6.1.44) is pyridoxal 5’-
phosphate-dependent enzyme, distributed in a wide range of animal species. It 
employs the organic cofactor to transfer the amino group of L-alanine to glyoxylate, 
producing pyruvate and glycine (Rowsell, 1969; Noguchi, 1978; Rowsell, 1972; 
Scheme 1). 
 
Scheme 1 
 
+ +
L-alanine
O
HO O
glyoxylate
O
HO O
pyruvate
O
HO NH2
glycine
O
HO NH2
 
Scheme 1. Reaction catalyzed by alanine-glyoxylate aminotransferase. 
 
Two forms of AGT were identified in animal cells (Noguchi, 1978; Noguchi, 
1987); one, designated AGT1, has an Mr of 80KDa with 2 identical subunits, and is 
present both in the mitochondria and in the peroxisomes. AGT enzymes from both 
organelles show identical physical, enzymatic and immunologic properties. The AGT, 
designated AGT2, has an Mr of 220KDa with 4 identical subunits. AGT1 is identical 
with serine-pyruvate aminotransferase (EC 2.6.1.51) and shows broad substrate 
specificity; in contrast, AGT2 is present only in the mitochondria, and is specific for L-
alanine and glyoxylate (Noguchi, 1978; Takada, 1982). 
The structure of human AGT1 has been solved (Zhang, 2003; Meyer, 2005), 
and the overall fold is similar to other enzymes of the fold-type I group (Grishin, 1995; 
Mehta & Christen, 2000; Christen & Mehta, 2001) the largest and the functionally 
most diverse family of PLP-dependent enzymes. Representative members of this 
group, in addition to alanine-glyoxylate aminotransferase, are 2,2-dialkyglycine 
decarboxylase, 4-aminobutyrate aminotransferase and ornithine aminotransferase 
(Mehta & Christen, 2000). 
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Clinical interest arose around alanine-glyoxylate aminotransferases because 
of their key role in glyoxylate detoxification. In fact, an AGT deficiency is the cause of 
Primary hyperoxaluria type 1 (PH1), a rare autosomal recessive disease 
characterized by progressive kidney failure due to renal deposition of calcium oxalate 
(Latta, 1990; Coulter-Mackie, 2004; Danpure, 2006). In AGT deficiency, glyoxylate is 
converted to oxalate, which forms insoluble calcium salts that accumulate in the 
kidney and other organs, culminating in renal failure and systemic oxalosis (Figure 
1). 
 
 
 
Figure 1. Metabolic consequences of peroxisomal AGT deficiency in PH1. AGT, 
alanine:glyoxylate aminotransferase; DAO, D-amino acid oxidase; GO, glycolate oxidase; 
GRHPR, glyoxylate/hydroxypyruvate reductase; LDH, lactate dehydrogenase. Solid arrows, 
metabolic conversions; dotted arrows, membrane or other transport. 
 
In a recent bioinformatics study, a series of complete or near-complete 
genomes were scanned to obtain an inventory and a preliminary classification of 
genes that encode PLP-dependent enzymes (Percudani & Peracchi, 2003).  
This analysis identified, in the genomes of several vertebrates (including man), 
two genes showing a high similarity to the second form of alanine-glyoxylate 
aminotransferase (these homologs are called AGXT2L1 and AGXT2L2). Both these 
genes coded for cytosolic proteins, this observation raised the intriguing possibility 
that an unknown cytosolic form of AGT might be expressed. If this hypothesis were 
confirmed, new perspective would open for treatment of primary hyperoxaluria-1.  
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However, these could be yet another example of genes identified as coding for 
enzymes with a defined activity (in this case, an alanine-glyoxylate aminotransferase 
activity) only based on sequence criteria, which however possess an activity different 
from the predicted (Roost, 2002).  
Moreover, it is reasonable to expect the discovery of PLP-dependent enzymes 
with activities that are not yet described or characterized, several examples support 
this possibility (Abe, 2006; Brushaber, 1998; Donini, 2006; Wolosker, 1999).      
The present chapter describes the bioinformatic analysis of the two AGT2-like 
genes, as well as the cloning of cDNAs encoding the two homologs, and the 
successive initial characterization of the expressed and purified recombinant 
proteins. 
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Materials and Methods 
Materials  
DNA primers were purchased from MWG Biotech (Ebersberg, Germany). 
Rabbit muscle lactate dehydrogenase (LDH) was purchased from Fluka. All the 
potential amino group donors were from Fluka, or Sigma-Aldrich. All the amino group 
acceptors were from Sigma-Aldrich. PLP, PMP, NADH and NADP+ were from Fluka. 
All other chemicals were of the highest purity available. 
 
Bioinformatics  
Initial identification of alanine-glyoxylate aminotransferase-like (AGXTL) genes 
in animal genomes was achieved through a search of PLP-dependent enzymes in 
genomic sequences using profiles Hidden Markov Models (HMM; Percudani & 
Peracchi, 2003).  
Prediction of protein localization sites in cells was inferred using two different 
programs, PSORT ΙΙ (http://psort.nibb.ac.jp/form2.html; Nakai & Horton, 1997 ) and 
pTarget (http://bioapps.rit.albany.edu/pTARGET/; Guda & Subramaniam, 2005). 
Physical and chemical parameters for each protein were calculated by means of 
ProtParam (http://psort.nibb.ac.jp/form2.html; Nakai & Horton, 1997 ) . 
The tissue-specific expression profile of AGXT2L1 and AGXT2L2  sequences 
was inferred using the UniGene's EST ProfileViewer at the National Center for 
Biotechnology Information (NCBI). Homology searches were performed at the B6 
DataBase (http://160.78.90.170/cgi-bin/bioinformatics/B6db/home.pl) using protein 
Blast.  
Multiple sequence alignments were produced with ClustalX (Thompson, 
1997). Phylogenetic analysis of alanine-glyoxylate aminotransferase-like was 
performed with the Boostrap Neighbor-joining method as implemented in the 
program ClustalX and tree-files in Phylip format were interpreted into visual trees by 
TreeView (http://taxonomy.zoology.gla.ac.uk/rod/treeview.html). 
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Molecular cloning of AGXT2L1 and AGXT2L2 cDNAs  
Clones of the complete cDNAs for both AGXT2L1 and AGXT2L2 (respectively, 
IMAGE Consortium ID 4797767 and 5220434, cDNA from different tissues) were 
obtained from RZPD (Berlin, Germany). 
 Both coding sequences were amplified from these clones, however the 
protocols were different. AGXT2L1 was amplified using the Fidelity Taq DNA 
polymerase (Stratagene) and adopting the following PCR conditions: 5 min of initial 
denaturation at 94°C, 3 cycles of 30 s denaturation at 94°C and  30 s annealing at 
46°C, followed by 120 s polymerization at 72°C, afterwards 25 cycles of 30 s 
denaturation at 95°C and  30 s annealing at 56°C, followed by 120 s  polymerization 
at 72°C. 
AGXT2L2 was also amplified using the Fidelity Taq DNA polymerase, but the 
adopted PCR conditions were different: 3 min of initial denaturation at 94°C, 25 
cycles of 30 s denaturation at 94°C and  30 s annealing at 57°C, followed by 120 s 
polymerization at 72°C. 
 The gene-specific primers were: 
 
 AGXT2L1_cpo+  atCGGTCCGatgtgcgagctgtacagtaagc 
AGXT2L1_cpo-  atCGGACCGatcttgctttaaaatgcaaatcag 
 
 
           AGXT2L2_cpo+  atCGGTCCGatggccgcagaccagcgc 
AGXT2L2_cpo-  atCGGACCGtaggcagagcagggctggc 
 
Underlined residues correspond to the start codon. The 5’ region of all the 
primers contained sequences (uppercase letters) recognized by the restriction 
enzyme CpoI, so that the amplification product contained restriction sites near to both 
ends. 
Amplicons were directly cloned into the vector pBlueScript ΙΙ KS+ (Stratagene) 
treated with SmaI (Bolchi, 2005). The cloned inserts were transformed into XL1B 
Escherichia coli cells (Stratagene) and sequence-verified. Then amplicons were 
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treated with CpoI and subcloned into the expression vector pET28-H6-Cpo (digested 
with CpoI, too).  
This plasmid is a derivative of pET28 (Novagen, Madison, WI) modified to 
present a single CpoI restriction site in the cloning region, downstream to a sequence 
encoding a hexahistidine tag.  A schematic description of the molecular cloning 
strategy is shown in Figure 2. 
 
Figure 2. Overview of the general procedure adopted for the molecular cloning and 
recombinant expression of AGXT2L1 and AGXT2L2.  
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In vitro site-directed mutagenesis of the AGXT2L2 clone 
The mutated AGXT2L2 was corrected using the QuikChangeTM site-direct 
mutagenesis method (Stratagene). Two oligonucleotide primers containing the 
desired mutation were extended during PCR, using the Pfu Ultra DNA polymerase 
(Stratagene) and adopting the following conditions: 5 min of initial denaturation at 
94°C, 12 cycles of 30 s denaturation at 95°C and  60 s annealing at 55°C, followed 
by 80 s polymerization at 72°C. 
 The primers were: 
 
 AGXT2L2_Anti  5’-ctgcgtggccgcaaACccagcctgtggcg-3’ 
AGXT2L2_Sense  5’-cgccacaggctggGTtgcggccacgcag-3’ 
 
Each primer is designed as recommended by the kit manufacturer. In the 
sequences, uppercase letters represent the desired mutation. Then, the corrected 
amplicon was transformed into XL1B Escherichia coli cells (Stratagene) and the 
identity of the construct was confirmed by DNA sequencing. 
 
Heterologous gene expression and protein purification 
The cloned inserts were then transformed into BL21-CodonPlus®-RIL 
Escherichia coli cells (BL21 codon+; Novagene), BL21 Star™ Escherichia coli cells 
(BL21 Star, Novagene) and Origami Escherichia coli cells (Novagene).  
Except for Origami, in the other two strains of E. coli the recombinant protein 
was expressed efficiently. However, BL21 Star was adopted as the expression 
system, because of the slightly higher fraction of soluble protein obtained. 
For AGXT2L1 a subculture was used to inoculate 1 liter of Lauria-Bertani (LB) 
broth containing 50 µg●ml-1 kanamycin (Sigma). The cells were grown at 37°C in 
vigorous aeration and agitation. After ∼ 3 h, when the cell density corresponded to an 
absorbance of ∼ 0.6 at 600 nm, isopropyl β-D-thiogalactoside (1 mM) was added.  
After aerobic culturing for 3 gg at 12°C, cell paste was obtained by 
centrifugation and stored at -80°C. The same procedure was employed to AGXT2L2 
expression, but in this case a minimal medium (M9) was used for the cellular growth. 
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After cell sonication, the soluble lysate fraction was loaded onto a metal-
affinity resin (Talon; Clontech) equilibrated in Buffer A (5% glycerol/ 300 mM NaCl/ 50 
mM phosphate-Na buffer pH 7.0) supplemented with 40 µM PLP, 5 mM β-
mercaptoethanol and protease inhibitors (1 µM leupeptine, 1 µM pepstatine, 0.5 mM 
benzamidine, 0.5 mM phenyl methyl sulfonyl fluoride). The recombinants AGXT2L1 
and AGXT2L2, carrying an N-terminal hexahistidine tag, were purified following the 
manufacturer’s instructions. 
The composition and purity of each protein fraction was assessed by gel 
electrophoresis on SDS-polyacrylamide (11%) gels (Laemmli, 1970); fractions with a 
purity > 90% were pooled, dialyzed against buffer A supplemented with 4 µM PLP 
and 1 mM dithiothreitol, and stored at -80 °C.  
The concentration of each purified recombinant protein was estimated by the 
Bradford assay (Bradford, 1976) with bovine serum albumin as a standard, and 
confirmed based on the calculated extinction coefficient at 280 nm (Gill & von Hippel, 
1989). 
 
Spectrophotometric measurements  
Solutions containing recombinant protein (6 µM final) in 40 mM bis-tris 
propane (BTP) buffer (pH 8), were supplemented with various potential substrates 
(10 mM, unless specified otherwise). Spectral changes were monitored using a Cary 
400 spectrophotometer (Varian). Cuvette holders were thermostated at 25 °C. Time-
dependent spectral changes (time-courses) and titration data were analyzed by 
nonlinear least-squares fitting to the appropriate kinetic or thermodynamic equation 
using Sigma Plot (SPSS Inc.). 
 
Enzymatic assays  
The cysteine aminotransferase assay (200 µl final volume) contained 40 mM 
BTP buffer (pH 8), 1 mM of α-keto acid, 20 mM of L-Cys, 0.25 mM NADH, 1.4 
units/ml lactate dehydrogenase, while the enzyme was 6 µM. Reactions were 
conducted at 37°C, and the rate of β-mercaptopyruvate production was measured 
following the disappearance of NADH at 340 nm.   
The possible disappearance of L-cysteine and the formation of a new amino 
acid was tested by incubating L-Cys in the same reaction conditions of the cysteine 
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amino transferase assay and then running the reaction mixture on a silica TLC plate, 
side-by-side with amino acid standards (L-Cys and the L-amino acid corresponding 
to the α-keto acid tested). Amino acids were visualized with fuorescamine (Meola 
and Brown, 1974).  
In order to assay the cysteine lyase activity, L-cysteine, and D-cysteine, were 
used as substrates and the rates of pyruvate production were measured 
spectrophotometrically by a coupled assay, in which the enzyme (6 µM) and 
substrate (10 mM) were incubated in the presence of lactate dehydrogenase and 
NADH. The reaction mixture (200 µl final volume) contained 40 mM BTP buffer (pH 
8), 0.25 mM NADH, 2 units/ml lactate dehydrogenase. The reactions were conducted 
at 37°C, and the disappearance of NADH was monitored at 340 nm. 
 
Thiazolidine formation  assay  
In order to detect the formation of thiazolidine (TZA), a general and simple 
method for the conjugation of L-cysteine and PLP was developed. This method is 
based on the specific reaction of the L-cysteine with the aldehyde group from 
cofactor under the same conditions used to evaluated the affinity of each enzyme 
with different ligands. 
Solutions containing PLP (250 µM final) in 40 mM BTP buffer (pH 8), were 
supplemented with L-Cys (5 mM). Spectral changes were monitored using a Cary 
400 spectrophotometer (Varian). Cuvette holders were thermostated at 30 °C. 
Spectral changes data were analyzed by nonlinear least-squares fitting to the 
appropriate kinetic or thermodynamic equation using Sigma Plot (SPSS Inc.). 
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Results 
Identification of AGXT2L1 and AGXT2L2  genes 
To help the identification and functional assignment of PLP-dependent enzymes, 
our group has created a database of PLP-dependent enzymatic activities and sequences 
(Percudani & Peracchi, 2003). While performing an inventory of PLP-dependent enzymes 
in different organisms it was noticed that several invertebrates and vertebrate genomes 
contained genes encoding proteins similar to the mitochondrial alanine-glyoxylate 
aminotransferase (AGT2), despite the fact that two other alanine-glyoxylate 
aminotransferase (AGXT1 and AGXT2) are known to occur in vertebrates. 
Notably, in vertebrates these alanine-glyoxylate aminotransferase-like (AGXTL) 
sequences are divided into two enzyme subtypes, AGXT2L1 and AGXT2L2, which 
generally were co-present in the same organism. A list of genes, some of which are 
annotated as AGXTL in public databases, is presented in Table 1. 
The human AGXT2L1 gene encodes a 499-amino acid protein with a 36% identity 
and 55% similarity to the human AGT2. While, the human AGXT2L2 gene encodes a 450-
amino acid protein with 36% identity and 58% similarity to AGT2. The most obvious 
difference between the two genes lies in a 40-aa C-terminal tail which occurs in the 
AGXT2L1 lineage and is absent in the AGXT2L2 gene products. 
Moreover, multiple sequence alignment of the AGXT2L1 and AGXT2L2 revealed a 
∼ 30% identity with enzymes of the AT ΙΙ subfamily in the fold-type Ι family (Mehta & 
Christen, 2000; data not show). 
In silico characterization of AGXT2L1 and AGXT2L2 has predicted molecular mass 
of 58 kDa and 52 kDa, respectively. According to several programs predicting the 
intracellular localization of proteins in the cell, both the enzymes should be cytoplasmic. 
Examination of the ESTs databases indicated that mRNAs for both genes are 
present in tissues from their respective organisms, confirming that the genes are 
expressed. Based on the high frequency with which transcripts are found in public EST 
libraries, expression of AGXT2L1 and AGXT2L2 appears to occur at high levels in 
humans. AGXT2L1 gene transcripts are observed predominantly in the brain, kidney and 
liver. AGXT2L2 transcripts are also detected in the brain, kidney and liver, however this 
gene is expressed in almost all the tissues.   
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Table 1 
List of metazoan genes encoding AGT2 or AGT2-like proteins 
Group Organism Abbreviation GenBank/Ensembl Accession # 
Predicted 
Protein Size 
(aa)a 
AGT2 Homo sapiens Hsa NP_114106 514 
 Rattus norvegicus Rno BAA07281 512 
     
AGXT2L Tribolium castaneum Tca XP_969816 472 
 Caenohrabditis  briggsae Cbr XP_001671708 467 
 Caenohrabditis  elegans Cel NP_001023346 467 
 Ciona intestinalis Cin AK114044 427 
 Glossina morsitans morsitans Gmm ABG77981 494 
 Aedes aegypti Aae XP_001656046 490 
 Apis mellifera Ame XP_392348 482 
 Strongylocentrotus purpuratus Spu XP_001187418 531 
 Anopheles gambiae Aga XP_310808 462 
 Drosophila melanogaster Dme NP_648665 494 
     
AGXT2L1 Homo sapiens Hsa1 Q8TBG4 499 
 Macaca fascicularis Mfa1 XP_001087348 499 
 Bos taurus Bta1 NP_001015605 497 
 Mus musculus Mmu1 Q8BWU8 499 
 Gallus gallus Gga1 XP_426301 505 
 Danio rerio Dre1 Q7SY54 492 
 Xenopus laevis Xla1 Q6DEB1 509 
 Rattus norvegicus Rno1 XP_001076965 472 
     
AGXT2L2 Homo sapiens Hsa2 Q8IUZ5 450 
 Macaca fascicularis Mfa2 XP_001095786 450 
 Bos taurus Bta2 XP_617398 450 
 Mus musculus Mmu2 Q8R1K4 467 
 Gallus gallus Gga2 XP_414688 533 
 Canis familiaris Cfa2 XP_538569 450 
 Danio rerio Dre2 NP_001032646 447 
 Tetraodon nigroviridis Tni2 CAG01207 434 
 
Table 1. The group, organism source, abbreviation, databank accession number, protein length, 
are shown for all the genes encoding alanine-glyoxylate aminotransferase-like proteins, or 
validated AGT2. aWhen multiple splice variants of the gene product are included in the databases, 
the size refers to the longest predicted polypeptide. 
 
Comparison and phylogeny of AGXT2L  gene products 
Preliminary phylogenetic of all the 26 amino acid sequences for AGT-like proteins 
illustrates the differences between vertebrates and invertebrates. In fact, the genomes of 
invertebrates such as C. elegans and insects contain a single AGT2-like gene. While, 
AGXT2L1 and AGXT2L2 seem derived from duplication of a single ancestor during 
metazoan evolution (Figure 3). 
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Figure 3. Phylogenetic tree of AGXTL proteins. The unrooted Neighbor-joining phylogenetic tree 
was constructed with the program ClustalX and displayed with the TreeView program. Sequences 
are indicated with abbreviations in Table 1.  
 
Multiple sequence alignment of AGT-like proteins with validated AGTs, confirmed 
significant homology, the catalytic lysine are conserved, too (Figure 4; Lee, 1995). Of the 
two vertebrate gene products, the AGXT2L2 proteins are slightly more divergent from the 
presumed ancestor.  
This may be appreciated especially by looking at a few diagnostic positions: in 
particular, at the position corresponding to C106 in the human AGXT2L1, all AGXT2L1 
and invertebrate AGXT2L contain a cysteine residue, whereas the AGXT2L2 proteins 
contain a phenylalanine; similarity, at position 218, all AGXT2L1 and most invertebrate 
AGXT2L proteins contain cysteine, whereas the AGXT2L2 proteins contain Val; at position 
211, AGXT2L1 and invertebrates AGXTL contain Ile, but AGXT2L2 proteins contain Phe 
(Figure 4). 
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Figure 4. Comparison of the amino acid sequence around the PLP-binding sites of AGT from 
Homo sapiens (NP_114106), and Rattus norvegicus (BAA07281) with AGT2-like proteins. A color-
scale represents the conservation: residues that are absolutely conserved are red, instead 
residues that are not conserved are blue. The black arrows signal those residues that are mutated 
between AGXT2L1, and AGXT2L2. The red arrow marks the catalytic lysine residue that binds the 
PLP cofactor through a Schiff base linkage.  
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Unfortunately there are not crystal structures of AGT2, showing the arrangement of 
residue involved in the active site. In order to understand how the active site could be 
organized, the amino acid sequences of AGXT2L1 and AGXT2L2 were compared with 
other enzymes classified in the AT ΙΙ subfamily, such that of AGT2 (Lee, 1995), which was 
characterized their structure, and the role played in the active site (Table 2). 
Notably, AGXT2L1 and AGXT2L2 were significantly homologous to P. cepacia 2,2-
dialkylglycine decarboxylase (Fogle, 2005; Keller, 1990; EC 4.1.1.64), H. sapiens ornithine 
aminotransferase (Shen, 1998; EC 2.6.1.13) and S. scrofa 4-aminobutyrate 
aminotransferase (Storici, 1999; Storici, 2004; EC 4.6.1.19). In fact, the active site 
sequences were well conserved among these validated enzymes, mainly in the PLP-
binding region (Figure 5; Table 2). 
 
Table 2 
Comparisons of the active site residues involved in the PLP-binding 
 
Role in the 
active site AGXT2L1 AGXT2L2 DGD OAT GABA-AT 
      
Catalytic Lysine K278 K278 K270 K292 K329 
      
Binds N1 PLP D246 D246 D241 D263 D298 
      
Binds O3 PLP Q249 Q249 Q244 Q266 Q301 
      
Supports the 
pyridine ring 
V248 
Y139 
I248 
Y140 
A243 
W1136 
I265 
F177 
V300 
F189 
      
Binds the oxygens 
of the Pi group 
S113 
G112 
T309 
S114 
G113 
T309 
A110 
G109 
T302 
V143 
G142 
T322 
S137 
G136 
T353 
      
 
Table 2. Topographical alignment of the active site residues among various PLP-dependent 
enzymes of the AT ΙΙ subfamily and both the recombinant enzymes. All the structures of the 
enzymes considered herein, except AGXT2L1 and AGXT2L2, have been characterized. Legend: 
P. cepacia 2,2-dialkylglycine decarboxylase (DGD), H. sapiens ornithine aminotransferase (OAT), 
S. scrofa 4-aminobutyrate aminotransferase (GABA-AT). 
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Figure 5. Alignment of the amino acid sequences of AGXT2L1 and AGX2L2, with those of P. 
cepacia 2,2-dialkylglycine decarboxylase (DGD), H. sapiens ornithine aminotransferase (OAT), S. 
scrofa 4-aminobutyrate aminotransferase (GABA-AT). A color-scale represents the conservation: 
identical residues are red, instead residues that are not conserved are blue. The black arrows 
signal those residues that bind the PLP cofactor. The red arrow marks the catalytic lysine residue 
that binds the PLP cofactor through a Schiff base linkage.  
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While the closest validated homologs of AGXT2L sequences are indeed metazoan 
AGT2 enzymes, there are other proteins of unknown function that show an even higher 
similarity to AGXT2L. These are (1) a series of peroxisomal plant enzymes that do not 
catalyze the transamination of glyoxylate and for whom the metabolic significance remains 
obscure (Liepman, 2003); (2) a series of bacterial enzymes (for example NP_437638 from 
Sinorhizobium) that are normally expressed as fusion proteins with an additional domain. 
This additional domain codes for a homoserine kynase type ΙΙ, but this function is only 
predicted; in fact, this definition apparently comes from a previous bioinformatic study 
(Gophna, 2005). The domain is also annotated as belonging to a phosphotransferase 
enzyme family that includes bacterial antibiotic resistance proteins, which confer 
resistance to various aminoglycosides.  
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Cloning,  expression and purification of recombinant AGXT2L1 and AGXT2L2 
The full-length human genes nucleotide sequences obtained from the IMAGE 
consortium (http://image.llnl.gov) were utilized to amplify the cDNAs fragment by PCR. 
Since Escherichia coli is by far the most widely employed host, and was used for example 
for the expression of wild type AGT1 (Lumb, 2000; Coulter-Mackie, 2004), and since post-
translational modifications of the products are presumably not essential, this organism was 
used for the expression of recombinant AGXT2L1 and AGXT2L2 (see Methods). 
Attempts to subclone AGXT2L1 in an E. coli expression vector were successful: 
several positive colonies were obtained, and the cloned insert, after sequence verification, 
did not contain frameshifts or deletions. However, when subcloning AGXT2L2 in the same 
E. coli expression vector, only one positive colony was observed; moreover, after 
sequence verification, the cloned insert contained a missense mutation, such that the 
mutated codon (acc → gac) coded for Asp instead of Thr. By employing the QuikChangeTM 
site-direct mutagenesis method (Stratagene), the original gene sequence was restored.  
The expression of both recombinant proteins in E. coli BL21 Star, and their 
purification by cobalt-resin affinity chromatography are described in the Materials and 
Methods. A great yield of soluble AGXT2L1 (~50% of the total recombinant protein) was 
obtained; in contrast, overexpression of AGXT2L2 protein was accomplished, but soluble 
protein could only be obtained in low yields (~10% of the total recombinant protein). 
Recombinant AGXT2L1 was 521 residues long (including the N-terminal 
hexahistidine tag) with a calculated molecular mass of 58 kDa. While AGXT2L2 was 472 
residues long (the N-terminal hexahistidine tag is included) with a calculated molecular 
mass of 52 kDa. Purified AGXT2L1 and AGXT2L2 were homogenous by SDS-PAGE (data 
not show), and exhibited the characteristic PLP absorption maximum at 408 nm for 
AGXT2L1 (Figure 6) and at 412 nm for AGXT2L2 (Figure 7). 
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Interaction of AGXT2L1 and AGXT2L2 with potential substrates 
AGT, like many other aminotransferases, operates by the same basic mechanism. 
Initially, L-alanine reacts with the pyridoxal form of the enzyme (E-PLP) to yield the keto 
acid (pyruvate) and the pyridoxamine form of the enzyme (E-PMP). In the second half-
transamination, glyoxylate reacts with E-PMP to reform E-PLP and glycine (Scheme 1).  
Usually, for aminotransferases, the pyridoxal form and pyridoxamine form of the 
enzyme show different absorption peaks, with a maxima at 410-420 nm (for E-PLP) and at 
∼ 330-340 nm (for E-PMP). Human alanine-glyoxylate aminotransferase 1 has been 
characterized by means of these spectroscopic properties (Cellini, 2007).  
Thus, AGXT2L1 and AGXT2L2, could be preliminarily characterized by monitoring 
the binding of substrates, substrate analogs and inhibitors, as well as the formation of 
catalytic intermediates by UV-absorption spectroscopy (e.g., Laber, 1994; Mozzarelli, 
1989; Sterk & Gehring, 1991; Karsten & Cook, 2002). 
First, the interaction of AGXT2L1 with L-Ala, or Gly (the physiological substrates of 
AGT) was tested spectroscopically. However, L-Ala and Gly did not induced absorption 
change spectra (data not shown), hinting that the enzyme may not be binding these amino 
acids. Analogous results were obtained with most of the other standard amino acids tested 
as ligands.  
In contrast, significant spectral changes were observed with L-Cys and L-Glu. 
Noteworthy, upon addition, L-cysteine induced a bigger change in absorbance, than L-Glu, 
suggesting an higher affinity for this ligand (Figure 6A).  
Mixing of AGXT2L1 with L-Cys, induces in the immediate appearance of a 
maximum band at 330 nm, and the disappearance of maximum band at 410 nm. This kind 
of change in absorbance takes place during the first half-transamination; in fact, the peak 
at 408 nm represents the E-PLP, while the peak at 330 nm resembles the typical 
absorption peak for E-PMP (Figure 6A). 
In contrast, addition of L-Glu at the same concentration did not induce an immediate 
change in absorption, but several minutes were necessary to detect spectral changes 
attributable to the first half-transamination (Figure 6A). 
Based on to the above results, compounds that show similarity to L-cysteine were 
tested spectroscopically. Only DL-homocysteate and cystathionine did not induce 
absorption changes (data not shown), while the addition of D-cysteine, DL-homocysteine, 
or cysteamine resulted in absorption changes compatible with the appearance of the 
species E-PMP, and the disappearance of E-PLP (Figure 6B).  
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Figure 6. Absorption spectra of AGXT2L1 in the presence and absence of amino acid ligands. The 
protein (6 µM) was incubated in 40 mM BTP, pH 8, 37°C. (A) Absorption spectra were recorded in 
the absence of ligands (dotted line) or in the presence of 10 mM L-Cys or 10 mM L-Glu (after 10’). 
(B) Absorption spectral change of AGXT2L1 (dotted line) in the presence of L-Cys analogous 
(ligands final concentrations was 10 mM). The ligands tested were D-cysteine (D-Cys), 
Cysteamine, DL-homocysteine (DL-HCys). 
   
Also for AGXT2L2 the interaction with L-Ala, or Gly (the physiological substrates of 
AGT) were tested spectroscopically. This enzyme, too, did not show affinity for these 
ligands. Moreover, as with AGXT2L1, most of the other standard amino acids, except L-
Cys, failed to give appreciable absorption changes (Table 3).  
However, this enzyme did not show a response identical to AGXT2L1. In fact, only 
binding of L-Cys was detected, instead addition of L-Glu did not induced absorption 
changes (Figure 7A). In order to compare the substrate specificity between these two 
PLP-dependent enzymes, compounds that show similarity to the substrate were tested 
spectroscopically in presence of AGXT2L2 (Figure 7B).  
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Figure 7. Absorption spectra of the purified recombinant AGXT2L2 in the presence and absence of 
amino acid ligands. Enzyme in native form (6 µM) was incubated in 40 mM BTP, pH 8, 37°C. (A) 
Absorption spectra were recorded in the absence of ligands (dotted line) or in the presence of 10 
mM L-Cys or 10 mM L-Glu. (B) Absorption spectral change of AGXT2L2 (dotted line) in the 
presence of L-Cys analogous (ligands final concentrations was 10 mM). The compound tested 
were D-cysteine (D-Cys), Cysteamine, DL-homocysteine (DL-HCys).   
 
Similar to AGXT2L1, the absorption spectrum of AGXT2L2 was changed in 
presence of the same ligands, however some differences were observed (Table 3); 
addition of D-cysteine induced formation of an higher peak at 330nm, suggesting better 
affinity of this enzyme for this ligand.  In contrast, with cysteamine, AGXT2L2 seems to 
show lower affinity. Only addition of DL-homocysteine gave similar results compared to the 
AGXT2L1 spectra (Figure 7B). 
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Table 3 
List of ligands tested 
Ligand AGXT2L1 AGXT2L2 
glycine - - 
L-alanine - - 
L-methionine - - 
L-valine - - 
L-isoleucine - - 
L-leucine - - 
L-lysine - - 
L-arginine - - 
L-threonine - - 
L-serine - - 
L-tryptophan - - 
L-phenylalanine - - 
L-tyrosine - - 
L-glutamate +/- - 
L-glutamine - - 
L-aspartate - - 
L-asparagine - - 
L-histidine - - 
L-cysteine ++++ ++++ 
   
D-cysteine ++ +++ 
DL-homocysteine +++ +++ 
cysteamine +++ ++ 
L-ornithine - - 
L-kynurenine - - 
γ-aminobutyric acid - - 
DL-homocysteate - - 
cystathionine - - 
 
Table 3. Ligands specificity of AGXT2L1 and AGXT2L2. relative specificity for different substrates 
is valuated measuring the change in ratio E-PMP/E-PLP. Spectra were perform at the same 
condition for all the compound (see Materials and Method).    
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Cysteine-oxoglutarate aminotransferase activity assay of AGXT2L1 
Based on its interactions with L-Cys and L-Glu, AGXT2L1 could be hypothesized to 
be a cysteine-oxoglutarate aminotransferase (CGT); notably, examples of this activity are 
documented in the literature (Ip, 1977; Akagi, 1982). 
CGT activity was assayed for AGXT2L1. The activity was measured as described in 
the Materials and Methods. However, negligible, or inexistent, β-mercaptopyruvate 
production was detected (data not show). 
Also, when AGXT2L1 was incubated with cysteine and oxoglutarate (under the 
same conditions of the coupled assay) for a few hours and the reaction products were 
analyzed by TLC followed by fluorescamine coloration, no evidence was found for the 
generation of L-Glu and disappearance of L-Cys (data not show).     
 
The spectral changes induced by L-Cys are due to formation of a thiazolidine adduct 
 
Thiazolidine (TZA) is a 5-membered saturated ring with an amine group and a 
sulfide group in 1 and 3 positions (Scheme 2; Canle, 1996), that can form upon reaction of 
PLP with various amino thiols (Ponticelli, 1983). 
 In principle, the spectrum of the thiazolidine formed by L-Cys with PLP should 
resemble the spectrum of PMP. If the cromophoric species shown for example in Figure 
6A were a thiazolidine adduct, this could explane the absence of activity as CGT for 
AGXT2L1 (Scheme 2). 
To test this hypothesis the formation of a TZA was assayed, in presence of L-
cysteine and PLP, by a spectrophotometric method as described (see in Matherials and 
Methods). When the amino acid was added the PLP spectrum showed the appearance of 
a band with maximum at 330 nm, undistinguishable from the peak of PMP. This datum 
supports the hypothesis that both the recombinant enzymes can bind L-Cys, in an 
unproductive way (data not show).    
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N
H
O-
OP
OH
HO
O
HS
N
OH
O
H
H+
H+
External aldimine TZA-complex
B
N
H
O-
OP
OH
HO
O
NH
S
OH
O
A
NH
S1 2
3
4
5
 
Scheme 2. Eventual unproductive bind with L-Cys. (A) Thiazolidine ring. (B) Hypothetical 
mechanism for the formation of the TZA-complex after binding with PLP.   
 
AGXT2L1 and AGXT2L2  catalyzes slow desulfhydrase reactions with L-Cys and D-Cys 
 
Even though AGXT2L1 and AGXT2L2 are not cysteine transaminases,  their high 
apparent specificity for L-Cys, and similar substrates, led us to test their activity as 
desulfhydrases. 
The purified enzymes were probed for this activity through the measurement of the 
pyruvate formed from L-cysteine, or D-cysteine, by using a spectrophotometric method 
with lactate dehydrogenase and NADH as described (see Matherials and Methods). 
Results were different between the two enzymes. L-cysteine, and D-cysteine, for 
AGXT2L2 were substrates. In contrast, reaction with AGXT2L1 showed a very slow 
formation of pyruvate (and presumably sulphide and ammonium ion), from both the tested 
substrates, suggesting that the enzyme can catalyze the cleavage of the C-S bond 
(Scheme 3). 
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When the kinetics were measured (described in Matherials and Methods) the 
calculated specific activity was 0.0114 µmol min-1 mg-1 for L-cysteine as substrate, and  
0.0075 µmol min-1 mg-1 with D-cysteine.  
Scheme 3 
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Scheme 3. Reaction catalyzed by AGXT2L1 in presence of L-Cysteine or D-cysteine. 
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Discussion 
AGXT2L1 and AGXT2L2  are  not alanine-glyoxylate aminotransferases 
The enzymes encoded by AGXT2L1 and AGXT2L2 genes show a high overall 
similarity (∼ 55%) to human alanine-glyoxylate aminotransferase (Baker, 2004). Despite 
this, the present results show that AGXT2L1, and AGXT2L2 do not act physiologically as  
an AGT2, confirming that sequence similarity is a weak criterion for ascribing a function to 
a newly identified enzyme (Rost, 2002). Moreover, both enzymes did not show affinity for 
the AGT2 substrates, suggesting the appearance of mutations in fundamental residues 
involved in the substrate binding.  
    
AGXT2L1 and AGXT2L2 ligands  specificity 
Recent genomic observations indicate that, in metazoa, enzyme homologs often 
assume non-catalytic functions – a role switch signaled by the accumulation of inactivating 
mutations (Pils & Schultz, 2004). In contrast to this hypothesis, however, both recombinant 
enzymes could still bind PLP, and react with potential substrates. 
The high level of transcription of the genes in several tissues and the selectivity of 
recombinant enzymes toward a particular group of ligands, suggest that the AGT2-like 
proteins may play a biological role in the metabolism of amino acids, or amino compounds, 
holding a thiol group. 
At least for AGXT2L1, both observations are confirmed by the finding that the 
enzyme catalyzes the β-elimination reactions with L-Cys and D-Cys. Clearly, AGXT2L1 
reacts too slowly to be classified as a cysteine desulfhydrase (CDes). For example, if the 
D-cysteine desulfhydrase (D-CDes) activity for the recombinant enzyme is compared to 
the value obtained for D-CDes in E.coli (Nagasawa, 1995), AGXT2L1 is ∼ 4x103 times 
slower.  
AGXT2L2 failed completely to catalyze the β-elimination reaction with L-Cys and D-
Cys. Moreover, this enzymes showed a different specificity toward the same ligands of 
AGT2L1, hinting that substrate specificities between these two AGT2 homologs are 
somewhat different.  
It should be considered that both these recombinant enzymes apparently bind L-
Cys and D-Cys in an unproditcive way, that is, via a thiazolidine adduct. However, in 
principle, studying this unproductive binding could still provide substantial information 
about the enzymes active sites.  
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First of all, AGXT2L1 and AGXT2L2 seem to prefer short amino compounds holding 
a thiol group. Second, based on the mechanism of formation of the TZA-complex 
(Scheme 2), could be inferred that the active site environment has to permit the 
deprotonation of the S group in γ-position.   
  
Evolution of AGXT2L1 and AGXT2L2  
Based on the contemporary presence of AGXT2L1 and AGXT2L2 in vertebrates 
genomes, several speculations can be done on their function; the enzymes can catalyze 
the same reaction, and maybe this two form can act in different moments, or different 
tissues. 
However, the two enzymes could have acquired different catalytic activities, after 
duplication in vertebrates as result of a selection pressure. In fact, during evolution, the 
development of new catalytic functions is believed to occur mainly by recruiting enzymes 
that already exist and catalyze similar reactions (O’Brien & Herschlag, 1999). In the 
simplest scenario, the triggering event is a duplication of the gene encoding the enzyme, 
which relieves the selective constraints on one gene copy, allowing for potential functional 
diversification. In this case, homology searches in complete genomes revealed that the 
AGT2-like enzymes seem derived from duplication of a single ancestor during metazoan 
evolution, too. 
 
Conclusions 
This work presents the first overexpression and characterization of two human 
recombinant alanine-glyoxylate aminotransferase type 2 homologs. Data show that both 
enzymes do not share substrate specificity and catalytic activity of authentic AGT2 
(Noguchi, 1978; Takada, 1982; Baker, 2004; Cellini, 2007). Comparison of the 
recombinant proteins has also revealed catalytic and physical differences between the two 
proteins with regard to ligands and catalytic specificity; AGXT2L1 showed a weak activity 
as cysteine desulfhydrase.  
 
Acknowledgments 
This work was funded by the Telethon Foundation. I would like to thank Angelo 
Bolchi for the pET28-H6-Cpo vector and Lara Abdulla for molecular cloning of AGXT2L1 
and AGXT2L2. 
Chapter 3     Molecular cloning and initial characterization of two putative  
alanine-glyoxylate aminotransferases 
 
104 
References 
Abe, K., S. Takahashi, et al. (2006). "Cloning and expression of the pyridoxal 5'-
phosphate-dependent aspartate racemase gene from the bivalve mollusk Scapharca 
broughtonii and characterization of the recombinant enzyme." J Biochem 139(2): 235-44. 
 
Akagi, R. (1982). "Purification and characterization of cysteine aminotransferase from rat 
liver cytosol." Acta Med Okayama 36(3): 187-97. 
 
Baker, P. R., S. D. Cramer, et al. (2004). "Glycolate and glyoxylate metabolism in HepG2 
cells." Am J Physiol Cell Physiol 287(5): C1359-65. 
 
Brushaber, K. R., G. A. O'Toole, et al. (1998). "CobD, a novel enzyme with L-threonine-O-
3-phosphate decarboxylase activity, is responsible for the synthesis of (R)-1-amino-2-
propanol O-2-phosphate, a proposed new intermediate in cobalamin biosynthesis in 
Salmonella typhimurium LT2." J Biol Chem 273(5): 2684-91. 
 
Canle, A., A. Lawley, E. C. McManus and R.A. More O’Ferrall (1996). "Rate and 
equilibrium constants for oxazolidine and thiazolidine ring-opening reactions." Pure & Appl. 
Chem 68(4): 813-818. 
 
Cellini, B., M. Bertoldi, et al. (2007). "Human wild-type alanine:glyoxylate aminotransferase 
and its naturally occurring G82E variant: functional properties and physiological 
implications." Biochem J 408(1): 39-50. 
 
Christen, P. and P. K. Mehta (2001). "From cofactor to enzymes. The molecular evolution 
of pyridoxal-5'-phosphate-dependent enzymes." Chem. Rec. 1(6): 436-447. 
 
Coulter-Mackie, M. B. and G. Rumsby (2004). "Genetic heterogeneity in primary 
hyperoxaluria type 1: impact on diagnosis." Mol Genet Metab 83(1-2): 38-46. 
 
Danpure, C. J. (2006). "Primary hyperoxaluria type 1: AGT mistargeting highlights the 
fundamental differences between the peroxisomal and mitochondrial protein import 
pathways." Biochim Biophys Acta 1763(12): 1776-84. 
 
Donini, S., R. Percudani, et al. (2006). "A threonine synthase homolog from a mammalian 
genome." Biochem Biophys Res Commun 350(4): 922-8. 
 
Fogle, E. J., W. Liu, et al. (2005). "Role of Q52 in catalysis of decarboxylation and 
transamination in dialkylglycine decarboxylase." Biochemistry 44(50): 16392-404. 
 
Gophna, U., E. Bapteste, et al. (2005). "Evolutionary plasticity of methionine biosynthesis." 
Gene 355: 48-57. 
 
Grishin, N. V., M. A. Phillips, et al. (1995). "Modeling of the spatial structure of eukaryotic 
ornithine decarboxylases." Protein Sci. 4(7): 1291-1304. 
 
Ip, M. P., R. J. Thibert, et al. (1977). "Purification and partial characterization of cysteine-
glutamate transaminase from rat liver." Can J Biochem 55(9): 958-64. 
 
Chapter 3     Molecular cloning and initial characterization of two putative  
alanine-glyoxylate aminotransferases 
 
105 
Karsten, W. E. and P. F. Cook (2002). "Detection of intermediates in reactions catalyzed 
by PLP-dependent enzymes: O-acetylserine sulfhydrylase and serine-glyoxalate 
aminotransferase." Methods Enzymol. 354: 223-237. 
 
Keller, J. W., K. B. Baurick, et al. (1990). "Pseudomonas cepacia 2,2-dialkylglycine 
decarboxylase. Sequence and expression in Escherichia coli of structural and repressor 
genes." J Biol Chem 265(10): 5531-9. 
 
Laber, B., K. P. Gerbling, et al. (1994). "Mechanisms of interaction of Escherichia coli 
threonine synthase with substrates and inhibitors." Biochemistry 33(11): 3413-3423. 
 
Latta, K. and J. Brodehl (1990). "Primary hyperoxaluria type I." Eur J Pediatr 149(8): 518-
22. 
 
Lee, I. S., Y. Muragaki, et al. (1995). "Molecular cloning and sequencing of a cDNA 
encoding alanine-glyoxylate aminotransferase 2 from rat kidney." J Biochem 117(4): 856-
62. 
 
Liepman, A. H. and L. J. Olsen (2003). "Alanine aminotransferase homologs catalyze the 
glutamate:glyoxylate aminotransferase reaction in peroxisomes of Arabidopsis." Plant 
Physiol 131(1): 215-27. 
 
Lumb, M. (2000). "Functional Synergism between the Most Common Polymorphism in 
Human Alanine:Glyoxylate Aminotransferase and Four of the Most Common Disease-
causing Mutations*." JBC 275: 36415-36422. 
 
Mehta, P. K. and P. Christen (2000). "The molecular evolution of pyridoxal-5'-phosphate-
dependent enzymes." Adv. Enzymol. 74: 129-184. 
 
Meola, J. M. and H. H. Brown (1974). "Letter: Fluorescamine as a fluorogenic reagent for 
d-amphetamine identification by TLC." Clin Chem 20(1): 88-9. 
 
Meyer, P., D. Liger, et al. (2005). "Crystal structure and confirmation of the 
alanine:glyoxylate aminotransferase activity of the YFL030w yeast protein." Biochimie 
87(12): 1041-7. 
 
Mozzarelli, A., A. Peracchi, et al. (1989). "Microspectrophotometric studies on single 
crystals of the tryptophan synthase a2b2 complex demonstrate formation of enzyme-
substrate intermediates." J. Biol. Chem. 264(27): 15774-15780. 
 
Nagasawa, T., T. Ishii, et al. (1985). "D-Cysteine desulfhydrase of Escherichia coli. 
Purification and characterization." Eur J Biochem 153(3): 541-51. 
 
Noguchi, T., E. Okuno, et al. (1978). "Characteristics of hepatic alanine-glyoxylate 
aminotransferase in different mammalian species." Biochem J 169(1): 113-22. 
 
Noguchi, T. and Y. Takada (1978). "Purification and properties of peroxisomal pyruvate 
(glyoxylate) aminotransferase from rat liver." Biochem J 175(2): 765-8. 
 
Noguchi, T. (1987). "Amino acid metabolism in animal peroxisomes." Peroxisomes in 
Biology and Medicine. Springer-Verlag, Berlin: 234-243. 
Chapter 3     Molecular cloning and initial characterization of two putative  
alanine-glyoxylate aminotransferases 
 
106 
O'Brien, P. J. and D. Herschlag (1999). "Catalytic promiscuity and the evolution of new 
enzymatic activities." Chem. Biol. 6(4): R91-R105. 
 
Percudani, R. and A. Peracchi (2003). "A genomic overview of pyridoxal-phosphate-
dependent enzymes." EMBO Rep. 4(9): 850-854. 
 
Pils, B. and J. Schultz (2004). "Inactive enzyme-homologues find new function in 
regulatory processes." J. Mol. Biol. 340(3): 399-404. 
 
Ponticelli, F., R. Pagani, et al. (1983). "Synthesis and NMR properties of 2-(4-pyridyl) 
thiazolidine-4-carboxylic acids." Ital J Biochem 32(2): 92-101. 
 
Rost, B. (2002). "Enzyme function less conserved than anticipated." J. Mol. Biol. 318(2): 
595-608. 
 
Rowsell, E. V., K. Snell, et al. (1969). "Liver-L-alanine-glyoxylate and L-serine-pyruvate 
aminotransferase activities: an apparent association with gluconeogenesis." Biochem J 
115(5): 1071-3. 
 
Rowsell, E. V., A. H. al-Tai, et al. (1972). "Liver L-serine-pyruvate aminotransferase activity 
in different animal species." Biochem J 127(2): 27P. 
 
Shen, B. W., M. Hennig, et al. (1998). "Crystal structure of human recombinant ornithine 
aminotransferase." J Mol Biol 277(1): 81-102. 
 
Sterk, M. and H. Gehring (1991). "Spectroscopic characterization of true enzyme-substrate 
intermediates of aspartate aminotransferase trapped at subzero temperatures." Eur. J. 
Biochem. 201(3): 703-7. 
 
Storici, P., G. Capitani, et al. (1999). "Crystal structure of GABA-aminotransferase, a target 
for antiepileptic drug therapy." Biochemistry 38(27): 8628-34. 
 
Storici, P., D. De Biase, et al. (2004). "Structures of gamma-aminobutyric acid (GABA) 
aminotransferase, a pyridoxal 5'-phosphate, and [2Fe-2S] cluster-containing enzyme, 
complexed with gamma-ethynyl-GABA and with the antiepilepsy drug vigabatrin." J Biol 
Chem 279(1): 363-73. 
 
Takada, Y. and T. Noguchi (1982). "Subcellular distribution, and physical and 
immunological properties of hepatic alanine: glyoxylate aminotransferase isoenzymes in 
different mammalian species." Comp Biochem Physiol B 72(4): 597-604. 
 
Thompson, J. D., T. J. Gibson, et al. (1997). "The CLUSTAL_X windows interface: flexible 
strategies for multiple sequence alignment aided by quality analysis tools." Nucleic Acids 
Res. 25(24): 4876-4882. 
 
Wolosker, H., K. N. Sheth, et al. (1999). "Purification of serine racemase: biosynthesis of 
the neuromodulator D-serine." Proc Natl Acad Sci U S A 96(2): 721-5. 
 
Zhang, X., S. M. Roe, et al. (2003). "Crystal structure of alanine:glyoxylate 
aminotransferase and the relationship between genotype and enzymatic phenotype in 
primary hyperoxaluria type 1." J Mol Biol 331(3): 643-52. 
  
Appendix 
 
The advantage of being locked 
 
 
 
Appendix   The advantage of being locked 
 
4
 The abbreviations used are: DNAzyme, a deoxyribozyme construct composed entirely of 
DNA; LNA, locked nucleic acid; LNAzyme, a deoxyribozyme construct containing some 
LNA nucleotides in the substrate-binding arms; HPV16, human papillomavirus type 16; 
PIPES, 1,4-piperazinediethansulfonic acid; nt, nucleotide.  
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Introduction 
In the past decade, several RNA-cleaving deoxyribozymes (DNAzymes)4 have 
been isolated in the laboratory through the application of a combinatorial technique 
known as “in vitro selection” (Silverman, 2005). The two most prominent examples 
are the 8-17 and 10-23 deoxyribozymes, originally identified in the Joyce lab 
(Santoro and Joyce, 1997). Both types of deoxyribozymes comprise a central “core” 
and two substrate-binding arms that can be varied in length and sequence.  
The chemical stability of these catalysts, their ease of synthesis and versatility 
in the sequence-specific cleavage of RNA have prompted a wealth of studies on the 
potential use of DNAzymes in therapy, to inhibit the expression of disease-causing 
genes by selectively binding and cleaving the corresponding mRNAs (Cairns, 2002; 
Dass, 2004; Dass, 2006).  
However, several factors limit the practical use of DNAzymes as anti-gene 
agents. For example, it may be difficult to achieve an intercellular concentration of 
DNAzyme high enough to ensure stable binding to the target mRNA and hence 
efficient knockdown. In part, this problem can be countered by lengthening the 
substrate-recognition arms, thus increasing the affinity of the DNAzyme for its target, 
but this entails the synthesis of larger DNA molecules, less manageable and more 
prone to the adoption of alternative structures and to off-target binding.  
The binding problem is made even worse by the potentially limited 
accessibility of the intended target sequence within the mRNA structure. Indeed, 
there are suggestions that up to 90% of potential cleavage sites in long mRNAs are 
inaccessible to classical DNAzymes (Cairns, 1999; Kurreck, 2002) presumably due to 
a complex secondary and tertiary folding of these RNAs. 
An important step forward in solving these problems of efficient binding at low 
DNAzyme concentrations and of target accessibility has been the introduction of LNA 
(locked nucleic acid; Figure 1A) LNA residues are capable of normal Watson-Crick 
basepairing, and the locked sugar enhances the preorganization of the phosphate 
backbone, stabilizing the helical (A-type) structure of a duplex (Vester, 2004; 
McTigue, 2004; Kaur, 2006).   
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Several studies have shown that the inclusion of a few LNA monomers into the 
arms of the 10-23 deoxyribozyme significantly improves the performances of this 
catalyst against small RNA substrates, and, more pronouncedly, against long RNA 
transcripts, promoting cleavage of highly structured RNAs (Vester, 2002; Schubert, 
2003; Fahmy, 2004; Schubert, 2004; Fluiter, 2005; Vester, 2006; Jakobsen, 2007).  
Although LNA monomers are expected to increase the affinity of a 
deoxyribozyme for its target, the kinetics and thermodynamics underlying the 
observed catalytic enhancements have not been analyzed in detail. With respect to a 
minimal kinetic scheme for a deoxyribozyme reaction (Figure 1B), it remains to be 
established whether the increased affinity alone can explain the improved kinetics, or 
if LNAs also accelerates the intramolecular cleavage step (described by the kinetic 
constant 2k ) (Vester, 2002; Schubert, 2003; Fahmy, 2004; Schubert, 2004; Fluiter, 
2005; Vester, 2006).  
 
 
Figure 1. (A) Structure of an LNA nucleotide. (B) A minimal kinetic scheme for the RNA 
cleavage reaction carried out by a DNAzyme (or LNAzyme), under single-turnover 
conditions. The catalyst (drawn with a dark line) must bind its substrate (thin line) to form a 
productive biomolecular complex. Within this complex, the target RNA is cleaved to yield two 
products, one of which containing a cyclic 2’,3’-phosphate (Santoro, 1997). 
 
Furthermore, the LNA monomers could in principle improve the RNA binding 
affinity of deoxyribozymes via an increased association rate ( 1k ) or a reduced 
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dissociation rate ( 1−k ), or both; data from model systems are somewhat contradictory 
on this point (Christensen, 2001; Ormond, 2006). Finally, it is not completely obvious 
why the improved performances of LNA-containing deoxyribozymes were particularly 
evident against long RNA transcripts. 
In relation to these issues, we provide here a detailed kinetic comparison 
between a well-characterized 8-17 construct and a corresponding LNA-armed 
version. Furthermore, we contrast the performances of four DNAzyme/LNAzyme 
pairs targeted against different regions of a viral RNA transcript (the E6 mRNA from 
HPV16). Our findings indicate that (i) LNA monomers located in the deoxyribozyme 
arms have only minimal effects on the cleavage step ( 2k ); (ii) LNA monomers greatly 
reduce the rate of substrate dissociation ( 1−k ), stabilizing the catalyst-substrate 
complex; (iii) finally, the effect on the association step ( 1k ) depends on the type of 
substrate: with short, unstructured substrates 1k  is nearly equal for DNAzymes and 
LNAzymes, whereas with long, structured RNAs, association is substantially faster 
for LNAzymes as compared to DNAzymes.  
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Materials and Methods 
Oligonucleotides 
DNA oligonucleotides were from MWG Biotech (Ebersberg, Germany) or from 
DNAtechnology (Aarhus, Denmark). LNAzymes were synthesized using published 
procedures (Wengel, 1999). The minimal (17-mer) RNA substrate for Dz122 and 
Lz122 was from Dharmacon Research (Lafayette, CO) and when necessary it was 
32P-5’-end labeled with T4 polynucleotide kinase. The other minimal substrates were 
synthesized with T7 RNA polymerase (Promega), employing the following templates: 
 
S32 Template 
5’GTGGTAACTTTCTGGGTCCTATAGTGAGTCGTATTAG3’ 
 
S51 Template 
5’TGCAGCTCTGTGCATAACCTATAGTGAGTCGTATTAG3’ 
 
S122 Template: 
5’CATATACCTCACGTCGCCCTATAGTGAGTCGTATTAG3’ 
 
S163 Template: 
5’CCCATCTCTATATACTACCTATAGTGAGTCGTATTAG3’ 
 
The templates were hybridized to the complementary deoxyoligonucleotide to form a 
double-stranded T7 promoter. 
 
T7 promoter: 
 
5’ TAATACGACTCACTATAGG3’  
 
Transcription was conducted using the buffer conditions recommended by the 
supplier, and 1 mM nucleoside triphosphates. After transcription, the reaction 
mixtures were extracted and precipitated and the full-length RNAs were isolated on a 
7M urea/13% polyacrylamide gel. RNAs were eluted from gel bands, extracted with 
phenol/chloroform, ethanol-precipitated and redissolved in H2O.  
RNA transcripts were generally 5´-radiolabeled by dephosphorylating using 
shrimp phosphatase (USB) and subsequently incubating with T4 polynucleotide 
kinase (New England Biolabs) and [γ-32P]-ATP. Concentrations of radioactive 
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oligonucleotides were determined from specific activities; concentrations of 
nonradioactive oligonucleotides were determined using extinction coefficients at 260 
nm estimated by the nearest neighbor method (Cantor, 1970). 
 
In vitro transcription of E6 and E6E7 mRNA 
The E6 and E6E7 mRNAs from HPV16 were transcribed in vitro from the 
corresponding genes. Two plasmids containing the E6 coding sequence (BSK-16-
E6) and the E6E7 coding sequence (BKS-16-E6E7) were kindly provided by 
Massimo Tommasino (International Agency for Research on Cancer, Lyon). These 
were Bluescript plasmids (the complete sequence and list of restriction sites are 
available at www.stratagene.com - Genbank® #X52327[KS(+)] and #52328 [SK(+)]). 
The plasmids were first cut with XhoI (a restriction enzyme whose cleavage 
site is located, in both constructs, shortly downstream of the stop codon – see Figure 
2) and then transcribed using either T3 RNA polymerase (for the E6 RNA) or T7 RNA 
polymerase (for the E6E7 RNA). The transcription mixture (50 µl) for the non-
radioactive substrates contained: 10 µl 5 x transcription buffer, 7 mM nucleoside 
triphosphate, 26 mM MgCl2, 30 mM DTT, 750 ng of template and 17 U T3 RNA 
polymerase (Amersham), or 20U T7 RNA polymerase (Stratagene). The transcription 
mixture (20 µl) for the radioactive substrate contained: 4 µl 5 x transcription buffer, 
1mM nucleoside triphosphate, 10 mM MgCl2, 10 mM DTT, 29 U RNAsin, 2 µg of 
template and polymerases as above. 
After transcription, the RNAs were extracted with phenol-chloroform, 
precipitated and purified on a 7M urea/6% polyacrylamide gel. Full-length transcripts 
were eluted from gel bands using 2 M NH4Ac, pH 5.3 (elution overnight with 150 µl 
and wash with 100 µl), extracted with phenol/chloroform, ethanol-precipitated and 
redissolved in H2O. Concentrations of radioactive and nonradioactive 
oligonucleotides were determined using extinction coefficients at 260 nm estimated 
by the nearest neighbor method (Cantor, 1970). 
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Figure 2 – The long RNA transcripts employed in this work. Boxed sequences correspond to 
the targets of the four 8-17 constructs described in the text. (A) The E6 RNA was transcribed 
with T3 RNA polymerase, using the linearized BSK-16-E6 plasmid as a template. The 
plasmid was linearized with XhoI. The sequence corresponding to the XhoI target site is 
underlined, whereas the start and stop triplets of the E6 coding sequence are shown in bold. 
(B) The E6E7 transcript was generated using T7 RNA polymerase and the XhoI-linearized 
BKS-16-E6E7 plasmid as a template. The underlined sequence signals the XhoI target site; 
bold letters indicate the start codon of the E6 coding sequence and the stop codon of the E7 
coding sequence. 
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Measurement of individual rate constants for Dz122 and Lz122. 
Reactions of Dz122 and Lz122 against a minimal substrate (17-nt long) were 
conducted in 50 mM PIPES-NaOH, pH 7.4, 3 mM Mg2+, to allow a direct comparison 
with an earlier study (Bonaccio, 2004) where the Dz122 construct was characterized 
in detail. 
Cleavage reactions were single-turnover, with the catalyst in large excess 
(≥10-fold) with respect to the labeled substrate, so that the product dissociation step 
did not affect the observed kinetics (Bonaccio, 2004). Substrate and catalyst were 
separately heated at 95 °C for 2 min to disrupt potential aggregates, spun briefly in a 
microfuge and equilibrated for 10-30 min at the reaction temperature. After 
supplementing the catalyst tube with MgCl2, reactions were initiated by adding the 
substrate. Time-points were collected at appropriate intervals and further reaction 
was quenched by adding formamide and excess EDTA. Radiolabeled substrates and 
products were separated on 7 M urea/20% polyacrylamide gels and quantitated by 
phosphorimaging. Reaction time-courses were fit to the appropriate kinetic equation 
using Sigma Plot (SPSS Inc.). 
2k  (describing cleavage within the enzyme-substrate complex) was measured 
employing saturating concentrations of the catalyst (≥ 1 µM), to ensure that all the 
substrate would be bound to the DNAzyme or LNAzyme (Bonaccio, 2004). As a 
control that saturation of the substrate was achieved, the measured rate constants 
remained identical, within error, when the concentration of catalyst was raised from 1 
µM to 5 µM or 10 µM. 
The rate constants for substrate dissociation ( 1−k ) and association ( 1k ) were 
measured through a pulse-chase strategy (Bonaccio, 2004). To determine 1−k , a 
saturating concentration of DNAzyme or LNAzyme (100 nM) was first allowed to bind 
a trace amount of radiolabeled substrate (~0.1 nM) for 4 min, in the presence of 3 
mM MgCl2 (over this time, <1% of the substrate was cleaved). Then a large excess of 
unlabeled substrate (1 µM final) was added to initiate the ‘chase‘ period, during which 
dissociation of labeled substrate from the catalyst was essentially irreversible. An 
otherwise identical reaction, but without the chase, was carried out in parallel. 
Partitioning of the labeled substrate between cleavage and release depended on the 
relative magnitude of 1−k  and 2k ; in particular, the fractional extent of cleavage in the 
presence of the chase (relative to the extent in the absence of chase) reflected the 
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ratio )kk/(k 212 +−  (Fersht, 1985). Thus, measuring 2k  and the final extent of cleavage 
allowed determination of 1−k . 
A pulse-chase method was also used to determine 1k . In these experiments, 
an excess DNAzyme or LNAzyme (1-15 nM) was first allowed to bind a trace amount 
of radiolabeled substrate for a period, t1, variable from 0.5 to 7 min (over this time, 
<1% of the substrate was cleaved). Then the sample was transferred into a solution 
containing a large excess of unlabeled substrate (to prevent any further binding of 
radioactive substrate) as well as 15 mM Mn2+, pH 7.8.  
Due to the high concentration of Mn2+ and the increased pH, all the bound 
labeled substrate was cleaved in less than 3 min (Bonaccio, 2004), so that the 
fraction of cleaved substrate reflected the amount of catalyst-substrate complex 
formed at t1. The dependence of such fraction on t1 was fit to a single exponential 
function, yielding a pseudo-first order rate constant for substrate binding, appk . 1k  
was obtained from a linear regression of the appk  values vs. the catalyst 
concentration. 
 
Cleavage of long RNA transcripts 
Cleavage of the E6 and E6E7 mRNAs were measured under single-turnover 
conditions at 37°C. The reaction buffer contained 50 mM Tris-HCl, pH 7.5, 150 mM 
NaCl and 0.008% SDS. 
Two distinct kinetic protocols were used. In protocol A, the DNAzyme (or 
LNAzyme) and the mRNA substrate were heated separately in reaction buffer, in the 
presence of 10 mM MgCl2. After this heating step (2 min at 80°C), the samples were 
spun briefly in a microfuge and equilibrated for 10 min at the reaction temperature. 
The cleavage reactions were initiated by mixing the catalyst and substrate solutions. 
The reaction mixture contained 10 nM RNA (final concentration) and 100 nM catalyst 
(tenfold molar excess). Aliquots were collected at appropriate times and quenched by 
adding formamide and excess EDTA. 
In protocol B, cleavage rates were determined after pre-annealing the catalyst 
and the mRNA. Annealing was achieved by heating together the DNAzyme (or 
LNAzyme) and RNA in reaction buffer at 80°C for two minutes, followed by cooling in 
two steps (50°C for 5 min; 37°C for 10 min). The cleavage reactions were then 
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started by adding MgCl2 to a final concentration of 10 mM. The concentrations of 
enzyme and RNA were as above. 
Substrates and products of the cleavage reactions were separated on 6% 
polyacrylamide gels and quantitated by a phosphorimager. The fraction of product at 
time t, Ft, was calculated by dividing the amount of product by the amount of 
substrate plus product and the data were fit to a single-exponential function: 
 
             ( )tkt obse1 FF −∞ −=                 (Eq. 1) 
 
Where F∞ is the fraction of product at the endpoint of the reaction and kobs is 
the rate constant of cleavage (Fersht, 1985). Sometimes the reaction was clearly 
biphasic, and the data were hence fit to a double exponential function: 
 
( ) ( )tk2tk1t obs2obs1 e1 Fe1 FF −− −+−=    (Eq. 2) 
 
Where F1 and F2 represent the endpoints of the first and second phase of the 
time-course, respectively. 
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Results 
Constructs used 
In this study, we compared the activities of four conventional 8-17 DNAzymes 
with their partially LNA-armed counterparts (‘LNAzymes’; Figure 3). All four 8-17 
constructs were directed against the E6 mRNA from Human Papillomavirus type 16 
(HPV16). This mRNA is a well-established model system to explore the application of 
antisense and catalytic antisense oligonucleotides and much experimental 
information is available about the accessibility of different parts of the RNA sequence 
(Cairns, 1999; Venturini, 1999; Pan, 2003; Cairns and Sun, 2004). 
 
 
Figure 3. Primary and secondary structures of the 8-17 DNAzymes and LNAzymes used in 
this study. The four constructs were designed to recognize 17-nt-long RNA targets on the E6 
RNA. The number in each construct’s name refers to the position of cleavage within the E6 
coding sequence. Against each target, we tested one 8-17 DNAzyme (composed only of 
DNA monomers) and one LNAzyme (in which four or five nucleotides in the arms were 
replaced by LNA monomers). DNA is shown in bold letters, and the positions at which LNA 
monomers were introduced are circled. Note that Cytidine LNA residues are methylated at 
the 5-position. The RNA target sequences are shown as normal letters while the arrows 
indicate the cleavage sites. 
 
The four 8-17 constructs were designed to cleave specific AG sites, located 
within the first 200 nucleotides of the E6 coding sequence. Dz32 was designed to 
hybridize to a sequence that overlaps the best target sequence identified by Pan et 
al., who tested the accessibility of the E6 mRNA by using a library of hammerhead 
ribozymes (Pan, 2003). The Dz122 target sequence includes two of the four best 
cleavage sites identified by Cairns and co-workers, using a library of 10-23 
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deoxyribozymes (Cairns, 1999). The target of Dz163 encompassed one accessible 
cleavage site identified by Pan et al. and two accessible sites described by Cairns et 
al. (Cairns, 1999; Pan, 2003). Finally, Dz51 was used as a control; it targets a 
sequence that previous studies found only modestly accessible (Cairns, 1999; Pan, 
2003), but RNA folding software such as mFold (Zuker, 2003) predicted that the 
cleavage site would lie in a single-stranded region. 
 
Kinetic and thermodynamic comparison of Dz122 and Lz122 
The construct Dz122 had been kinetically well characterized in previous 
studies, where it was named (8-17)cb (Bonaccio, 2004; Peracchi, 2005; Ferrari, 
2002). Therefore we employed this construct for a detailed kinetic and 
thermodynamic comparison with the corresponding LNAzyme (termed Lz122), using 
a short 17mer RNA substrate. 
The rate constant for cleavage of the 17-mer RNA within the enzyme-
substrate complex ( 2k ) was measured in single-turnover reactions (ensuring that the 
product dissociation step did not affect the observed kinetics) and at saturating 
deoxyribozyme concentration (≥ 1 µM; Bonaccio, 2004). Dz122 and Lz122 showed 
very similar 2k  values, both at 25°C and 37°C (Table 1), indicating that the 
introduction of the four LNA monomers in the 8-17 arms has only marginal effects on 
the intramolecular strand-scission step. 
 
Table 1 
Comparison of the catalytic parameters for the reactions catalyzed by Dz122 and 
Lz122. 
 
 
Construct 
 
Temperature 
 
k2 
(min-1) 
 
k1 
(M-1min-1) 
 
k-1 
(min-1) 
 
KS 
(nM) 
 
Dz122 
 
25°C 
 
10-2 
 
1.7×107 
 
0.02 
 
1.2 
 
Lz122 
 
25°C 
 
6×10-3 
 
3.3×107 
 
0.0016 
 
0.05 
 
Dz122 
 
37°C 
 
2.8×10-2 
 
- 
 
- 
 
- 
 
Lz122 
 
37°C 
 
2.2×10-2 
 
- 
 
- 
 
- 
 
Table 1. Conditions: PIPES-NaOH buffer, pH 7.4, 3 mM Mg2+. Data are the average of at 
least two independent determinations, which differed by less than 25% from each other. The 
1k  and 1−k  values for the Dz122 construct had already been reported in Bonaccio, 2004.  
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The measured association rate constants ( 1k ) also showed differences of less 
than twofold between Dz122 and Lz122 (Table 1), in agreement with previous 
indications that LNAs have only minimal effects on the hybridization rate between 
short oligonucleotides (Christensen, 2001). Much larger differences were observed 
when measuring 1−k , the rate constant for dissociation of the enzyme-substrate 
complex. The values of 1−k for Dz122 and Lz122 differed by more than tenfold, 
reflecting the different stabilities of binding for the two catalysts. From the kinetic 
constants 1k  and 1-k  we could also calculate the thermodynamic constant for 
substrate dissociation ( 11 k/kKS −= ), which was ∼25-fold lower for the LNAzyme 
(Table 1). 
These data were buttressed by UV melting studies on the complexes formed 
by the enzymes with a non-cleavable substrate analog, bearing a single 
deoxyribonucleotide at the cleavage site. The experiments showed that the melting 
temperature (Tm) for the complex between Lz122 and the substrate analog was 
≈20°C higher than for the Dz122 complex (58°C vs. 38°C, using 2 µM catalyst and 2 
µM substrate analog; Figure 4).  
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Figure 4. Thermal denaturation of the complexes formed between Dz122 or Lz122 and a 
substrate analog containing a single deoxyribonucleotide at the cleavage site.  Denaturation 
was monitored in PIPES-NaOH buffer, pH 7.4 (at 37°C), 3 mM MgCl2. In each experiment, 
catalyst and substrate analog were both present at 2 µM concentration. Measurements were 
performed on a Perkin-Elmer Lambda Bio 20 spectrophotometer, equipped with a PTP-6 
Peltier temperature programmer. Enzyme and substrate analog were heated together at 95 
°C for 2 min, then cooled at room temperature, supplemented with 3 mM MgCl2 and finally 
placed into the spectrophotometer and equilibrated at 10 °C. Melting curves (absorbance at 
260 nm vs. temperature) were recorded by heating the samples (1°C/minute) and following 
the absorbance variation at 260 nm. The exterior of the cuvette was kept under a stream of 
dry N2 gas to prevent water condensation at low temperatures. (A) Melting curves. The 
ordinate represents the relative change of absorbance as a function of temperature. (B) First 
derivative of UV absorption with respect to temperature. The two graphs for Dz122 and 
Lz122 show maxima near (respectively) 38°C and 58°C. 
 
 
 
 
 
Appendix   The advantage of being locked 
 
 
121 
These findings are in agreement with published data, which report that the Tm 
of short DNA-RNA duplexes is increased by 4 to 7°C per each pyrimidine LNA 
monomer introduced in the DNA sequence (Singh, 1998; Singh, 1998, 
Bondensgaard, 2000). The results also indicate that, length and sequence of the 
binding arms being equal, an LNAzyme can be employed at a range of temperatures 
much wider than its all-DNA counterpart (Figure 5). 
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Figure 5 – Temperature dependence of the cleavage rates observed with Dz122 and Lz122, 
under single turnover conditions, at pH 7.4, 3 mM Mg2+. The concentration of catalyst was 1 
µM. The decrease in activity of Dz122 at T>37°C reflects the dissociation of the DNAzyme 
from its substrate (see preceding figure) and the ensuing loss of catalytic efficiency. 
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Activities of Dz122 and Lz122 as a function of catalyst concentration and Mg2+ 
concentration 
 
The higher thermodynamic stability of the LNAzyme-substrate complex, 
coupled with the minimal effects of LNA on the cleavage step, imply that LNAzymes 
can outperform DNAzymes under a number of conditions. For example, when 
measuring substrate cleavage as a function of catalyst concentration, at 37°C, Lz122 
was substantially more efficient than Dz122 at concentrations <50 nM (Figure 6A). 
Presumably, the lower SK  of Lz122 allowed this catalyst to saturate its substrate 
more easily. 
We also compared the Mg2+-dependences of activity for Dz122 and Lz122. It 
is known that the intramolecular reaction rate ( 2k ) of 8-17 is stimulated by Mg2+, and 
that such activation follows a hyperbolic titration curve (Bonaccio, 2004); also, the 
thermodynamic substrate dissociation constant, SK , is expected to decrease when 
the concentration of Mg2+ increases (Nakano, 1999). When we tested Dz122 and 
Lz122 (at a fixed 100 nM concentration) vs. [Mg2+], the LNAzyme activity showed a 
hyperbolic dependence, while the curve for Dz122 was sigmoidal, indicating an 
apparently cooperative activation (Figure 6B).  
As a result, the LNAzyme was significantly superior to the DNAzyme at 
[Mg2+]≤1.5 mM (Figure 6B). We explain these findings as follows. For Lz122, the 100 
nM catalyst concentration is sufficient to saturate the substrate over the whole range 
of [Mg2+] explored, so that only the effect on 2k  is apparent. Dz122, however, is 
unable to saturate its substrate at low magnesium concentrations, hence performing 
with suboptimal efficiency. The apparent cooperativity arises because Mg2+ ions, at 
low concentrations, stimulate both formation of the Dz122-substrate complex (effect 
on SK ) and catalysis within the complex (effect on 2k ).  
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Figure 6. (A) Concentration dependence of the cleavage rates observed with Dz122 and 
Lz122 at 37°C, pH 7.4, 3 mM Mg2+. Error bars represent the range of variation in duplicate 
experiments. The data were fit to the following equation: 
[ ]
[ ]EK
Ekk
s
obs +
×
=
2
     (Eq. 3) 
where [E] represents the catalyst concentration. The solid lines through the data represent 
binding curves with SK =30 nM (Dz122) and 1 nM (Lz122). The estimated 30-fold greater 
affinity of Lz122 for its substrate compares well with the 24-fold difference obtained at 25°C 
(Table 1). (B) Mg2+-dependence of the cleavage rates. Conditions as in panel A, except that 
the concentration of the catalyst was constant (100 nM) and the concentration of Mg2+ varied 
from 0.15 to 100 mM. The solid line trough the Lz122 data is the best fit to a binding 
hyperbola with Kd=14 mM. The dotted line through the Dz122 data is the best fit to the Hill 
equation (Fersht, 1985). The Hill coefficient, n, gauging the apparent cooperativity of Mg2+ 
activation, was 1.4. 
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LNAzymes, but not DNAzymes, cleave efficiently the folded E6 and E6E7 transcripts 
We next compared the relative cleavage efficiencies of 8-17 DNAzymes and 
LNAzymes against targets that are embedded in large, structured RNA molecules. 
To this end, we assayed the ability of the four DNAzymes and of the respective 
LNAzymes to cleave the full-length E6 transcript (E6 mRNA, 544 nt long). Table 2 
summarizes the results obtained with this long transcript, together with controls 
where minimal (19-mer) substrates were used. Note that, during HPV16 infection, the 
E6 sequence is part of a polycistronic mRNA that also encodes the E7 oncoprotein; 
accordingly, as a further control, we tested the DNAzymes and LNAzymes also 
against an E6E7 polycistronic transcript (E6E7 mRNA 830 nt long; Supplemental 
Figure 1).  
Reaction rates were initially measured using ‘protocol A’ (see Experimental 
Procedures). In this protocol, mRNA transcripts are allowed to fold into stable 
structures (presumably similar to the structures adopted in the cytoplasm) prior to 
being exposed to the catalysts. Under these conditions, the LNAzymes (at a 100 nM 
concentration) could efficiently cleave the long RNAs (Figure 7A), yielding kinetic 
time-courses that were well described by simple exponential functions (Figure 7B). 
The observed rate constants closely resembled those measured for the cleavage of 
minimal substrates (Table 2, left). Moreover, the rates of cleavage were virtually 
unchanged when the four LNAzymes were tested against the E6 mRNA or the E6E7 
mRNA, in spite of the additional ∼300 nt in the E6E7 transcript (Table 3). 
While three out of four LNAzymes showed similar activities against the long 
RNAs, Lz51 cleaved much more slowly and to a lower extent (Figure 7B). As stated 
above, previous studies implied that the target sequence of Lz51 could be 
intrinsically less accessible than those of the other three constructs, but this would 
not explain why Lz51 behaved poorly even against a short 19-mer substrate (Table 
2). A more likely explanation lies in the propensity of free Lz51 to adopt alternative 
secondary structures, that are expected to reduce binding of the substrate and hence 
catalysis (data not shown). In agreement with this hypothesis, control experiments 
suggested that the LNAzyme, at the 100 nM concentration used, was far from 
saturating its E6 substrate (data not shown). Despite these problems, it is remarkable 
that Lz51 was able to access and cleave its target within the long RNAs, whereas the 
corresponding all-DNA construct, Dz51, failed to cleave at concentrations as high as 
10 µM (Table 2 and data not show). 
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Indeed, in strong contrast to the LNAzymes, all four of the DNAzymes showed 
a nearly complete inability to cleave the long substrates under the ‘protocol A’ 
conditions (Table 2, left). This suggests that the local RNA structure prevents the 
access of unmodified 8-17 DNAzymes to fully folded targets, exacerbating the 
differences in activity between DNAzymes and LNAzymes. 
 
Figure 7. (A) Single turnover reaction of the LNAzymes under ‘protocol A’ conditions. The 
internally-labeled E6 transcript (544 nt long; 10 nM final concentration) was reacted with 
each of the four LNAzymes (100 nM) at 37°C, pH 7.5, 10 mM Mg2+. Aliquots were collected 
at appropriate times and the substrate and products were separated on a 5% polyacrylamide 
denaturing gel. (B) Time-courses of the cleavage reactions shown in panel A. The solid lines 
represent least-squares fits of the experimental data to Equation 1. 
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Table 2 
Performance of DNAzymes and LNAzymes against the E6 mRNA transcript 
 
 
Protocol A 
(cleavage of pre-folded RNA) 
 
Protocol B 
(cleavage after pre-annealing catalyst 
and substrate) 
 
 
19-mer substrate 
 
E6 mRNA 19-mer substrate E6 mRNA 
 
kobs 
(min-1) 
 
F∞ 
kobs 
(min-1) 
 
F∞ 
kobs 
(min-1) 
 
F∞ 
kobs 
(min-1) 
 
F∞ 
         
Lz32 4.6×10-2 0.79 4.4×10-2 0.64 6.6×10-2 0.73 4.5×10-2 0.67 
Lz51 a 
 
3.6×10-3 
 
0.8 
 
5.5×10-3 
 
0.44 
 
2.6×10-3 
 
0.50 
 
1st: 5.2×10-2 
2nd: 2.0×10-3 
F1=0.12 
F2=0.64 
Lz122 b 2.0×10-2 0.68 2.5 ×10-2 0.80 3.7×10-2 0.74 4.1 ×10-2 0.75 
Lz163 c 2.9×10-2 0.85 3.2×10-2 0.85 0.14 0.76 5.2×10-2 0.86 
         
Dz32 d 1.6×10-2 0.90 ≤10-4 - 2.1×10-2 0.90 2.7×10-3 0.15 
Dz51 e ≤7×10-5 - - - ≤7×10-5 - - - 
Dz122 f 3.8×10-2 0.80 ≤7×10-5 - 5.0×10-2 0.82 5.6×10-4 0.30 
Dz163 f 1.3×10-2 0.90 ≤7×10-5 - 1.3×10-2 0.90 2.7×10-4 0.30 
 
Table 2. Conditions: Tris-HCl buffer, pH 7.5, 10 mM Mg2+, 37°C. Cleavage was performed 
under single-turnover conditions, using 10 nM substrate and 100 nM catalyst (DNAzyme or 
LNAzyme). In experiments with the 19-mer substrates, the 100 nM concentration was 
saturating for the LNAzymes (except for Lz51) but slightly subsaturating for the DNAzymes, 
as the observed reaction rates of Dz32, Dz122 and Dz163 increased by 1.5 to twofold when 
the DNAzyme concentration was raised to 1 mM. The kinetic time-courses were fit to 
Equation 1, where F∞ indicates the final extent of cleavage. For each reaction, the reported 
kobs values are the average of two to four independent experiments. kobs values from 
individual experiments differed by no more than 20% from the mean, except for reactions of 
DNAzymes with the E6 RNA (‘Protocol B’ conditions) where the range of variation was within 
±40% of the mean.  
a
 When Lz51 was tested according to ‘Protocol B’, the kinetics of cleavage of the long RNA 
substrates were distinctly biphasic. The data were therefore fit to Equation 2, and the table 
reports the rate constants and the extent of cleavage for both phases. b To compare these 
data with those in Table 1, the reaction of Lz122 (100 nM) against the E6 transcript was also 
tested in the presence of 3 mM Mg2+, yielding, kobs= 1.6×10-2 min-1 and F∞= 0.74. c Lz163 
cleaved its 19-mer substrate ~fourfold faster under the ‘Protocol B’ conditions than with 
‘Protocol A’. The behavior was reproducible but remains unexplained, since the minimal 
substrate of Lz163 is not expected to form any stable secondary structure. d When Dz32 was 
tested against the E6 transcript according to ‘Protocol A’, less than 5% of product was 
formed in ten hours. During this time, some unspecific degradation of the long mRNA also 
began to occur. Based on these data, and assuming an endpoint of 0.9, we estimated that 
cleavage by Dz32 would occur with a kobs ≤10-4 min-1. e The reaction of 100 nM Dz51 with the 
19-mer substrate was too slow to be reliably measured (no appreciable product formation in 
eight hours). By using a tenfold higher concentration of catalyst, we measured kinetics with 
an apparent endpoint of 0.60 and observed rate constants of 7x10-4 min-1 (with both 
protocols). f Upper limits for the rates of E6 cleavage were estimated as in d, except that less 
than 4% product was formed in ten hours. 
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Table 3 
Comparing the performance of LNAzymes against the E6 and E6E7 transcripts. 
 
 
Protocol A 
(cleavage of pre-folded RNA) 
 
Protocol B 
(cleavage after pre-annealing catalyst and 
substrate) 
 E6 mRNA E6E7 mRNA E6 mRNA E6E7 mRNA 
 
kobs 
(min-1) 
 
F∞ 
kobs 
(min-1) 
 
F∞ 
kobs 
(min-1) 
 
F∞ 
kobs 
(min-1) 
 
F∞ 
         
Lz32 4.4×10-2 0.64 4.8×10-2 0.83 4.5×10-2 0.67 6.4×10-2 0.87 
Lz51 
 
 
 
5.5×10-3 
 
 
 
0.44 
 
 
 
7.0×10-3 
 
 
 
0.49 
 
 
 
1st: 5.2×10-
3
 
2nd: 2.0×10-
3
 
F1: 0.12 
F2: 0.64 
1st: 1.2×10-
2
 
2nd: 3.7×10-
3
 
F1: 0.16 
F2: 0.57 
Lz122 2.5 ×10-2 0.80 2.2 ×10-2 0.74 4.1 ×10-2 0.75 3 ×10-2 73 
Lz163 3.2×10-2 0.85 3.3×10-2 0.77 5.2×10-2 0.86 5.3×10-2 81 
 
Table 3. The conditions are as described in the legend of Table 2 in the main text. Reactions 
were performed under single-turnover conditions (10 nM substrate + 100 nM catalyst) in 50 
mM Tris-HCl buffer, pH 7.5, 10 mM Mg2+, 37°C. Kinetic parameters (kobs and F∞) were 
obtained from exponential fits of the kinetic time-courses. When Lz51 was tested according 
to ‘Protocol B’, the kinetics of cleavage of E6 and E6E7 were distinctly biphasic. The data 
were therefore fit to a double exponential function, and the table reports the rate constants 
and the extent of cleavage for both phases. 
 
Cleavage of the E6 mRNA under “pre-annealing” conditions 
Could the performance gap between DNAzymes and LNAzymes be reduced 
by allowing the catalysts to encounter an unfolded target? To address this possibility, 
we measured cleavage of the E6 transcript using a distinct protocol (protocol B), 
where the LNAzyme (or DNAzyme) and its substrate were mixed together, heated at 
80°C for two minutes and cooled at 37°C prior to starting the cleavage reaction. This 
protocol represents a stage between the cleavage of a fully folded mRNA and the 
cleavage of a minimal, unstructured substrate: the denaturation step at 80°C is 
expected to disrupt the local secondary and tertiary structures, thus allowing a direct 
access of the catalysts to their targets, even though binding of the catalysts (during 
cooling) would have to compete with the refolding process of the long RNA. 
For the LNAzymes the differences between the data from the two protocols 
were mostly minor (Table 2). On the other hand, three of the all-DNA constructs, 
which were essentially inactive against the pre-folded long transcripts, showed in this 
case an appreciable ability to cleave the E6 RNA (Table 2, right), albeit with lower 
rates as compared to LNAzymes and with a modest overall yield.  
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Discussion 
We have incorporated four or five LNA monomers in the arms of the 8-17 
deoxyribozyme and shown that such a modification substantially improves the 
deoxyribozyme performances under a number of conditions. This result parallels 
those reported in previous studies on the 10-23 motif (Vester, 2002; Fahmy, 2004; 
Schubert, 2004; Fluiter, 2005; Vester, 2006), demonstrating that the inclusion of LNA 
monomers in the target-binding arms is advantageous for deoxyribozymes in 
general. More fundamentally, our work has addressed the mechanistic basis of the 
advantages conferred by LNAs, providing a detailed rationale for the effects reported 
by us and by other authors. 
 
LNAzyme advantages in the cleavage of short, unstructured substrates 
The kinetic data obtained with short RNA substrates indicate that deployment 
of LNA monomers in the 8-17 arms (at least, at positions not immediately adjacent to 
the central ‘core’) does not have major effects on the intrinsic rate of cleavage, 
described by 2k  in Figure 1B. This conclusion stems from the detailed comparison 
between Dz122 and Lz122 (Table 1) as well as from data on the Dz32/Lz32 and 
Dz163/Lz163 couples (see legend of Table 2). The point is not trivial, as previous 
studies suggested that alterations in the helices formed by the 8-17 arms could 
substantially affect catalysis (Li, 2000; Liu, 2004). 
On the other hand, the comparison between Dz122 and Lz122 confirms that 
LNA monomers enhance binding of the deoxyribozyme to its target, raising the 
thermodynamic stability of the enzyme-substrate complex in consistency with 
published studies on short LNA-containing duplexes (Singh, 1998; Singh, 1998, 
Bondensgaard, 2000). In principle, this effect could partially arise from an 
improvement in hybridization kinetics, because the association rate constant ( 1k ) for 
the unmodified 8-17 is about 10-fold lower the constants typical for the annealing of 
short complementary oligonucleotides (Bonaccio, 2004; Santoro, 1998; Joyce, 2001).  
However, 1k  values for Lz122 and Dz122 were very similar, in agreement with 
previous indications that LNAs do not accelerate substantially the hybridization 
between short, unstructured oligos (Christensen, 2001). Thus, the LNA-mediated 
increase in binding affinity can be attributed almost entirely to slowed-down kinetics 
of substrate release (Table 1). 
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The higher substrate affinity of the LNAzymes means that they can saturate 
their substrates and reach maximum catalytic efficiency at much lower concentrations 
than DNAzymes having the same sequence. For example, Figure 6A shows that, in 
reactions carried out at 1 nM enzyme, Lz122 is about tenfold more efficient than 
Dz122 in cleaving a minimal substrate. This gap is predicted to become even wider if 
lower concentrations of catalyst were used: the maximum difference in kobs 
(attainable at enzyme concentrations well below the SK  of Lz122) is predicted to be 
~30-fold, directly mirroring the difference in affinity between LNAzyme and DNAzyme 
(Figure 6A). 
 It is very likely that the 10-23 LNAzyme constructs described in previous 
studies (Vester, 2002; Schubert, 2003; Fahmy, 2004; Schubert, 2004; Fluiter, 2005; 
Vester, 2006; Jakobsen, 2007) behave similar to Lz122. The lower concentration 
requirements may explain, for example, earlier data showing that the activity of 10-23 
against a short RNA substrate was improved by including LNA monomers within the 
deoxyribozyme arms (Vester, 2002). In fact those data were collected at nanomolar 
concentrations of catalyst – that is, under conditions that presumably did not allow 
efficient substrate binding by the all-DNA construct, but permitted a stable binding 
and cleavage by the LNAzyme. 
 
LNAzyme advantages in the cleavage of long, structured substrates 
In the presence of long substrates, the disparity in performance between 
DNAzymes and LNAzymes is impressive, and does not seem to simply reflect the 
diverse binding affinities for the two types of catalysts. In particular, we just noted that 
the difference in activity between Dz122 and Lz122, predicted from experiments with 
a minimal substrate and attributable to the relative binding affinities, should be at 
most ~30-fold. The actual difference observed against the long transcripts, however, 
greatly exceeds this value (Table 2, left). More fundamentally, the differences in 
substrate binding affinities ( SK ) or in substrate dissociation rates ( 1−k ) would not 
explain why the performance gap between DNAzymes and LNAzymes depends on 
the reaction protocol, i.e. why cleavage of the E6 RNA by the DNAzymes (but not 
LNAzymes) is improved by pre-annealing the catalysts to their targets (Table 2).  
When DNAzymes and LNAzymes are reacted with the fully folded E6 
transcript (i.e., under Protocol A conditions), the local RNA structure represents a 
kinetic barrier to binding of the catalysts, which is expected to slow down the 
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association process; under this condition, LNAzymes performed well, whereas the 
activity of DNAzymes was hardly measurable. The heating and cooling step in 
protocol B allows a direct access of the catalysts to their target sequences, removing 
at least in part the initial kinetic barrier to association; in this case, Dz32, Dz122 and 
Dz163 showed a substantially increased activity (Table 2). Hence, our data suggest 
that annealing to a folded substrate is kinetically much more difficult for DNAzymes 
than for LNAzymes. Put another way, the data in table 2 suggest that LNAzymes 
bind to structured targets with a faster association rate ( 1k ) as compared to 
DNAzymes.  
This conclusion is not completely unexpected. Previous studies on 10-23 
constructs had implicitly suggested that LNA facilitates the kinetics of deoxyribozyme 
annealing to structured RNA (Vester, 2002; Schubert, 2004; Vester, 2006). 
Moreover, in contrast with earlier results obtained with short, unstructured oligos 
(Christensen, 2001), Ormond et al. recently showed that the hybridization between 
structured oligonucleotides (i.e., oligos forming an intramolecular stem-loop) could be 
accelerated by including a few LNA residues in one of the two complementary 
strands (Ormond, 2006).  
 
A model for LNAzymes reacting with structured substrates 
LNA did not greatly affect the kinetics of 8-17 binding to a short substrate, so 
why should things be different with long, folded RNAs? Binding of a DNAzyme to a 
structured target is almost certainly a more complex phenomenon than annealing to 
a minimal substrate, and presumably occurs through the formation of intermediates 
in which the hybridization is only partially complete (Reynaldo, 2000; Walton, 2002). 
For example, a simple two-step model can be envisaged, whereby the enzyme 
initially base-pairs to a stretch of just a few accessible residues (nucleation), after 
which the hybridization proceeds to completion, leading to disruption of the local RNA 
secondary structure (Figure 8). 
Analogous models have been suggested before in other systems. For 
example, while this paper was in preparation, a model very similar to the one in 
Figure 5 was proposed to explain the binding of microRNAs to their target sequences 
within structured mRNAs; the model was also shown to account accurately for a 
series of in vivo results (Long, 2007). MicroRNAs and deoxyribozymes are both short 
oligonucleotides with an extended, but not perfect, complementarity to their targets, 
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thus it seems reasonable that their binding mechanisms may share several common 
features. 
 
Figure 8. A schematic model for the binding of DNAzymes and LNAzymes to target 
sequences embedded in large, structured RNAs. In principle, the catalyst may bind to its 
target when the target sequence becomes completely accessible, thanks to a local unfolding 
event (e.g., the occasional fraying of a double helix; upper pathway). Binding to a fully 
accessible target, however, is presumably very rare in the context of a large mRNA, at 
physiological temperatures. More often, complete hybridization of the catalyst may entail 
formation of binding intermediates, which precede and favor the disruption of the local mRNA 
structure. For example, the enzyme might initially form interactions with a few unpaired 
nucleotides on the target (‘nucleation’; lower pathway). Such interactions would be 
particularly stable for LNA-armed catalysts, thereby promoting a more efficient disruption of 
the local structure and a faster completion of binding. Note that other types of intermediates 
(e.g., triple-stranded species) might be formed during the initial nucleation events: whatever 
the nature of these transient intermediates, their stabilization might ease the overall binding 
process. 
 
The two-step model offers an explanation as to why LNAzymes can bind faster 
than DNAzymes to structured targets. In fact, normal DNAzymes would form 
relatively weak interactions in the initial nucleation complex, so that the catalyst 
would generally fall off before completing the hybridization process. For the 
LNAzymes, however, nucleation would yield a more stable binding intermediate, 
providing a bridgehead for the invasion of the nearby structure and therefore 
promoting a faster formation of the catalyst-substrate complex. Once formed, this 
complex would be more stable than the corresponding DNAzyme-substrate complex 
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(due to the intrinsically lower 1−k ), thus reducing the chances that the catalyst may 
dissociate before cleaving. 
While the model in Figure 8 certainly needs to be further refined and tested, it 
represents a useful starting point for future mechanistic analyses. The model has 
implications not just for LNAzymes, but also, more generally, for oligonucleotides 
containing residues that form especially strong basepairs with RNA – be they LNA, 
2’-O-methyl nucleotides or other monomers. The model predicts that, broadly 
speaking, these modified oligonucleotides will bind to structured RNA at a faster rate 
as compared to unmodified oligos. The actual extent of acceleration would 
presumably depend on factors such as the number and location of the modified 
monomers within the oligonucleotide. 
 
Multiple turnover and specificity issues 
The data obtained in this work demonstrate the advantages of introducing LNA 
monomers in the deoxyribozyme arms. In principle, however, the use of LNAzymes 
may be disadvantageous under some conditions. 
In particular, LNA-armed deoxyribozymes are expected to interact strongly 
with the cleavage products - a feature that may decrease the reaction rate under 
multiple turnover conditions. This problem, however, should arise only when the 
deoxyribozyme arms contain a high number of LNA monomers. Indeed, recent 
studies have shown that LNAzymes containing just two LNA monomers on each arm 
(similar to Dz122) function usually better than plain DNAzymes under multiple-
turnover conditions (Vester, 2006, Jakobsen, 2007).  
The possibility of off-target binding is also an important concern. In fact, LNA 
monomers could favor annealing of a deoxyribozyme not only to the intended target, 
but also to sequences that differ from the target by just a few nucleotides. 
Nevertheless data in the literature suggest that mismatches involving LNA monomers 
are not more stable than normal mismatches (You, 2006) and that, in general, LNA 
improves the single-nucleotide mismatch discrimination with respect to that obtained 
with DNA (You, 2006; Mouritzen, 2003). We also note that the LNAzymes used in 
this study showed no sign of off-target cleavage within the E6 mRNA (Figure 7A) or 
the E6E7 mRNA (not show). 
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Conclusions 
We have analyzed in detail the kinetic and thermodynamic properties of LNA-
containing deoxyribozymes, highlighting the mechanistic differences between these 
catalysts and their all-DNA counterparts. Overall, the results of this work emphasize 
that the advantageous features of LNAzymes become fully manifest when performing 
reactions at low catalyst concentrations, at low magnesium concentrations and 
against large, structured RNAs. These are exactly the conditions that are expected to 
occur in cells, helping to explain why LNA-armed deoxyribozymes have proven 
substantially superior to conventional DNAzymes for the knockdown of specific 
mRNAs in vivo (Fahmy, 2004; Jakobsen,2007). 
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